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Abstract 
Eating and maintaining optimal nutrition are essential to health and quality of life. In both 
health and disease, eating is influenced by multiple factors including swallowing, oral health, 
and saliva production. Perturbations to any, or all, of these inter-related factors may result in 
consequences that negatively affect the health and wellness of an individual. Eating and 
swallowing impairment are common symptoms of neurodegenerative diseases such as 
dementia, and these symptoms are associated with a host of negative sequelae such as 
malnutrition, dehydration, aspiration pneumonia, and reduced quality of life. The studies 
reported in this dissertation explored elements of eating and swallowing, saliva production, 
and saliva modulation in healthy individuals and in persons with Alzheimer’s disease (AD).  
This dissertation is composed of three studies. First, a scoping review methodology was used 
to examine literature that addressed autonomic nervous system and/or swallowing 
dysfunction in individuals with AD. Then, systematic review and meta-analysis 
methodologies were used to examine a potential effect of aging on saliva production. Finally, 
a within-subjects methodology was used to examine the modulation of salivary flow by tooth 
brushing in healthy older adults.  
In the first study, swallowing dysfunction and autonomic nervous system dysfunction, 
including salivary flow dysfunction, were found to occur in persons with AD. In the second 
study, salivary flow was found to be reduced in adults aged 60 years and older who were free 
of major systemic disease. In the third and final study, the use of manual and electric tooth 
brushing was found to increase whole salivary flow rates in adults aged 60 years of age and 
older who were free of major systemic disease.  
The results of this dissertation have very important implications for the future research and 
management of eating and swallowing, oral health, and saliva production in a variety of 
populations, including aging individuals and persons with AD.  
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Chapter 1  
1 Introduction 
1.1 Eating 
The ability to eat in order to meet one’s metabolic requirements is a basic human need 
(Maslow, 1954), an integral part of homeostatic regulation (Langhans & Geary, 2010), 
and fundamental to survival. Eating and maintaining optimal nutrition are essential to 
health (Waxman & World Health Assembly, 2004) and quality of life (Vailas, Nitzke, 
Becker, & Gast, 1998). Being unable to eat results in dietary imbalances, which are 
known to contribute to disease (Waxman & World Health Assembly, 2004), as well as 
malnutrition, which can result in physical, mental, and social disability (La Rue et al., 
1997; Muhlethaler, Stuck, Minder, & Frey, 1995). The inability to eat often results in an 
individual receiving nutrition via another route, such as parenterally (intravenous 
nutrition) or enterally (tube feeding). Even when other routes are used to provide 
nutrition, however, the inability to eat significantly detracts from an individual’s quality 
of life (Winkler, 2005). 
Eating disability, or the inability to eat, may occur as a symptom of many neurologic 
(Bakke, Moller, Thomsen, Dalager, & Werdelin, 2007; Benfer et al., 2014), anatomic 
(Patterson, McColl, Wilson, Carding, & Rapley, 2015), or psychological conditions and 
diseases (Baijens, Koetsenruijter, & Pilz, 2013). Eating impairment is a common 
symptom of neurodegenerative conditions such as dementia (Affoo, Foley, Rosenbek, 
Shoemaker, & Martin, 2013) and may be characterized by distraction during meals, 
refusal to eat, agitation/aggression at mealtimes, using food as nonfood play objects, 
expectorating food/refusing to swallow, inability to masticate, choking, or aspiration 
(Durnbaugh, Haley, & Roberts, 1996; Morris, Hope, & Fairburn, 1989; Priefer & 
Robbins, 1997). 
There are several physiological components that are fundamental to eating. Eating 
involves transportation of food and fluid to the mouth, salivary secretion in order to 
lubricate the mouth and initiate chemical digestion of starches, preparation of the material 
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in the oral cavity such as mastication of solid food material, and swallowing to transport 
food or fluid from the mouth to the stomach (Miller, 2013). 
1.2 Swallowing 
Swallowing is a fundamental component of eating and is the process by which saliva, 
food, and fluid is safely transported from the mouth to the stomach. Swallowing involves 
the integration of volitional and sensorimotor events. The process begins with the 
preparation and softening of food or fluid into a bolus through mastication and 
manipulation in the oral cavity. During this process, the salivary glands secrete saliva into 
the oral cavity, which initiates the process of chemical digestion. Once formed, the bolus 
is propelled through the oral cavity towards the pharynx and the ascending sensory 
information associated with preparing and transporting the bolus trigger the pharyngeal 
phase of swallowing. A complex and coordinated series of muscular contractions results 
in airway closure and movement of the bolus through the pharynx and into the 
esophagus, where it is eventually transported to the stomach (Matsuo, 2013). 
1.3 Dysphagia 
The term dysphagia refers to deficits in transporting saliva, food, or fluid from the mouth 
to the stomach (Logemann, 1998). Dysphagia is a symptom of many congenital 
abnormalities, acquired neurologic or physical dysfunctions, progressive degeneration, 
and psychiatric disorders (Murry, 1999) and often contributes to impaired eating in these 
populations. A host of negative physiological consequences are associated with 
dysphagia, such as dehydration (Whelan, 2001), and malnutrition (Namasivayam & 
Steele, 2015). Dysphagia may lead to aspiration, which is the misdirection of 
oropharyngeal or gastric contents into the larynx and lower respiratory tract. Aspiration is 
associated with aspiration pneumonia, which occurs when bacteria colonize the 
misdirected contents and infect the lung (Marik, 2001), and results in suboptimal patient 
outcomes and increased mortality (Foley, Affoo, & Martin, 2014). Dysphagia and eating 
impairment often lead to an increased sense of isolation and loss of self-esteem, 
avoidance of social eating situations, and anxiety or panic during mealtimes (Ekberg, 
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Hamdy, Woisard, Wuttge-Hannig, & Ortega, 2002), all of which negatively impact a 
person’s social and psychological well being, and quality of life. 
Estimates of the prevalence of dysphagia vary by setting, population, disease state, 
country, and manner in which dysphagia is assessed. The prevalence of self-reported 
dysphagia in primary care patients has been found to be 22% (Wilkins, Gillies, Thomas, 
& Wagner, 2007). Dysphagia prevalence has been reported anywhere from 0.35% to 55%  
in the acute care in-patient setting (Altman, Yu, & Schaefer, 2010; Cabre et al., 2010) and 
68% in long-term care (Steele, Greenwood, Ens, Robertson, & Seidman-Carlson, 1997). 
Up to 78% of individuals experience dysphagia after a stroke (Martino et al., 2005), 
between 35% and 82% of persons with Parkinson’s disease have dysphagia (Kalf, de 
Swart, Bloem, & Munneke, 2012), and the prevalence of dysphagia in individuals with 
Alzheimer’s disease is anywhere from 45% to 93% (Affoo et al., 2013). 
1.4 Oral Health  
The oral health of an individual is defined as “a state of being free of mouth and facial 
pain, oral and throat cancer, oral infection and sores, birth defects such as cleft lip and 
palate, periodontal disease, tooth decay and tooth loss, and other disease and disorders 
that limit an individual’s capacity in biting, chewing, smiling, speaking, and 
psychological wellbeing” (WHO, 1992). The relationship between oral health and overall 
health is complex, however, links between poor oral health and oral preparatory and oral 
stage dysphagia (Liedberg & Owall, 1991), malnutrition (Daly, Elsner, Allen, & Burke, 
2003; Poisson, Laffond, Campos, Dupuis, & Bourdel-Marchasson, 2014), aspiration 
pneumonia (Langmore et al., 1998), and increased mortality from pneumonia (Awano et 
al., 2008) have been documented.  
1.5 Saliva 
One essential component necessary for adequate oral health is salivary flow. Saliva is 
important for maintaining oral and general health (Mandel, 1989) and has many and 
varied functions including protection against mechanical, thermal and chemical irritation, 
reducing demineralization and facilitating remineralization of the teeth, facilitating 
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antimicrobial actions and clearance of bacteria, initiating chemical digestion, and 
facilitating taste (Whelton, 2004). 
Saliva production is often limited by disease or pharmaceutical use (Sreebny, 2000). 
Reduced saliva production results in rapid deterioration of oral health and increased 
bacterial colonization in the oral cavity. Many of the diseases and disorders associated 
with dysphagia may also be associated with reduced salivary flow. Additionally, 
individuals with reduced salivary flow may experience dysphagia (Poisson et al., 2014).  
In an individual experiencing hyposalivation and associated increased bacterial 
colonization and oral pathology, the co-occurrence of dysphagia may increase the risk of 
the individual aspirating bacteria-rich oral contents and developing aspiration pneumonia 
(Ortega et al., 2014). Aspiration pneumonia is associated with increased risk of mortality 
in certain populations (Foley et al., 2014). Thus, there appears to be a critical relationship 
between factors associated with eating and swallowing function, oral health, and saliva 
production. Perturbations to any, or all, of these factors may result in consequences that 
negatively affect the health and wellness of an individual (Figure 1). 
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Figure 1. Inter-Related Factors Associated with Impaired Eating and Swallowing, 
Oral Health, Saliva Production, and Respiratory Health 
1.6 Alzheimer’s Disease 
Alzheimer’s disease (AD) and other dementias are a growing epidemic in Canada. 
Alzheimer’s disease currently affects approximately 747,000 Canadians. This number is 
expected to nearly double to 14 million Canadians by 2031 (Alzheimer Society of 
Canada, 2012). Dysphagia (Affoo et al., 2013), poor oral health (Foley, Affoo, Siqueira, 
& Martin, 2015 unpublished), and reduced saliva production (Ship, DeCarli, Friedland, & 
Baum, 1990; Ship & Puckett, 1994) have been reported in individuals with AD. There is 
also evidence to suggest that this population is at increased risk of pneumonia-associated 
mortality (Foley et al., 2014), and it is well documented that pneumonia is the primary 
cause of mortality in AD (Beard et al., 1996). Therefore, in individuals with AD, it 
appears that impairments in eating and swallowing, oral health, and saliva production 
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together increase the risk of morbidity, including aspiration pneumonia, as well as 
suboptimal health outcomes and mortality (Figure 2).  
 
Figure 2: Proposed Model of the Relationship between Reduced Salivary Flow, Poor 
Oral Health, Dysphagia, and Suboptimal Outcomes 
1.7 Eating and Swallowing, Oral Health, and Saliva 
Production 
Eating and swallowing, oral health, and saliva production are crucial factors for 
maintaining a person’s overall health and an optimal quality of life (Sreebny & Vissink, 
2010; Vailas et al., 1998; Waxman & World Health Assembly, 2004; WHO, 1992). 
While published evidence suggests that these factors are inter-related in both health and 
disease, there is a paucity of evidence that has explored these factors and their potential 
relationships. Generating new knowledge of these factors and the relationships between 
them has the potential to positively impact health care provision for a variety of patient 
populations, including older adults and persons with dementia. Thus, the goal of the 
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present research was to broaden current understanding of eating and swallowing function 
and dysfunction, saliva production, and saliva modulation.  
Three studies were conducted as part of this dissertation. In the first, eating and 
swallowing dysfunction and autonomic nervous system dysfunction, including salivary 
flow dysfunction, were examined in individuals with AD through a scoping review.  In 
addition to gaining a better understanding of the current knowledge on eating and 
swallowing impairment and autonomic nervous system impairment in individuals with 
AD, the study identified gaps in the literature. One gap that was identified pertained to 
the rate of saliva production, or salivary flow rate, in individuals with AD. Saliva, a 
secretion crucial for maintaining oral homeostasis and for completing the oral preparatory 
and oral phases of swallowing, may be reduced as part of the disease process. This 
finding led us to question whether salivary flow rate is reduced as a function of aging.  
In the second study in this dissertation, published literature examining salivary flow rate 
in adults of different ages was reviewed, described, and meta-analyzed in order to 
determine whether aging is associated with a change in saliva production. We found that, 
despite conflicting findings previously recorded in the literature, unstimulated and 
stimulated whole and submandibular/sublingual salivary flow rates were decreased in 
adults aged 60 years and older compared with younger adults aged 18 to 40 years.  
Given that saliva is important for maintaining oral and general health (Mandel, 1989) and 
salivary flow rates have been found to be decreased in older adults compared with 
younger adults, it would be beneficial to elucidate whether salivary flow rates in older 
individuals can be modulated. One approach to modulating salivary flow rates is to use 
sensory stimulation. Previous studies examining the effects of sensory stimulation in the 
oral cavity have found that oral stimulation is associated with increased salivary flow 
rates (Karami Nogourani, Janghorbani, Kowsari Isfahan, & Hosseini Beheshti, 2012; 
Ligtenberg, Brand, Bots, & Nieuw Amerongen, 2006; Papas et al., 2006). Therefore, in 
the third study in this dissertation, the potential effects of manual and electric tooth 
brushing on whole salivary flow rates were examined in adults 60 years of age and older 
who were free of major systemic disease. We found that tooth brushing stimulates saliva 
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production for up to 5 minutes. A moderate, positive correlation was observed between 
age and maximum salivary flow rate increase associated with tooth brushing. 
The knowledge generated from the three studies presented in this dissertation has the 
potential to improve the current understanding of oral physiology and inform the design 
of future research. It also has important implications for preventative, acute, and 
rehabilitative care for a number of patient populations, including aging individuals and 
individuals with dementia.  
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Chapter 2  
2 Swallowing Dysfunction and Autonomic Nervous 
System Dysfunction in Alzheimer’s Disease: A Scoping 
Review of the Evidence 
This scoping review aims to describe, synthesize, and interpret literature on swallowing 
impairment (dysphagia) and autonomic nervous system (ANS) dysfunction in 
Alzheimer’s disease (AD), and to identify gaps in the existing literature*.   
2.1 Introduction 
Alzheimer’s disease (AD) is a neurodegenerative condition marked by cognitive and 
behavioural decline (Wimo et al., 2013). Currently, AD affects more than 3.4 million 
North Americans and its incidence is expected to exceed 5.5 million by 2030 
(Alzheimer's Association, 2013; Rising tide: The impact of dementia on Canadian 
society, 2010). People with AD experience significant eating problems, particularly as the 
disease progresses (Njegovan, Hing, Mitchell, & Molnar, 2001). Although these eating 
problems arise from deficits across a range of dimensions, swallowing impairment 
(dysphagia) may be a critical factor; however, its impact is unknown. Understanding the 
contribution of dysphagia to altered eating in AD is especially important since the risk of 
AD increases with age and dysphagia in the elderly is associated with increased 
morbidity, including pneumonia (Loeb, McGeer, McArthur, Walter, & Simor, 1999) and 
malnutrition (Serra-Prat et al., 2012), and mortality (Groher & Crary, 2010).  
Swallowing is regulated by both the somatic-voluntary nervous system and the 
autonomic nervous system (ANS) (Jean, 2001; Miller, 1999). The somatic-voluntary 
nervous system plays a fundamental role in the voluntary oral preparatory and oral stages 
of swallowing, during which ingested material is formed into a bolus and transported 
posteriorly across the tongue surface (Miller, 1999). The somatic-voluntary and ANS 
                                                
*
 A version of this chapter has been published (Affoo et al., 2013) 
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mediate the semi-automatic pharyngeal stage, during which the bolus is transported 
through the pharynx as the airway closes to protect against entry of material into the 
lower respiratory tract (Miller, 1999). The ANS then regulates contraction of the smooth 
muscle esophagus during the esophageal stage of swallowing (Miller, 1999). However, 
both animal and human studies have documented ANS involvement in all stages of 
swallowing, including salivary secretion required for the oral breakdown and lubrication 
of ingested material (Stuchell & Mandel, 1988), sensory processing of laryngeal and 
esophageal inputs necessary for swallowing (Aziz et al., 2000; Kalia & Mesulam, 1980), 
and esophageal peristalsis (Camilleri, 2004). 
The AD literature has focused primarily on the voluntary nervous system, as documented 
by several systematic reviews (Marlatt & Lucassen, 2010; Nordberg, Rinne, Kadir, & 
Langstrom, 2010).  Nevertheless, ANS dysfunction in AD has been reported, although 
systematic reviews are lacking (Lampe et al., 1989; Otsuka et al., 1990). 
Given (i) the probability that swallowing impairment contributes to eating problems in 
AD, (ii) that ANS mechanisms play a fundamental role in swallowing regulation, and (iii) 
ANS dysfunction occurs in AD, a broad literature review examining dysphagia and ANS 
dysfunction in AD could provide important insights into these deficits and their potential 
associations.  
The objectives of this study were to (i) describe, synthesize, and interpret literature on 
dysphagia/ANS dysfunction in AD, and (ii) identify gaps in the existing literature, 
utilizing a scoping review, a technique aimed at mapping relevant literature in a broad 
field of interest where several study designs may be represented (Arksey & O'Malley, 
2005; Landa, 2011). 
2.2 Methodology 
Relevant studies were identiﬁed through a literature search encompassing the years 1978 
to July 2012. Three searches of the PubMed, EBSCOhost, PsychINFO, Cochrane, 
EMBASE, and Scopus databases were conducted to identify studies of (i) dysphagia in 
AD, (search terms: dementia, Alzheimer’s disease, swallowing, deglutition disorders, 
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aspiration pneumonia, choking, and dysphagia) (ii) ANS dysfunction in AD, (search 
terms: dementia, Alzheimer’s disease, autonomic nervous system, parasympathetic 
nervous system, sympathetic nervous system), and (iii) dysphagia and ANS dysfunction 
in AD, combining the search terms above.  Reference lists of the retrieved articles were 
manually searched. 
The inclusion criteria were:  (i) clinical studies, (ii) physiological reports (including 
neuroanatomical studies) wherein any portion of the sample met the study author’s 
criteria for having AD, and ANS dysfunction or dysphagia was examined; (iii) reviews, 
(iv) commentaries, or (v) case studies of dysphagia or ANS dysfunction in AD, and (vi) 
English language studies. Animal studies, human trials examining pharmacological 
treatment effects on dysphagia/ANS dysfunction, and studies on cerebral hemodynamics 
were excluded. Two reviewers (RA and RM) evaluated the surviving literature.   
Clinical and physiological reports were evaluated using the Oxford Centre for Evidence-
Based Medicine Levels of Evidence† ("CEBM Levels of Evidence," 2009) (OCEBM) 
criteria. Where possible, studies were classified as:  treatment/prevention, prognosis, 
diagnosis, prevalence, or decision making/economic evaluation. Following 
categorization, the literature was synthesized and interpreted by the same two reviewers 
in order to form conclusions and identify knowledge gaps. Results were categorized and 
analyzed according to topics identified post hoc. 
One expert in each of the fields of dysphagia, ANS physiology, and epidemiology was 
then consulted to verify the completeness of the literature retained for final review, to 
identify references that were not captured in the searches, and to comment on the 
appropriateness of the literature synthesis, interpretation, and gap identification. 
2.3 Results 
The initial search returned 7,422 results of which 95 met the study criteria and were 
reviewed (Figure 3). Summaries of all the included articles can be found in Appendix A –
                                                
†
 CEBM Levels of Evidence 2009 (online). Available at http://www.cebm.net/index.aspx?o=1025 
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D. Thirty-one studies examined dysphagia in AD, 64 examined ANS dysfunction in AD. 
No studies were identified that examined both dysphagia and ANS dysfunction in AD. 
 
Figure 3. Flow Chart of Scoping Review 
2.3.1 Diagnosis of Alzheimer’s Disease 
Eighty clinical reports addressed either dysphagia or ANS dysfunction in AD. In 56 of 
these, the diagnosis of AD was based on (i) the National Institute of Neurological and 
Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders 
Association (NINCDS-ARDRA) diagnostic criteria (Algotsson, Nordberg, Almkvist, & 
Winblad, 1995; Algotsson, Viitanen, Winblad, & Solders, 1995; L. Allan, McKeith, 
Ballard, & Kenny, 2006; L. M. Allan et al., 2007; L. M. Allan, Ballard, Rowan, & 
Kenny, 2009; L. M. Allan et al., 2005; Andersson, Hansson, Minthon, Ballard, & 
Londos, 2008; Benedetti et al., 2004; Durnbaugh et al., 1996; Elmstahl et al., 1992; 
Elmstahl & Winge, 1993; Fotiou et al., 2009; Franceschi, Ferini-Strambi, Minicucci, 
Sferrazza-Papa, & Smirne, 1986; Horner, Alberts, Dawson, & Cook, 1994; Idiaquez, 
Alvarez, Villagra, & San Martin, 1994; Idiaquez, Rios, & Sandoval, 1997; Idiaquez, 
Sandoval, & Seguel, 2002; Ikeda, Brown, Holland, Fukuhara, & Hodges, 2002; Pascualy 
et al., 2000; Rainero, Vighetti, Bergamasco, Pinessi, & Benedetti, 2000; Ransmayr et al., 
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2008; Shinagawa et al., 2009; Ship et al., 1990; Taki, Yoshita, Yamada, & Tonami, 2004; 
Vitiello et al., 1993; Wada et al., 2001; Watanabe et al., 2001; Zakrzewska-Pniewska, 
Gawel, Szmidt-Salkowska, Kepczynska, & Nojszewska, 2012), (ii) the Diagnostic and 
Statistical Manual of Mental Disorders (DSM) III or IV criteria (Borson, Barnes, Veith, 
Halter, & Raskind, 1989; Davidson, Borrie, & Crilly, 1991; Del-Ser, Munoz, & 
Hachinski, 1996; Guo, Viitanen, Fratiglioni, & Winbland, 1998; Lampe et al., 1989; 
Morris et al., 1989; Raskind, Peskind, Halter, & Jimerson, 1984), (iii) both the NINCDS-
ARDRA and DSM-III/IV criteria (Aharon-Peretz, Harel, Revach, & Ben-Haim, 1992; 
Ahlskog et al., 1996; de Vilhena Toledo & Junqueira, 2008; Jhee, Sramek, Wardle, & 
Cutler, 1995; Mehrabian et al., 2010; Passant, Warkentin, & Gustafson, 1997; Peskind et 
al., 1998; Peskind et al., 1995; Toledo & Junqueira, 2010; Volicer et al., 1989; S. J. Wang 
et al., 1994; Zulli et al., 2005), or (iv) neuropathology (Andin, Passant, Gustafson, & 
Englund, 2007; Bonthius, Solodkin, & Van Hoesen, 2005; Burke, Coronado, Schmitt, 
Gillespie, & Chung, 1994; Chu, Tranel, Damasio, & Van Hoesen, 1997; Orimo et al., 
2005; Rub et al., 2001; Shankle et al., 1993; Wakabayashi et al., 1999). Five (5) of the 
studies used the NINCDS-ARDRA criteria as well as a score of < 5 on Hachinski’s Index 
to rule out vascular pathology (Hornqvist, Henriksson, Back, Bucht, & Winblad, 1987; 
Humbert et al., 2010; Humbert, McLaren, Malandraki, Johnson, & Robbins, 2011; 
Otsuka et al., 1990; Priefer & Robbins, 1997). The remaining nineteen (19) studies 
reported physician-specific diagnostic criteria (Bautmans, Demarteau, Cruts, Lemper, & 
Mets, 2008; Chouinard, Lavigne, & Villeneuve, 1998; Edahiro et al., 2012; Eisdorfer & 
Cohen, 1978; Feinberg, Ekberg, Segall, & Tully, 1992; Logemann et al., 2008; Robbins 
et al., 2008; Suh, Kim, & Na, 2009) or did not report diagnostic criteria (Bordier, Colsy, 
Robert, & Bourenane, 2007; Burge, 1994; Choi, Kim, & Kim, 2009; Correia, 2010; 
Garon, Sierzant, & Ormiston, 2009; Grunberger et al., 1999; Khurana & Garcia, 1981; 
Mizushima, 2005; Suski & Nielsen, 1989; Szili-Torok et al., 2001). 
2.3.2 Dysphagia in Alzheimer’s Disease 
Thirty-one studies addressed dysphagia in AD, including identification of dysphagia 
(n=11), descriptions of swallowing difficulties (n=22), and treatment (n=3) (Figure 3). Of 
22 clinical reports, nine employed an instrumental assessment of swallowing in 
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individuals with AD. Seven studies used videofluoroscopic swallow studies (VFSS) 
(Feinberg et al., 1992; Garon et al., 2009; Horner et al., 1994; Humbert et al., 2010; 
Humbert et al., 2011; Priefer & Robbins, 1997; Suh et al., 2009) and two used 
electromyography (EMG) following water injection into the pharynx (Mizushima, 2005; 
Wada et al., 2001). In contrast, 10 clinical reports employed a clinical evaluation of 
dysphagia or feeding difficulties (Burge, 1994; Chouinard et al., 1998; Correia, 2010; 
Durnbaugh et al., 1996; Edahiro et al., 2012; Ikeda et al., 2002; Morris et al., 1989; 
Shinagawa et al., 2009; Suski & Nielsen, 1989; Volicer et al., 1989) including 
observation at mealtimes, caregiver interview, and questionnaire. Three studies examined 
the treatment of dysphagia in AD (Bautmans et al., 2008; Logemann et al., 2008; Robbins 
et al., 2008). 
2.3.2.1 Dysphagia in Alzheimer’s Disease: Oxford Centre for 
Evidence-Based Medicine Levels of Evidence (OCEBM) 
Classification using the OCEBM system was possible for eight studies of dysphagia in 
AD (Tables 1–3). 
2.3.2.2 Studies Employing Instrumental Assessment of Swallowing 
in Alzheimer’s Disease 
The nine studies (Feinberg et al., 1992; Garon et al., 2009; Horner et al., 1994; Humbert 
et al., 2010; Humbert et al., 2011; Mizushima, 2005; Priefer & Robbins, 1997; Suh et al., 
2009; Wada et al., 2001) that employed instrumental assessment of swallowing in AD 
provide preliminary evidence to support the following conclusions: 
1. The prevalence of dysphagia in moderate-to-severe AD is 84% (Horner et al., 1994) to 
93% (Feinberg et al., 1992). Only one study failed to identify significant swallowing 
dysfunction in AD (Mizushima, 2005); it examined swallow-related and cough-related 
EMG responses to graded volumes of water injected into the pharynx through a nasal 
catheter.  
2. Dysphagia may occur early in AD. Three studies using VFSS documented swallowing 
alterations in small groups of patients with mild AD, compared with healthy age-matched 
controls (Humbert et al., 2010; Humbert et al., 2011; Priefer & Robbins, 1997). 
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3. Dysphagia occurring early in AD may be associated with functional changes in the 
cortical swallowing network (i.e., pre- and post-central gyrus, and frontal and Rolandic 
operculum) as measured with functional magnetic resonance imaging (fMRI) (Humbert 
et al., 2010; Humbert et al., 2011; Priefer & Robbins, 1997). 
4. The oral and pharyngeal stages of swallowing may be affected in AD (Feinberg et al., 
1992; Garon et al., 2009; Horner et al., 1994; Humbert et al., 2010; Humbert et al., 2011; 
Priefer & Robbins, 1997; Suh et al., 2009; Wada et al., 2001). Oral deficits include 
prolonged bolus preparation and oral transit times. Pharyngeal deficits include delayed 
pharyngeal swallow initiation, reduced hyo-laryngeal excursion, laryngeal penetration, 
tracheal aspiration, and pharyngeal residue post swallow. 
5. Dysphagia severity and AD severity may be associated. One study (Wada et al., 2001) 
reported that subjects with severe AD demonstrated greater pharyngeal swallow delay 
than patients with mild and moderate AD. Another study (Horner et al., 1994) identified a 
non-significant trend wherein subjects with lower Mini-Mental State Examination 
(MMSE) scores had more severe dysphagia.  
Table 1. Clinical Reports Employing Instrumental Assessment of Swallowing in 
Alzheimer's Disease (AD) 
Conclusion Supporting 
Studies 
Study Description Level of 
Evidence 
Prevalence of 
dysphagia in AD 
Horner et al. 
1994 
Prospective Case Series 4 
Feinberg et al. 
1992 
Retrospective Cohort 2b 
Mizushima et al. 
2005 
Described/characterized dysphagia in AD 
through comparison of two or more groups 
of individuals 
NA 
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Dysphagia occurs 
early in AD 
Humbert et al. 
2010 
Described/characterized dysphagia in AD 
through comparison of two or more groups 
of individuals 
NA 
Priefer & 
Robbins 1997 
Humbert et al. 
2011 
Dysphagia in early 
AD may be 
associated with 
functional change 
of the cortical 
swallowing 
network 
Humbert et al. 
2010 
Described/characterized dysphagia in AD 
through comparison of two or more groups 
of individuals 
NA 
Humbert et al. 
2011 
Dysphagia occurs 
in both the oral 
and pharyngeal 
phases of 
swallowing 
Garon et al. 
2009 
Retrospective Cohort 2b 
Horner et al. 
1994 
Prospective Case Series 4 
Suh et al. 2009 Described/characterized dysphagia in AD 
through comparison of two or more groups 
of individuals 
 
NA 
 Wada et al. 2001 
Priefer & 
Robbins 1997 
Humbert et al. 
2010 
Disease severity Wada et al. 2001 Described/characterized dysphagia in AD NA 
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may be associated 
with dysphagia 
severity 
through comparison of two or more groups 
of individuals 
Horner et al. 
1994 
Prospective Case Series 4 
NA = not applicable. See Appendix A for more details.  
2.3.2.3 Studies Employing Subjective Assessment of Swallowing in 
Alzheimer’s Disease 
Eleven studies (Burge, 1994; Chouinard et al., 1998; Correia, 2010; Durnbaugh et al., 
1996; Edahiro et al., 2012; Ikeda et al., 2002; Morris et al., 1989; Priefer & Robbins, 
1997; Shinagawa et al., 2009; Suski & Nielsen, 1989; Volicer et al., 1989) assessed 
eating or swallowing in AD through clinical assessments, including one clinical report 
that also used an instrumental swallowing evaluation. These studies provide preliminary 
support for the following conclusions: 
1. Prevalence estimates of dysphagia in AD based on clinical assessments are lower than 
estimates based on instrumental swallowing assessments. One study reported that 32% of 
residents with AD living in a long-term care facility were observed to choke on food and 
drink (Volicer et al., 1989). Another group (Chouinard et al., 1998) reviewed the health 
records of 47 institutionalized patients with dementia (45% AD) who had died over a 
two-year period and reported that 45% of the entire dementia sample had dysphagia, 
which was correlated with death from pneumonia. 
2. Dysphagia occurs in all stages of AD and may be a marker of disease severity. One study 
(Correia, 2010) reported delayed swallowing and difficulty with ingestion of specific 
consistencies in moderate to severe AD. Another study (Edahiro et al., 2012) found signs 
of dysphagia in all stages of AD, although the frequency of signs increased in the 
advanced stages. 
3. Behavioural eating difficulties occur in all stages of AD. Individuals with mild AD 
required and received significantly more cueing during a meal assessment compared to 
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controls (Priefer & Robbins, 1997) and demonstrated problematic mealtime behaviors 
such as attempting to eat pieces of food too big for the oral cavity (Durnbaugh et al., 
1996; Morris et al., 1989). Difficulty initiating a meal, as well as severity of AD, 
significantly predicted eating dependence (Edahiro et al., 2012) and individuals with 
severe AD in long-term care facilities tended to receive mechanically altered diets and 
feeding assistance (Burge, 1994; Suski & Nielsen, 1989).  
4. Eating and swallowing difficulties are less severe in AD than in other types of dementia. 
Two studies compared caregiver perceptions of eating and swallowing difficulties in AD, 
frontotemporal lobe dementia (Ikeda et al., 2002) and Lewy body dementia (Shinagawa et 
al., 2009)  at similar stages. Both reported that AD caregivers perceived fewer abnormal 
eating and swallowing behaviours; however, AD caregivers also reported that eating and 
swallowing problems appear to develop earlier in AD progression. 
Table 2. Clinical Reports Employing Clinical Assessment of Swallowing in 
Alzheimer's Disease (AD) 
Conclusion Supporting 
Studies 
Study Description Level of 
Evidence 
Prevalence of 
dysphagia in AD 
Volicer et al. 
1989 
Described/characterized an aspect of eating 
or swallowing dysfunction through the 
examination of a single group of patients 
with AD 
NA 
Chouinard et al. 
1998 
Retrospective Cohort 2b 
Dysphagia may 
occur in all stages 
of AD 
Correia et al. 
2010 
Described/characterized dysphagia in AD 
through comparison of two or more groups 
of individuals 
NA 
Edahiro et al. 
2012  
Prospective Cohort Study 2b 
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Behavioural eating 
difficulties may 
occur in all stages 
of AD 
Priefer & 
Robbins, 1997 
Described/characterized dysphagia in AD 
through comparison of two or more groups 
of individuals 
NA 
Edahiro et al. 
2012 
Prospective Cohort Study 2b 
Durnbaugh et al. 
1996 
Described/characterized an aspect of eating 
or swallowing dysfunction through the 
examination of a single group of patients 
with AD 
NA 
Morris et al. 
1989 
Burge 1994 
Suski & Nielsen 
1989 
Dysphagia and 
eating difficulties 
in AD may be less 
severe than in 
other types of 
dementia  
Ikeda et al. 2002 Described/characterized dysphagia in AD 
through comparison of two or more groups 
of individuals 
NA 
Shinagawa et al. 
2009 
NA = not applicable. See Appendix B for more details. 
2.3.2.4 Treatment of Dysphagia in Alzheimer’s Disease 
Three randomized trials assessed the efficacy of intervention strategies on outcomes 
related to dysphagia in individuals with dementia (Bautmans et al., 2008; Logemann et 
al., 2008; Robbins et al., 2008). These studies provide support for the following 
conclusions: 
1. Providing honey-thickened liquids to individuals with AD may eliminate thin liquid 
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aspiration; however, this intervention may not reduce long-term morbidity or mortality. 
One study (Logemann et al., 2008) compared the effects of chin-down posture during 
swallowing, honey-thickened liquids, and nectar-thickened liquids, on thin liquid 
aspiration during VFSS in patients with dementia (15% AD), Parkinson’s disease (PD), 
or PD with dementia. Aspiration was most successfully eliminated through use of the 
honey-thickened liquids for each diagnostic category. In a second study, the same authors 
also reported a non-significant trend towards reduced incidence of pneumonia favouring 
patients drinking nectar-thickened liquids compared to those drinking honey-thickened 
liquids, as well as a longer median length of hospital stay for participants randomly 
assigned to the honey-thickened liquid intervention who developed pneumonia (Robbins 
et al., 2008).   
2. A physiotherapist-administered cervical spine mobilization protocol may improve 
“dysphagia limit” (defined as the maximum bolus of water that can be swallowed in a 
single movement) in individuals with severe AD and altered neck posture, based on a 
single crossover design randomized controlled trial (Bautmans et al., 2008). Dysphagia 
limit improved significantly following one treatment session and remained improved one 
week following the intervention. 
Table 3. Clinical Reports Examining the Treatment of Dysphagia in Alzheimer's 
Disease (AD) 
Conclusion Supporting 
Studies 
Study Description Level of 
Evidence 
Thickening liquids 
to a honey-
thickened 
consistency may 
eliminate thin 
liquid aspiration in 
individuals with 
Logemann et al. 
2008  
Randomized Clinical Trial 2b 
Robbins et al. 
2008 
Randomized Clinical Trial 2b 
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AD, however this 
intervention may 
not affect long-
term morbidity 
and mortality 
A physiotherapist 
administered 
cervical spine 
mobilization 
protocol may 
improve 
“dysphagia limit” 
in individuals with 
severe AD and 
altered neck 
posture 
Bautmans et al. 
2008 
Randomized Controlled Crossover Trial  2b 
See Appendix C for more details. 
2.3.2.5 Reviews 
One narrative review (Chouinard, 2000) and one systematic review (Alagiakrishnan, 
Bhanji, & Kurian, 2013) were identified. While published 12 years apart, these reviews 
came to similar conclusions: dysphagia may occur early in AD, however, studies 
investigating prevalence, assessment, management and treatment of dysphagia in 
individuals with dementia are lacking; the existing literature is heterogeneous in design, 
methodology, type of assessment, and outcomes (Alagiakrishnan et al., 2013; Chouinard, 
2000). 
2.3.2.6 Commentaries 
Four commentaries (Brush, Slominski, & Boczko, 2006; Clibbens, 1996; Kalia, 2003; 
Sumer, Sumer, & Sumer, 2005) covered a wide array of topics associated with dysphagia 
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and support the following conclusions: 
1. The ethical issues surrounding eating and feeding in the final stages of AD are complex. 
One author (Clibbens, 1996) suggested that evidence-based decision-making is vital when 
providing clinical care to individuals with AD.  
2. Dysphagia, aspiration pneumonia, and oral care are important issues when caring for 
individuals with AD. One author (Kalia, 2003) reported that dysphagia and aspiration 
pneumonia are severe and growing issues in the AD population. One group (Brush et al., 
2006) cited mealtime strategies and caregiver education as useful management strategies 
for AD. Another group (Sumer et al., 2005) noted that diminishing cognitive function 
results in neglect of oral hygiene leading to increased prevalence of dental problems; 
reduced submandibular salivary flow, increased the risk of gingivitis, tooth decay, oral 
infections, as well as dysfunctional speech, chewing, and swallowing. 
2.3.2.7 Case Studies 
Three (3) case studies (Asplund, Norberg, & Adolfsson, 1991; Barratt, 2000; Yamaguchi, 
Maki, & Maki, 2010) described treatments for eating and swallowing impairments in five 
individuals with AD: 
1. One group (Asplund et al., 1991) examined sucking behaviour in two patients with severe 
AD. Patients were observed to suck at different rates and pressures, and one 
demonstrated improved sucking over time. The authors concluded that the sucking 
method could be of value for end-of-life nutritional care in severe AD patients. 
2. One case report (Barratt, 2000) described a 70-year-old woman with AD who exhibited 
eating deficits and severe dysphagia yet minimal communication and mobility deficits. 
She was treated with a percutaneous endoscopic gastrostomy for non-oral feeding, the 
most ethical choice given the patient’s level of function.  
3. Another group (Yamaguchi et al., 2010)  reported 3 cases of concurrent dementia and 
dysphagia, two of which had late-stage AD and severe dysphagia. Treatment with 
dopamine agonists and angiotensin-converting enzyme inhibitors (ACEIs) resulted in 
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positive outcomes in swallowing and feeding, with associated prolonged oral intake and 
weight maintenance. 
2.3.3 Autonomic Nervous System Dysfunction in Alzheimer’s 
Disease 
The review identified 64 studies that investigated autonomic function in AD (Figure 3). 
2.3.3.1 Autonomic Nervous System Dysfunction in Alzheimer’s 
Disease: Oxford Centre for Evidence-Based Medicine 
Levels of Evidence (OCEBM) 
Two studies met the OCEBM criteria for classification (Table 4). 
2.3.3.2 Autonomic Nervous System Dysfunction in Alzheimer’s 
Disease 
Of the 51 clinical reports and seven physiological studies, 49 studies identified at least 
one variable reflecting ANS dysfunction in AD (Aharon-Peretz et al., 1992; Ahlskog et 
al., 1996; Algotsson, Nordberg, et al., 1995; Algotsson, Viitanen, et al., 1995; L. Allan et 
al., 2006; L. M. Allan et al., 2007; L. M. Allan et al., 2009; Andersson et al., 2008; Andin 
et al., 2007; Benedetti et al., 2004; Bonthius et al., 2005; Bordier et al., 2007; Borson et 
al., 1989; Burke et al., 1994; Chu et al., 1997; Davidson et al., 1991; de Vilhena Toledo 
& Junqueira, 2008; Del-Ser et al., 1996; Eisdorfer & Cohen, 1978; Elmstahl et al., 1992; 
Elmstahl & Winge, 1993; Fotiou et al., 2009; Franceschi et al., 1986; Grunberger et al., 
1999; Guo et al., 1998; Hornqvist et al., 1987; Idiaquez et al., 1994; Idiaquez et al., 1997; 
Idiaquez et al., 2002; Jhee et al., 1995; Kalman et al., 2002; Lampe et al., 1989; 
Mehrabian et al., 2010; Otsuka et al., 1990; Pascualy et al., 2000; Passant et al., 1997; 
Peskind et al., 1998; Peskind et al., 1995; Rainero et al., 2000; Ransmayr et al., 2008; 
Raskind et al., 1984; Rub et al., 2001; Ship et al., 1990; Szili-Torok et al., 2001; Vitiello 
et al., 1993; S. J. Wang et al., 1994; Zakrzewska-Pniewska et al., 2012; Zulli et al., 2005). 
These included measurements of blood pressure, heart rate, baroreflex sensitivity, 
vasomotor function, plasma norepinephrine levels, pupillary dilation, skin responses, 
urinary incontinence, constipation, blood pressure and heart rate responses to pain 
stimuli, and salivary flow. The remaining nine controlled studies failed to find significant 
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differences in autonomic function in individuals with AD compared with controls or 
patients with other types of dementia (L. M. Allan et al., 2005; Choi et al., 2009; Khurana 
& Garcia, 1981; Orimo et al., 2005; Raskind, Peskind, Holmes, & Goldstein, 1999; 
Shankle et al., 1993; Taki et al., 2004; Wakabayashi et al., 1999; Watanabe et al., 2001). 
Twenty-eight studies were identified that provide evidence for the occurrence of 
cardiovascular ANS dysfunction in AD, supporting the following conclusions: 
1. Individuals with AD demonstrate blood pressure differences compared with controls 
(Bordier et al., 2007; Burke et al., 1994; Elmstahl et al., 1992; Guo et al., 1998; Idiaquez 
et al., 1997; Kalman et al., 2002; Lampe et al., 1989; Otsuka et al., 1990). These include 
blunted diastolic pressor responses to thyrotropin stimulating hormone (Lampe et al., 
1989), higher baseline systolic blood pressure in bedridden patients with advanced AD 
(Otsuka et al., 1990) and, in contrast, lower baseline systolic and diastolic blood pressure 
was documented in mild to moderate AD (Elmstahl et al., 1992). Yearly systolic, 
diastolic, and mean arterial blood pressures decreased in 3 AD subjects every year 
following diagnosis (Burke et al., 1994) and lower systolic and diastolic blood pressures 
were associated with greater AD severity and shorter survival (Guo et al., 1998).  
2. AD patients exhibit orthostatic hypotension, that is, significant decreases in blood 
pressure when transitioning from supine to standing position (L. M. Allan et al., 2007; L. 
M. Allan et al., 2009; Andersson et al., 2008; Andin et al., 2007; Jhee et al., 1995; 
Mehrabian et al., 2010; Passant et al., 1997; Vitiello et al., 1993; S. J. Wang et al., 1994; 
Zakrzewska-Pniewska et al., 2012), which may contribute to the risk of falls (L. M. Allan 
et al., 2009). Compared with controls, AD patients showed greater increases in heart rate, 
and greater decreases in mean systolic blood pressure in response to a tilting test 
(Elmstahl et al., 1992) and reduced change in diastolic blood pressure during an isometric 
handgrip exercise (Kalman et al., 2002).  
3. Resting heart rate variability is significantly reduced in AD (Aharon-Peretz et al., 1992; 
Algotsson, Viitanen, et al., 1995; de Vilhena Toledo & Junqueira, 2008; Franceschi et al., 
1986; Idiaquez et al., 2002; Szili-Torok et al., 2001; Toledo & Junqueira, 2010; Zulli et 
al., 2005). Although the interpretation of heart rate variability as a marker of sympathetic 
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nervous system (SNS) function is debated (Eckberg, 1997), some studies reported 
increased SNS activation (Aharon-Peretz et al., 1992; de Vilhena Toledo & Junqueira, 
2008; Toledo & Junqueira, 2010) and decreased parasympathetic nervous system (PNS) 
activation (Aharon-Peretz et al., 1992; de Vilhena Toledo & Junqueira, 2008), whereas 
others reported decreased SNS and PNS activation in relation to heart rate variability 
(Algotsson, Viitanen, et al., 1995; Franceschi et al., 1986).  
4. Blood pressure and heart rate responses to pre-stimulus pain and stimuli delivered at just 
above the pain threshold are blunted in AD (Rainero et al., 2000). Autonomic responses 
to pain appear to be related to the severity of cognitive impairment, as measured by the 
MMSE (Benedetti et al., 2004).   
Twenty studies were identified that examined other aspects of ANS function in AD, 
supporting the following conclusions: 
1. ANS dysfunction in AD may be subtle compared with other types of dementia such as 
Parkinson’s disease dementia or Lewy body dementia. Clinical complaints of ANS 
dysfunction are less common among AD patients (L. Allan et al., 2006; L. M. Allan et 
al., 2007). 
2. Baseline plasma norepinephrine levels are significantly higher in severe AD patients 
compared with moderate AD patients and controls (Pascualy et al., 2000; Raskind et al., 
1984). Basal plasma norephinephrine levels and plasma norepinephrine levels in response 
to an alpha-2 adrenergic antagonist may be increased in AD, potentially indicating 
increased SNS activation (Peskind et al., 1998; Peskind et al., 1995), however decreased 
SNS activation in response to thyrotropin stimulating hormone has also been reported 
(Lampe et al., 1989). Modulation of plasma norepinephrine levels following stimulation 
with a cognitive task may be blunted in early AD (Borson et al., 1989).  
3. Vasomotor function may be reduced in AD (Algotsson, Nordberg, et al., 1995; Hornqvist 
et al., 1987; Kalman et al., 2002) in response to vasodilating substances, adrenergic 
agonists, and maximal contraction. Skin vessel vasodilation in response to iontophoresis 
of acetylcholine and isoprenaline was significantly reduced in AD (Algotsson, Nordberg, 
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et al., 1995; Hornqvist et al., 1987). Decreased skin blood flow and increased change in 
cutaneous vascular resistance was reported in AD subjects compared to age-matched 
controls following an isometric handgrip exercise (Kalman et al., 2002). 
4. Individuals with AD demonstrate anhydrosis (impaired sweating) (Elmstahl & Winge, 
1993) following stimulation with a receptor agonist. Estimated mean sweat sodium 
concentration was significantly higher among women with AD compared with healthy 
controls and significantly more AD patients (27%) did not demonstrate a sweat response 
following stimulation (Elmstahl & Winge, 1993). 
5. Increased pupillary sensitivity to a parasympathomimetic receptor agonist and a 
sympathomimetic receptor antagonist are seen in AD (Fotiou et al., 2009; Grunberger et 
al., 1999; Idiaquez et al., 1994). Pupillary dilatation following application of 
acetylcholine was greater in AD subjects at all measurement points (Grunberger et al., 
1999; Idiaquez et al., 1994), indicating AD-induced changes in post-junctional receptor 
function.  Functional stimulation with a pupil light reflex evaluation which engages the 
integrated reflex response, revealed a significantly slower reflex among AD patients 
compared to controls (Fotiou et al., 2009).  
6. AD patients may experience constipation (Zakrzewska-Pniewska et al., 2012) and urinary 
incontinence (Davidson et al., 1991; Del-Ser et al., 1996; Ransmayr et al., 2008), 
indicating PNS dysfunction. 
7. Individuals with AD may experience heightened cardiovascular arousal during learning 
(Eisdorfer & Cohen, 1978). 
8. Resting and stimulated submandibular salivary flow is reduced in AD (Ship et al., 1990). 
Forty-six percent of a sample of AD patients had flow rates below the 10th percentile 
compared to 11% of a control group. 
Four studies examined AD neuropathology, supporting the following conclusions:  
1. AD neuropathology may infiltrate central ANS structures, including the ventromedial 
frontal cortex (Chu et al., 1997), pons (Rub et al., 2001) medial parabrachial nucleus, 
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subpeduncular pigmented nucleus, and intermediate zone of the brainstem medullary 
reticular formation (Burke et al., 1994).  
2. Telencephalic structures such as the insula may also be affected (Bonthius et al., 2005). 
Table 4. Clinical/Physiological Reports Examining Autonomic Nervous System 
(ANS) Dysfunction in Alzheimer's Disease (AD) 
Conclusion Supporting 
Studies 
Study Description Level of 
Evidence 
Individuals with 
AD demonstrate 
blood pressure 
differences at 
baseline and 
following 
stimulation, as 
compared with 
controls  
Lampe et al., 
1989 
Described/characterized ANS dysfunction 
in AD through comparison of two or more 
groups of individuals 
NA 
Otsuka et al. 
1990 
Elmstahl et al. 
1992 
Burke et al. 
1994 
Retrospective chart review and 
neuroanatomical analysis of 3 postmortem 
AD subjects and characterization of an 
aspect of ANS dysfunction in AD through 
comparison of two or more groups of 
individuals, one or more of these groups 
being comprised of AD patients  
NA 
Idiaquez et al. 
1997 
Described/characterized ANS dysfunction 
in AD through comparison of two or more 
groups of individuals 
NA 
Guo et al. 1998 Prospective cohort study 2b 
Kalman et al. Described/characterized ANS dysfunction NA 
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2002 in AD through comparison of two or more 
groups of individuals 
Bordier et al. 
2007 
Individuals with 
AD demonstrate 
significantly 
greater falls in 
blood pressure 
(particularly 
systolic) when 
transitioning from 
supine to standing 
(orthostatic 
hypotension) 
compared with 
healthy age-
matched controls 
 
Elmstahl et al. 
1992 
Described/characterized ANS dysfunction 
in AD through comparison of two or more 
groups of individuals 
NA 
Vitiello et al. 
1993 
Wang et al. 
1994 
Jhee et al. 1995 Retrospective description of ANS 
dysfunction in AD through examination of 
a single group of AD subjects 
NA 
Passant et al. 
1997 
Described/characterized ANS dysfunction 
in AD through comparison of two or more 
groups of individuals 
NA 
Kalman et al. 
2002 
Andin et al. 
2007 
Allan et al. 2007 
Andersson et al. 
2008 
Allan et al. 2009 Prospective Cohort Study 2b 
Mehrabian et al. 
2010 
Described/characterized ANS dysfunction 
in AD through comparison of two or more 
NA 
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Zakrzewska-
Pniewska et al. 
2012 
groups of individuals 
Significantly less 
heart rate 
variability has 
been reported in 
individuals with 
AD  
Franceschi et al. 
1986 
Described/characterized ANS dysfunction 
in AD through comparison of two or more 
groups of individuals 
NA 
Aharon-Peretz 
et al. 1992 
Algotsson et al. 
1995 a 
Szili-Torok et 
al. 2001 
Idiaquez et al. 
2002 
Zulli et al. 2005 
Zakrzewska-
Pniewska et al. 
2012 
Toledo and 
Junqueira Jr, 
2008 
Toledo and 
Junqueira Jr. 
2010 
Described/characterized an aspect of ANS 
dysfunction through the examination of a 
single group of patients with AD 
NA 
Individuals with Rainero et al. Described/characterized ANS dysfunction NA 
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AD also 
demonstrate 
altered blood 
pressure and heart 
rate responses to 
pain stimuli 
2000 in AD through comparison of two or more 
groups of individuals 
Benedetti et al. 
2004 
Described/characterized an aspect of ANS 
dysfunction through the examination of a 
single group of patients with AD 
NA 
Autonomic 
nervous system 
dysfunction 
appears to be 
subtle in patients 
with AD when 
compared with 
other types of 
dementia  
Allan et al. 2007 Described/characterized ANS dysfunction 
in AD through comparison of two or more 
groups of individuals 
NA 
Allan et al. 2006 
Plasma 
norepinephrine 
levels may be 
altered in AD 
Borson et al. 
1989 
Described/characterized ANS dysfunction 
in AD through comparison of two or more 
groups of individuals 
NA 
Raskind et al. 
1984 
Lampe et al. 
1989 
Peskind et al. 
1995 
Ahlskog et al. 
1996 
Peskind et al. 
1998 
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Pascualy et al. 
2000 
Vasomotor 
function may be 
reduced in 
individuals with 
AD 
Algotsson et al. 
1995 
Described/characterized ANS dysfunction 
in AD through comparison of two or more 
groups of individuals 
NA 
Kalman et al. 
2002 
Hornqvist et al. 
1987 
Individuals with 
AD may 
demonstrate an 
impaired sweat 
response 
Elmstahl and 
Winge 1993 
Described/characterized ANS dysfunction 
in AD through comparison of two or more 
groups of individuals 
NA 
Pupillary 
responses in AD 
are altered in AD 
Idiaquez et al., 
1994 
Described/characterized ANS dysfunction 
in AD through comparison of two or more 
groups of individuals 
NA 
Grunberger et 
al. 1999 
Fotiou et al. 
2009 
Constipation and 
urinary 
incontinence may 
occur in AD 
Davidson et al. 
1991 
Described/characterized an aspect of ANS 
dysfunction through the examination of a 
single group of patients with AD 
NA 
Del-Ser et al. 
1996 
Described/characterized ANS dysfunction 
in AD through comparison of two or more 
NA 
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Ransmayr et al. 
2008 
groups of individuals 
Zakrzewska-
Pniewska et al. 
2012 
Heightened 
arousal during 
learning may 
occur in AD 
Eisdorfer and 
Cohen in 1978 
Described/characterized an aspect of ANS 
dysfunction through the examination of a 
single group of patients with AD 
NA 
Salivary flow is 
decreased in AD 
Ship et al. 1990 Described/characterized ANS dysfunction 
in AD through comparison of two or more 
groups of individuals 
NA 
The 
neuropathology of 
AD may affect 
central ANS 
control mediated 
by the 
ventromedial 
frontal cortex  
Chu et al. 1997 Neuroanatomical and Described/ 
characterized ANS dysfunction in AD 
through comparison of two or more groups 
of individuals 
NA 
The 
neuropathology of 
AD may affect 
central ANS 
central control 
mediated by the 
pontine regions of 
Rub et al. 2000 Neuroanatomical and Described/ 
characterized an aspect of ANS 
dysfunction through the examination of a 
single group of patients with AD 
NA 
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the brainstem 
The 
neuropathology of 
AD may affect the 
insula 
Bonthius et al. 
2005 
Neuroanatomical and Described/ 
characterized an aspect of ANS 
dysfunction through the examination of a 
single group of patients with AD 
NA 
The 
neuropathology of 
AD may affect the 
C-1 neurons of the 
rostral 
ventrolateral 
reticular nucleus 
Burke et al. in 
1994 
See Above See Above 
No significant 
differences 
between 
individuals with 
AD and controls 
Khurana and 
Garcia 1981 
Described/characterized ANS dysfunction 
in AD through comparison of two or more 
groups of individuals 
NA 
Shankle et al. 
1993 
Neuroanatomical and Described/ 
characterized ANS dysfunction in AD 
through comparison of two or more groups 
of individuals 
NA 
Wakabayashi et 
al. 1999 
Taki et al. 2001 Described/characterized ANS dysfunction 
in AD through comparison of two or more 
groups of individuals 
NA 
Allen et al. 2004 
Orimo et al. 
2005 
Neuroanatomical and Described/ 
characterized ANS dysfunction in AD 
through comparison of two or more groups 
of individuals 
NA 
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Choi et al. in 
2009 
Described/characterized ANS dysfunction 
in AD through comparison of two or more 
groups of individuals 
NA 
Watanabe et al. 
2001 
Raskind et al. 
1999 
NA = not applicable. See Appendix D for more details. 
2.3.3.3 Reviews 
Four non-systematic, narrative reviews (Borson et al., 1989; Idiaquez & Roman, 2011; 
Kenny, Kalaria, & Ballard, 2002; Royall, 2008) were identified.  
One review (Borson et al., 1989) described studies of ANS function in AD that were 
published between 1978 and 1990 and concluded that:  
1. SNS over-arousal may be a feature of advanced AD, whereas SNS arousal in mild to 
moderate AD appears to be significantly reduced. 
2. Studies of heart-rate variability in AD have indicated reduced SNS activity, as well as 
SNS and PNS dysfunction. 
3. Disordered vascular skin reactivity and reduced basal and stimulated salivary flow may 
occur in AD. 
One narrative review described “neurocardiovascular instability” among patients with 
dementia, including AD, and suggested that this disorder may result in autonomic 
dysregulation (Kenny et al., 2002). Another review reported on the association of right 
cerebral hemisphere dysfunction, insular pathology, and mortality secondary to 
cardiovascular and autonomic dysregulation in AD (Royall, 2008). One further review 
suggested that dysautonomia is mild in AD and primarily manifests as cardiovascular and 
urinary dysfunction (Idiaquez & Roman, 2011). 
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2.3.3.4 Case Studies 
Two case studies addressed ANS dysfunction in AD (Diamond & Diamond, 1991; 
Novak, Novak, Li, & Remillard, 1994). One described a patient with AD who developed 
thermoregulatory dysfunction (Diamond & Diamond, 1991). The other described an AD 
patient in whom spontaneous hypotension, accompanied by cardio-acceleration, occurred 
repeatedly in the supine position and/or during applied hyperventilation (Novak et al., 
1994). 
2.3.4 Dysphagia and Autonomic Nervous System Dysfunction in 
Alzheimer’s Disease 
The literature search did not identify any studies that directly examined both dysphagia 
and ANS dysfunction in AD. While one clinical report identified significantly decreased 
submandibular salivary flow in AD (Ship et al., 1990), its potential impact on swallowing 
was not examined. One commentary on oral health in AD suggested that reduced salivary 
flow might result in dysfunctional swallowing (Sumer et al., 2005). 
2.3.5 Gap Analysis 
2.3.5.1 Dysphagia in Alzheimer’s Disease 
1. Demographics – While there is preliminary evidence that dysphagia occurs in AD, few 
studies have examined its prevalence, or variations in prevalence as a function of disease 
progression.  
2. Nature of dysphagia – While the evidence indicates that both the oral and pharyngeal 
stages of swallowing may be affected in AD, studies examining the esophageal stage of 
swallowing in AD are lacking.  
3. Contribution of dysphagia to eating problems – The functional significance of dysphagia 
to eating problems in AD has not been elucidated.  
4. Assessment of dysphagia – A variety of assessment approaches have been employed to 
examine dysphagia in AD. However, an optimized swallowing assessment, 
contextualized with respect to the manifestations of AD, has not been examined. 
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5. Treatment of dysphagia –Three studies have examined interventions for dysphagia in AD 
patients. The treatment paradigms were limited and long-term outcomes were either not 
measured or not identified. Sensory stimulation, or motor training approaches, to 
dysphagia treatment that have been examined in other neurodegenerative conditions, 
have not been examined in AD.   
6. Relationship of dysphagia to other manifestations of AD – While there is preliminary 
evidence suggesting that dysphagia severity may be related to overall AD severity, or 
cognitive or executive dysfunction, associations between dysphagia and other signs of 
AD, such as independence in activities of daily living (ADL), have not been elucidated. 
7. Neural mechanisms underlying dysphagia – A small number of studies have shown that 
changes in the cortical swallowing network occur early in AD and may be correlated with 
early functional changes in swallowing. However, the neuropathophysiology of 
dysphagia in AD is unclear. 
2.3.5.2 Autonomic Nervous System Dysfunction in Alzheimer’s 
Disease 
1. Demographics – While a substantial literature has identified ANS dysfunction in AD, its 
prevalence remains unclear. 
2. Relationships between ANS functions – The relative extent of impairment across a range 
of ANS functions in AD is not understood. 
3. Functional significance of ANS dysfunction – The functional significance of ANS 
dysfunction in AD in terms of, for example, ability to perform ADLs, including eating, is 
unclear. 
4. Neuropathophysiology of ANS dysfunction – The neural mechanisms that contribute to 
ANS dysfunction, how they relate to the disease process, and whether the severity 
changes as the disease progresses, remain unclear. 
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2.3.5.3 Dysphagia and Autonomic Nervous System Dysfunction in 
Alzheimer’s Disease 
Although it is known that ANS function is important in regulating swallowing, the 
relationship between oropharyngeal dysphagia and ANS dysfunction in AD has not been 
examined directly. No study has examined oropharyngeal dysphagia in relation to 
swallow-related ANS functions such as salivary flow, or esophageal smooth muscle 
function. 
2.4 Discussion 
This scoping review was undertaken to (i) describe, synthesize, and interpret literature on 
dysphagia and/or ANS dysfunction in AD, and (ii) identify gaps in the existing literature. 
The review identified an emergent literature on dysphagia in AD, with 31 articles 
matching our search criteria.  These articles provide preliminary evidence on the 
prevalence, nature, and treatment of dysphagia in AD.  The available prevalence data 
suggest that oropharyngeal dysphagia may be a significant problem in AD, even early in 
the disease progression. However, knowledge gaps were also identified with respect to 
demographics, nature of dysphagia including the potential of an esophageal component, 
significance in relation to eating problems, assessment, treatment, and underlying 
mechanisms of dysphagia in AD.  
The review identified 64 articles that examined ANS dysfunction in AD. While the 
literature on ANS dysfunction in AD is larger and broader than the literature on 
dysphagia in AD, there are inconsistent findings regarding the presence, severity, and 
nature of ANS dysfunction. Current evidence suggests that a variety of ANS functions, 
particularly cardiovascular regulation, may be impaired in AD, but the impact of 
dysfunction among multiple ANS systems remains unknown. Knowledge gaps were 
identified with respect to demographics, functional significance, relationships between 
ANS functions, and underlying neural mechanisms. No systematic reviews of ANS 
dysfunction in AD have been published previously.   
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No studies were identified that examined both dysphagia and ANS dysfunction in AD. 
Given the, albeit limited, evidence that salivary flow is reduced in AD, a relationship 
between oropharyngeal dysphagia and ANS dysfunction might be expected. 
2.5 Conclusions 
A scoping review of the literature revealed that dysphagia, as well as ANS dysfunction, 
may occur in AD. However, the potential relationship between dysphagia and ANS 
dysfunction in AD has not been explored. Moreover, the functional significance of 
dysphagia and eating-related ANS dysfunction, for example, reduced saliva, to eating 
problems in AD is not clear. 
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Chapter 3  
3 A Meta-Analysis of Salivary Flow Rates in Young and 
Older Adults 
This meta-analysis aims to determine whether salivary flow decreases as a function of 
aging‡. 
3.1 Introduction 
Saliva plays a vital role in maintaining oral homeostasis (Mandel, 1989). Saliva is a clear, 
slightly acidic oral fluid composed of more than 99% water. The remaining 1% is 
composed of a variety of electrolytes including sodium and potassium, proteins, and 
nitrogenous products such as urea and ammonia (Humphrey & Williamson, 2001). The 
electrolytes and proteins in saliva modulate pH levels in the oral cavity. Proteins 
contribute to cleaning the oral cavity and metabolizing dental plaque (i.e., oral biofilm). 
Calcium, phosphate and proteins combine to interfere in demineralization and promote 
remineralization of the teeth. Immoglobulins and proteins combine to provide 
antibacterial protection (Humphrey & Williamson, 2001). Decreased salivary flow, or 
hyposalivation, leads to drying of the oral mucosa, inefficient food bolus formation and 
transport, demineralization of dentition, mucosal ulceration, altered oral flora, dysphonia, 
impaired taste and smell while eating, and discomfort (Baum, 1989). 
Saliva is secreted from three pair of major salivary glands: the parotid, submandibular, 
and sublingual glands, as well as numerous minor salivary glands. Another constituent of 
saliva is an exudate called gingival crevicular fluid (Sreebny & Vissink, 2010). The 
combination of all these fluids, as well as oral bacteria, and their products, is referred to 
as whole saliva. Glandular saliva is secreted in response to neurotransmitter stimulation 
from innervating sympathetic and parasympathetic nerves. The minor salivary glands 
function continuously day and night (Eliasson & Carlen, 2010) during wake and sleep. 
                                                
‡
 A version of this chapter has been published (Affoo, Foley, Garrick, Siqueira, & Martin, 2015). 
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The major salivary glands, in contrast, secrete in response to low-grade mechanical 
stimulation associated with movements of the tongue and lips, and in response to mucosal 
dryness to lubricate and protect the oral cavity (Baum, 1987; Ekstrom, Khosravani, 
Castagnola, & Messana, 2012). Although this major salivary gland basal, or resting 
secretion is produced in response to nervous activity, it is known as “unstimulated 
salivary flow rate” (Ekberg, 2012; Ekstrom et al., 2012). Approximately 75% of 
unstimulated, whole saliva is derived from the submandibular/sublingual glands, about 
15-20% from the parotid, and 5-8% from the minor salivary glands (Edgar, 1992; 
Humphrey & Williamson, 2001; Sreebny, 2000). At mealtimes, in response to taste, 
smell, visual, and mechanical stimuli, salivary flow rates increase by 5 to 50 times. The 
percentage contribution from the parotid gland increases to more than 50% of total 
salivary secretions. This increased flow rate is referred to as “stimulated salivary flow 
rate”.  
Age-related degenerative changes in the cellular structure of the submandibular and the 
parotid salivary glands have been previously identified (Scott, 1977; Scott, Flower, & 
Burns, 1987). A 20-40% decrease in the volume of cells responsible for saliva secretion 
and a corresponding increase by fatty and fibrous tissue in the glandular area has been 
reported (Baum, 1989; Scott, 1977; Scott et al., 1987; Sreebny, 2000). Comparable 
changes have been described for the labial minor glands (Drummond & Chisholm, 1984; 
Syrjanen, 1984). This evidence of age-related salivary gland degeneration suggests that 
functional reductions of salivary flow may also occur. Many studies have examined 
salivary flow rates in the context of aging. The results, however, are conflicting.  Some 
authors have reported significantly decreased salivary flow with age (Ben-Aryeh, Miron, 
Szargel, & Gutman, 1984; Billings, Proskin, & Moss, 1996; Chang, Chang, Kim, Lee, & 
Kho, 2011; Cowman, Frisch, Lasseter, & Scarpace, 1994; Fenoll-Palomares et al., 2004; 
Flink, Bergdahl, Tegelberg, Rosenblad, & Lagerlof, 2008; Ghezzi, Lange, & Ship, 2000; 
Ghezzi & Ship, 2003; Gutman & Ben-Aryeh, 1974; Hershkovich, Shafat, & Nagler, 
2007; Johnson, Yeh, & Dodds, 2000; Marotta et al., 2012; Meurman & Rantonen, 1994; 
Moritsuka et al., 2006; Nagler & Hershkovich, 2005a, 2005b; Navazesh, Mulligan, 
Kipnis, Denny, & Denny, 1992; Pedersen, Schubert, Izutsu, Mersai, & Truelove, 1985; 
Percival, Challacombe, & Marsh, 1994; Sawair, Ryalat, Shayyab, & Saku, 2009; Smith et 
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al., 2013; Streckfus, Bigler, & O'Bryan, 2002; Tanida et al., 2001; Toida et al., 2010; X. 
P. Wang et al., 2012; Yaegaki, Ogura, Kameyama, & Sujaku, 1985; Yeh, Johnson, & 
Dodds, 1998; Yeh et al., 2000), while others have not (Bakke et al., 2004; Baum, 1981; 
Baum, Costa, & Izutsu, 1984; Ben-Aryeh et al., 1986; Bourdiol, Mioche, & Monier, 
2004; Chauncey, Feller, & Kapur, 1987; Eliasson, Birkhed, Heyden, & Stromberg, 1996; 
Fischer & Ship, 1997, 1999; Gandara, Izutsu, Truelove, Ensign, & Somers, 1985; Heft & 
Baum, 1984; Malhotra, Wood, & Sachse, 2009; Ogura et al., 1983; Parvinen & Larmas, 
1982; Salvolini et al., 2000; Shern, Fox, & Li, 1993; Ship & Baum, 1990; Ship & 
Fischer, 1997; Sonnenberg et al., 1982; Takada, Suzuki, Okada, Nakashima, & Ohsuzu, 
2006; Tylenda, Ship, Fox, & Baum, 1988; Yoshikawa et al., 2012). Variations in study 
designs, saliva collection methods, and selection of outcome measures may account for 
the lack of consistent findings among studies. This variation has been acknowledged in 
several narrative reviews, which themselves have drawn conflicting conclusions (Baum, 
Ship, & Wu, 1992; de Almeida Pdel, Gregio, Machado, de Lima, & Azevedo, 2008; 
Dodds, Johnson, & Yeh, 2005; Ekstrom et al., 2012; Eliasson & Carlen, 2010; Sreebny, 
2000). The results from some reviews suggest that the flow of unstimulated whole saliva 
and unstimulated and stimulated submandibular/sublingual saliva (Dodds et al., 2005; 
Sreebny, 2000) decreases with increasing age. Other reviews have suggested that no age-
related decreases in either unstimulated or stimulated parotid saliva occur.  (Baum et al., 
1992) Still other reviews have reported no age-related effects on any type of salivary flow 
(de Almeida Pdel et al., 2008; Ekstrom et al., 2012). To date, the issue remains 
unresolved, in part, because no pooled analyses have been undertaken. Therefore, the 
objective of this study was to determine whether there is an effect of age on salivary flow 
rates, using a meta-analytic approach. We hypothesized that salivary flow rates decrease 
with advancing age. 
3.2 Methodology 
Potentially relevant studies that examined salivary flow rate in adults of different ages 
were identiﬁed through literature searches of the PubMed, EBSCOhost, Web of Science, 
Cochrane, EMBASE, Dissertations and Theses, and Scopus databases, published from 
the inception of the databases through June 2013.  Although search terms varied slightly 
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across databases, the terms “saliva” and “salivation” or “secretion” and “aged” or “aging” 
and “normal” or “disease-free” were used as MeSH terms, key words, or subject headings 
(Appendix E). Hand searching of the bibliographies of the included studies was 
conducted to identify potentially relevant articles not recovered using the search terms. 
Inclusion/Exclusion Criteria: Our inclusion criteria were intentionally broad to capture as 
many studies as possible. Studies were included if saliva had been collected on at least 
one occasion, among participants aged 18 to 60 + years who had been classified in some 
manner to form “younger” and “older” groups. Additional inclusions were a sample size 
of at least 6 participants, studies published in the English language and sufficient 
reporting detail to enable extraction (or calculation) of data needed for pooled analysis. 
Studies that examined salivary flow rates from any/all sources (whole, parotid, 
submandibular/sublingual, and/or minor glands), in either physiological condition 
(stimulated and/or unstimulated condition), and using any established collection method 
(draining, expectoration, cotton rolls, suction, Carlson Crittenden/Curby/Lashley cup, 
mastication stimulated, or gustatory stimulated) were included. Studies that examined a 
therapy or medication were used if baseline measures of salivary flow rates were 
conducted prior to the introduction of the intervention, and reported. Normal aging was 
not defined a priori; instead studies were included if the participants were described as 
“healthy” by the authors, or if the participants were free of major systemic diseases. 
Reviews, commentaries, opinion pieces, case reports, case series, studies examining 
salivary flow in individuals with disease, and animal studies were excluded. 
Two authors (RA and RG) independently reviewed titles and abstracts to determine initial 
eligibility. If an abstract was in question by either reviewer, the full article was retrieved 
and reviewed.  Following this initial screen, the same authors reviewed the full text of the 
remaining articles to determine final eligibility. A third author (NF) resolved 
discrepancies. The degree of agreement between the two independent reviewers was 
calculated using a kappa value.  
One author (RA) extracted data on trial design, sample sizes, participant characteristics, 
salivary flow rate (volume/collection time) for each of the salivary sources of interest 
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under unstimulated and stimulated conditions for the young and the older groups, as well 
as method of saliva collection, health status, and medication use from each study, and a 
second reviewer verified them for accuracy. 
To enable comparisons of young and older subjects, the age groups operationally defined 
in individual studies were used. The two comparison groups were: (i) subjects closest in 
age to 18 – 40 years (i.e., young); and (ii) subjects closest to >60 years (i.e., old). Studies 
where little separation between age data occurred (e.g. young subjects were aged 18 to 64 
years, and old subjects were aged 65 years and older) were excluded. Differences in 
salivary flow rates between age groups were calculated for each salivary source and 
condition and the results pooled using the software Comprehensive Meta-Analysis 
(version 2, Biostat Inc., 2007)§. This software enables the calculation of a pooled 
estimate of a treatment effect using differing forms of summary level data.  Standardized 
mean differences (SMDs), standard errors (SEs), and 95% confidence interval (CIs) was 
calculated using the reported means and standard deviations of the two groups, or using 
the formula (Standardized Difference equals 2 times the correlation divided by the square 
root of 1, minus the correlation squared) for conversion when a Pearson’s correlation co-
efficient for salivary flow rates across the age continuum was reported. Separate analyses 
were conducted for each salivary source and condition, with subgroup analyses 
completed for collection method, gender, and health status, providing at least four studies 
were available for analysis.  A separate analysis including subjects from studies where 
authors excluded those taking prescription and/or nonprescription medication was also 
conducted. The younger subject group data were used as the basis of comparison; 
therefore, differences between the younger and older subject groups observed to be 
greater than zero indicated that younger subjects had greater salivary flow rates than the 
older subjects.  Cohen has suggested the following guide to interpretation of effect sizes: 
0.80 = large; 0.50 = moderate; 0.20 = small (Cohen, 1988). A Cohen’s d value of zero 
indicates no effect. Where possible, the effect size was also converted to more clinically 
interpretable measurement (mL/min) using a standard technique (Lipsey & Wilson, 
                                                
§
 Suppliers Version 2; Biostat Inc, 14 N. Dean St, Englewood, NJ 07631. 
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2001). A random effects model was used to address two sources of potential variance: 
within-study error in estimating the effect in each study, as well as the variation in the 
true effects across studies (Borenstein, 2009). In order to examine the observed 
dispersion in true effect sizes, and to estimate both the true variance and random error 
within the observed dispersion, a standardized weighted sum of squares (Q) was 
calculated and compared with the expected weighted sum of squares in order to yield a 
test of the null. Heterogeneity was considered statistically significant if p < 0.05. An 
estimate of the variance (T2), the standard deviation (T), and confidence intervals of the 
true effects were calculated. Additionally, the proportion of true variance found within 
the observed variance was also calculated (I2) (Borenstein, 2009). A rough guide to the 
interpretation of the I2 statistic is: 0 to 40% may not be important, 30 to 60% may 
represent moderate heterogeneity, 50 to 90% may represent substantial heterogeneity, 75 
to 100% considerable heterogeneity (Higgins et al., 2011). 
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3.3 Results 
 
Figure 4. Flow Chart of Meta-Analysis 
The initial search returned 7,030 results, of which 187 were selected for full review 
(Figure 4). After elimination of an additional 138 articles, 51 studies remained, four of 
which reported duplicate data.  Forty-seven studies met the inclusion criteria and were 
included (Bakke et al., 2004; Baum, 1981; Baum et al., 1984; Ben-Aryeh et al., 1984; 
Ben-Aryeh et al., 1986; Billings et al., 1996; Bourdiol et al., 2004; Chang et al., 2011; 
Chauncey et al., 1987; Cowman et al., 1994; Eliasson et al., 1996; Fenoll-Palomares et 
al., 2004; Fischer & Ship, 1997, 1999; Flink et al., 2008; Gandara et al., 1985; Ghezzi et 
al., 2000; Ghezzi & Ship, 2003; Gutman & Ben-Aryeh, 1974; Heft & Baum, 1984; 
Henkin, Velicu, & Papathanassiu, 2007; Hershkovich et al., 2007; Johnson et al., 2000; 
Malhotra et al., 2009; Marotta et al., 2012; Meurman & Rantonen, 1994; Moritsuka et al., 
2006; Nagler & Hershkovich, 2005a, 2005b; Navazesh et al., 1992; Ogura et al., 1983; 
Parvinen & Larmas, 1982; Pedersen et al., 1985; Percival et al., 1994; Salvolini et al., 
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2000; Sawair et al., 2009; Shern et al., 1993; Ship & Baum, 1990; Ship & Fischer, 1997; 
Smith et al., 2013; Sonnenberg et al., 1982; Streckfus et al., 2002; Takada et al., 2006; 
Tanida et al., 2001; Toida et al., 2010; Tylenda et al., 1988; X. P. Wang et al., 2012; 
Yaegaki et al., 1985; Yeh et al., 1998; Yeh et al., 2000; Yoshikawa et al., 2012). 
Agreement between raters as to which studies should be retained was good to excellent 
(kappa: κ=0.836, SE=0.420). 
The details of all studies included in the analyses are presented in Appendix F and 
summarized in Table 5. The 47 studies included sample sizes ranging from 15 to 1427 
participants, arranged into two to seven age groupings. Young subjects ranged in age 
from 15 to 59 years and elderly subjects ranged in age from 60 to 97 years. Twenty-four 
studies examined the salivary flow rates of males and females separately.  
Thirty-five studies described the included participants as “healthy” or “generally 
healthy”, or included a healthy control group, or reported excluding participants with 
health problems that could affect salivary flow, such as history of treatment for cancer, or 
systemic disease. Other studies reported that participants with common illnesses such as 
hypertension and compensated diabetes were not excluded, while other studies reported 
using data from cohorts of community-dwelling volunteers, or recruiting participants 
from dental clinic registries where older individuals appeared to be free of major 
systemic disease, but may have had some common age-related conditions.  
Twenty-six studies excluded subjects taking certain medications. Some studies reported 
excluding subjects taking any medications, while others excluded subjects taking 
prescription medications and antihistamines or any saliva-affecting medications, but not 
hormone replacement therapy or birth control. We referred to participants in these 
studies, who were taking either no medications or minimal medications, as being 
“medication-free”. Twenty-one studies reported that individuals taking routine 
medications were included in the study or did not report the medication status of the 
participants.  
The 47 studies included 33 trials examining unstimulated whole salivary flow rates; 23 
trials examining stimulated whole salivary flow rates; eight trials examining unstimulated 
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parotid salivary flow rates; 19 trials examining stimulated parotid salivary flow rates; six 
trials examining unstimulated submandibular/sublingual (SMSL) salivary flow rates; 
seven trials examining stimulated SMSL salivary flow rates; and four each examining 
unstimulated minor buccal salivary flow rates, unstimulated minor palatal salivary flow 
rates, and unstimulated minor labial salivary flow rates. Some studies included more than 
one trial. 
Of all studies included in the meta-analysis (N=47), 21 reported no significant differences 
in mean salivary flow between younger and older subjects, 15 reported age-related 
declines in salivary flow, one reported both age-related decreases and increases in 
salivary flow, and 10 studies reported equivocal results (i.e. in studies in which more than 
one result was reported, significant and nonsignificant results were reported in the same 
study).  
Separate analyses for each of the salivary sources are presented below. 
3.3.1 Whole Salivary Flow Rate 
Whole salivary flow rate (Figure 5) was significantly reduced in the elderly group (SMD 
= 0.551, SE = 0.056, 95% CI = 0.423–0.678, p < 0.001). In subgroup analysis including 
the results from 33 studies, whole salivary flow rate in the unstimulated condition was 
significantly lower in the elderly group (SMD = 0.611, SE = 0.075, 95% CI = 0.464–
0.758, p < 0.001). Similarly, subgroup analyses examining stimulated whole salivary 
flow rate (n = 23) revealed significantly lower flow rate in the elderly group (SMD = 
0.367, SE = 0.131, 95% CI = 0.110–0.625, p = 0.005). Moderate and small effect sizes 
were identified, respectively. 
Heterogeneity:  
The results of the heterogeneity analysis indicated that the included studies did not share 
a common effect size (Q = 277.4, p < 0.001). The variance and standard deviation of the 
true difference between the whole salivary flow rates of young and older individuals 
indicated that the range of true differences crossed the no difference line, despite the 
summary effect being statistically significant (T2  = 0.187, T = 0.432, 95% CI = -0.296 – 
61 
 
1.398). Eighty percent of the observed variance was found to be true variance of the 
effect size (I2 = 80.17%).  
The results of the heterogeneity analysis for whole salivary flow rate in the unstimulated 
condition indicated significant heterogeneity (Q = 80.70, p < 0.001). The range of true 
effects, although wider than the confidence interval of the summary interval, did not 
cross the no difference line (T2  = 0.091, T = 0.301, 95% CI = 0.021 – 1.201). Sixty 
percent of the observed variance was found to be true variance of the effect size (I2 = 
60.35%).   
The results of the heterogeneity analysis for whole salivary flow rate in the stimulated 
condition also indicated significant heterogeneity (Q = 195.37, p < 0.001). The range of 
true effects was observed to cross the no difference line, despite the summary effect 
being statistically significant (T2  = 0.303, T = 0.551, 95% CI = -0.713 – 1.447). Eighty-
eight percent of the observed variance was found to be true variance of the effect size (I2 
= 88.74%). 
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Group by
Subgroup within study
Study name Subgroup within study Std diff in means and 95% CI
Stim Shern et al., 1993 m Stim
Stim Bourdiol et al., 2003 Stim
Stim Navazesh et al., 1992 Stim
Stim Shern et al., 1993 f Stim
Stim Parvinen & Larmas, 1982 m Stim
Stim Parvinen & Larmas, 1982 f Stim
Stim Flink et al., 2008 m Stim
Stim Meurman & Rantonen, 1994 Stim
Stim Flink et al., 2008 f Stim
Stim Ben-Aryeh et al., 1984 m Stim
Stim Takada et al., 2006 Stim
Stim Gandara et al., 1985 Stim
Stim Ben-Aryeh et al., 1986 Stim
Stim Toida et al., 2010 Stim
Stim Ben-Aryeh et al., 1984 f Stim
Stim Billings et al., 1996 m Stim
Stim Chang et al., 2011 Stim
Stim Streckfus et al., 2001 Stim
Stim Moritsuka et al., 2006 Stim
Stim Billings et al., 1996 f Stim
Stim Smith et al., 2013 f Stim
Stim Smith et al., 2013 m Stim
Stim Tanida et al., 2001 Stim
Stim
Unstim Shern et al., 1993 m Unstim
Unstim Shern et al., 1993 f Unstim
Unstim Gandara et al., 1985 Unstim
Unstim Yoshikawa et al., 2011 Unstim
Unstim Malhotra et al., 2009 Unstim
Unstim Yeh et al., 1998 m Unstim
Unstim Salvolini et al., 2000 Unstim
Unstim Gutman & Ben-Aryeh, 1974 Unstim
Unstim Ben-Aryeh et al., 1986 Unstim
Unstim Billings et al., 1996 m Unstim
Unstim Yeh et al., 1998 f Unstim
Unstim Yeh et al., 2000 Unstim
Unstim Flink et al., 2008 m Unstim
Unstim Fenoll-Palomares et al 2004 Unstim
Unstim Sonnenberg et al., 1982 Unstim
Unstim Wang et al., 2012 Unstim
Unstim Meurman & Rantonen, 1994 Unstim
Unstim Flink et al., 2008 f Unstim
Unstim Ogura et al., 1983 Unstim
Unstim Bakke et al., 2004 Unstim
Unstim Billings et al., 1996 f Unstim
Unstim Bourdiol et al., 2003 Unstim
Unstim Sawair et al., 2009 Unstim
Unstim Percival et al., 1994 Unstim
Unstim Ben-Aryeh et al., 1984 f Unstim
Unstim Ben-Aryeh et al., 1984 m Unstim
Unstim Navazesh et al., 1992 Unstim
Unstim Nagler & Hershkovich, 2005 Unstim
Unstim Yaegaki et al., 1985 Unstim
Unstim Chang et al., 2011 Unstim
Unstim Hershkovich et al., 2007 Unstim
Unstim Marotta et al., 2012 Unstim
Unstim Tanida et al., 2001 Unstim
Unstim
Overall
-4.00 -2.00 0.00 2.00 4.00
Favours Older Adults Favours Younger Adults
Meta Analysis
 
Figure 5: Forest Plot of the Difference in Whole Salivary Flow Rate Between Older 
and Younger Subjects 
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The first (left) column lists studies by primary author and publication date. An “f” 
or “m” following the primary author and date of publication indicates data that 
were reported separately for males and females in the same study. The second 
column indicates the subgrouping by condition (stimulated and unstimulated). The 
forest plot is illustrated in the right column. The solid squares illustrate the 
standardized mean difference (SMD) and the lines represent the 95% confidence 
intervals (CI). The younger subject group data were used as the basis of 
comparison, therefore, differences between younger and older subject groups 
observed to be greater than zero are represented on the right hand side of the line-
of-no-difference, and indicate that younger subjects had greater salivary flow rates 
than the older subjects. The solid diamonds represent the pooled SMD and 95% CI. 
3.3.2 SMSL Salivary Flow Rate 
SMSL salivary flow rate (Figure 6) was significantly reduced in the elderly group (SMD 
= 0.582, SE = 0.123, 95% CI = 0.341–0.823, p < 0.001). Subgroup analyses indicated 
that both unstimulated (n = 6) and stimulated (n = 7) SMSL salivary flow rates were 
significantly reduced in the elderly group (unstimulated: SMD = 0.569, SE = 0.159, 95% 
CI = 0.257–0.881, p < 0.001; and stimulated: SMD = 0.600, SE = 0.193, 95% CI = 
0.222–0.978, p = 0.002). Moderate effect sizes were identified. 
Heterogeneity:  
The results of the heterogeneity analysis indicated that the included studies did not share 
a common effect size (Q = 31.12, p = 0.002). The variance and standard deviation of the 
true difference between the SMSL salivary flow rates of young and older individuals 
indicated that the range of true effects, although wider than the confidence interval of the 
summary interval, did not cross the no difference line (T2  = 0.084, T = 0.290, 95% CI = 
0.014 – 1.150). Sixty-one percent of the observed variance was found to be true variance 
of the effect size (I2 = 61.44%).  
The results of the heterogeneity analysis for SMSL salivary flow rate in the unstimulated 
condition did not reveal significant heterogeneity (Q = 10.51, p = 0.062). The range of 
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true effects, although wider than the confidence interval of the summary interval, did not 
cross the no difference line (T2  = 0.073, T = 0.290, 95% CI = 0.014 – 1.150). Fifty-two 
percent of the observed variance was found to be true variance of the effect size (I2 = 
52.41%).   
The results of the heterogeneity analysis for SMSL salivary flow rate in the stimulated 
condition indicated significant heterogeneity (Q = 20.45, p = 0.002). The range of true 
effects was observed to cross the no difference line, despite the summary effect being 
statistically significant (T2  = 0.169, T = 0.411, 95% CI = -0.206 – 1.406). Seventy 
percent of the observed variance was found to be true variance of the effect size (I2 = 
70.66%). 
Group by
Subgroup within study
Study name Subgroup within study Std diff in means and 95% CI
Stim Tylenda et al., 1988 f Stim
Stim Ghezzi et al., 2000 Stim
Stim Yeh et al., 2000 Stim
Stim Tylenda et al., 1988 m Stim
Stim Yeh et al., 1998 Stim
Stim Cowman et al., 1994 Stim
Stim Pedersen et al., 1985 Stim
Stim
Unstim Tylenda et al., 1988 m Unstim
Unstim Tylenda et al., 1988 f Unstim
Unstim Yeh et al., 2000 Unstim
Unstim Yeh et al., 1998 Unstim
Unstim Cowman et al., 1994 Unstim
Unstim Pedersen et al., 1985 Unstim
Unstim
Overall
-4.00 -2.00 0.00 2.00 4.00
Favours Older Adults Favours Younger Adults
Meta Analysis
 
Figure 6: Forest Plot of the Difference in Submandibular/Sublingual Salivary Flow 
Rate Between Older and Younger Subjects 
3.3.3 Parotid Gland Salivary Flow Rate 
Parotid gland salivary rate was not significantly reduced in the elderly group (SMD = 
0.023, SE = 0.063, 95% CI = -0.099–0.146, p = 0.71).  
65 
 
Heterogeneity:  
The results of the heterogeneity analysis for parotid salivary flow rate did not reveal 
significant heterogeneity (Q = 37.31, p = 0.07). The variance and standard deviation of 
the true difference between the parotid salivary flow rates of young and older individuals 
indicated that the range of true differences crossed the no difference line (T2  = 0.029, T = 
0.169, 95% CI = -0.101 – 0.561). Thirty percent of the observed variance was found to be 
true variance of the effect size (I2 = 30.32%). 
3.3.4 Minor Gland Salivary Flow Rate 
Only unstimulated, minor gland salivary flow rate was analyzed because an insufficient 
number of studies examining stimulated minor gland flow rates were identified. 
Unstimulated buccal (n = 4, SMD = -0.143, SE = 0.392, 95% CI = -0.912–0.626, p = 
0.715), labial (n = 4, SMD = 0.069, SE = 0.213, 95% CI = -0.348–0.485, p = 0.747), and 
palatal (n = 4, SMD = 0.250, SE = 0.416, 95% CI = -0.566–1.065, p = 0.548) minor 
gland salivary flow rates were not significantly reduced in the elderly group. 
Heterogeneity:  
The results of the heterogeneity analysis for unstimulated buccal salivary flow rate 
indicated that the included studies did not share a common effect size (Q = 10.47, p = 
0.015). The variance and standard deviation of the true difference between the buccal 
salivary flow rates of young and older individuals indicated that the range of true 
differences crossed the no difference line (T2  = 0.436, T = 0.660, 95% CI = -1.437 – 
1.151). Seventy-one percent of the observed variance was found to be true variance of the 
effect size (I2 = 71.34%). 
The results of the heterogeneity analysis for unstimulated labial salivary flow rate did not 
reveal significant heterogeneity (Q = 3.288, p = 0.349). The variance and standard 
deviation of the true difference between the labial salivary flow rates of young and older 
individuals indicated that the range of true differences crossed the no difference line (T2  
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= 0.016, T = 0.127, 95% CI = -0.180 – 0.318). Eight percent of the observed variance 
was found to be true variance of the effect size (I2 = 8.77%). 
The results of the heterogeneity analysis for unstimulated palatal salivary flow rate 
indicated that the included studies did not share a common effect size (Q = 8.506, p = 
0.037). The variance and standard deviation of the true difference between the palatal 
salivary flow rates of young and older individuals indicated that the range of true 
differences crossed the no difference line (T2  = 0.438, T = 0.662, 95% CI = -1.048 – 
1.548). Sixty-four percent of the observed variance was found to be true variance of the 
effect size (I2 = 64.73%). 
3.3.5 Analysis of “Medication-Free” Subjects 
When the analysis was limited to studies that excluded subjects taking medications (n = 
26), a moderate effect size was observed for unstimulated whole salivary flow rate (n = 
17, SMD = 0.641, SE = 0.155, 95% CI = 0.388–0.944, p < 0.001) (Figure 7). Similarly, 
moderate effect sizes were observed for unstimulated (n = 5, SMD = 0.668, SE = 0.189, 
95% CI = 0.297–1.039, p < 0.001) and stimulated (n = 6, SMD = 0.646, SE = 0.249, 95% 
CI = 0.158–1.133, p = 0.01) SMSL salivary flow rates (Figure 8). 
Heterogeneity:  
The results of the heterogeneity analysis for whole salivary flow rate in the unstimulated 
condition indicated significant heterogeneity (Q = 48.88, p < 0.001). The range of true 
effects was observed to cross the no difference line, despite the summary effect being 
statistically significant (T2  = 0.212, T = 0.460, 95% CI = -0.261 – 1.543). Sixty-seven 
percent of the observed variance was found to be true variance of the effect size (I2 = 
67.27%). 
The results of the heterogeneity analysis for SMSL salivary flow rate in the unstimulated 
condition did not reveal significant heterogeneity (Q = 6.587, p = 0.159). The range of 
true effects, although wider than the confidence interval of the summary interval, did not 
cross the no difference line (T2  = 0.070, T = 0.264, 95% CI = 0.151 – 1.185). Thirty-nine 
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percent of the observed variance was found to be true variance of the effect size (I2 = 
39.28%). 
The results of the heterogeneity analysis for SMSL salivary flow rate in the stimulated 
condition indicated significant heterogeneity (Q = 16.61, p = 0.005). The range of true 
effects was observed to cross the no difference line, despite the summary effect being 
statistically significant (T2  = 0.258, T = 0.508, 95% CI = -0.350 – 1.642). Sixty-nine 
percent of the observed variance was found to be true variance of the effect size (I2 = 
69.89%). 
Stimulated whole salivary flow rate (Figure 7), and unstimulated and stimulated parotid 
salivary flow rates (data not shown), were not significantly different between groups. The 
analysis could not be completed for unstimulated minor gland salivary flow rate due to 
small sample sizes (n < 4). 
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Group by
Subgroup within study
Study name Subgroup within study Std diff in means and 95% CI
Stim Shern et al., 1993 m Stim
Stim Navazesh et al., 1992 Stim
Stim Shern et al., 1993 f Stim
Stim Parvinen & Larmas, 1982 m Stim
Stim Parvinen & Larmas, 1982 f Stim
Stim Ben-Aryeh et al., 1984 m Stim
Stim Gandara et al., 1985 Stim
Stim Ben-Aryeh et al., 1986 Stim
Stim Ben-Aryeh et al., 1984 f Stim
Stim Chang et al., 2011 Stim
Stim Streckfus et al., 2001 Stim
Stim Smith et al., 2013 f Stim
Stim Smith et al., 2013 m Stim
Stim
Unstim Shern et al., 1993 m Unstim
Unstim Shern et al., 1993 f Unstim
Unstim Gandara et al., 1985 Unstim
Unstim Yeh et al., 1998 m Unstim
Unstim Salvolini et al., 2000 Unstim
Unstim Ben-Aryeh et al., 1986 Unstim
Unstim Yeh et al., 1998 f Unstim
Unstim Wang et al., 2012 Unstim
Unstim Ogura et al., 1983 Unstim
Unstim Sawair et al., 2009 Unstim
Unstim Percival et al., 1994 Unstim
Unstim Ben-Aryeh et al., 1984 f Unstim
Unstim Ben-Aryeh et al., 1984 m Unstim
Unstim Navazesh et al., 1992 Unstim
Unstim Chang et al., 2011 Unstim
Unstim Hershkovich et al., 2007 Unstim
Unstim Marotta et al., 2012 Unstim
Unstim
Overall
-4.00 -2.00 0.00 2.00 4.00
Favours Older Adults Favours Younger Adults
Meta Analysis
 
Figure 7: Forest Plot of the Difference in Whole Salivary Flow Rate Between 
"Medication-Free" Older and Younger Subjects 
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Figure 8: Forest Plot of the Difference in SMSL Salivary Flow Rate Between 
"Medication-Free" Older and Younger Subjects 
Table 5: Summary of Results 
     Effect Size 
Source Condition Trials 
n 
Subjects 
in 
Analysis
n 
Collection Method Standardized Mean 
Difference, 95% 
Confidence Interval 
Whole 
Salivary 
Flow 
All 56  5870  0.551, 95% CI 0.423 
– 0.678* 
Un-
stimulated 
Whole 
33 2687 Draining Method: (Bakke et 
al., 2004; Flink et al., 2008; 
Navazesh et al., 1992; 
Sonnenberg et al., 1982; X. 
P. Wang et al., 2012) 
0.611, 95% CI 0.464 
– 0.758* 
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Spitting Method: (Ben-
Aryeh et al., 1984; Ben-
Aryeh et al., 1986; Chang et 
al., 2011; Fenoll-Palomares 
et al., 2004; Gandara et al., 
1985; Gutman & Ben-
Aryeh, 1974; Hershkovich 
et al., 2007; Marotta et al., 
2012; Meurman & 
Rantonen, 1994; Nagler & 
Hershkovich, 2005b; 
Percival et al., 1994; 
Salvolini et al., 2000; 
Sawair et al., 2009; Yaegaki 
et al., 1985; Yeh et al., 
1998; Yeh et al., 2000) 
Cotton Rolls or the Saxon 
Test: (Bourdiol et al., 2004; 
Malhotra et al., 2009; Ogura 
et al., 1983; Takada et al., 
2006; Tanida et al., 2001; 
Yoshikawa et al., 2012) 
Suction Method of Bertram: 
(Billings et al., 1996) 
Stimulated 
Whole 
23  3183 Mastication: (Bourdiol et 
al., 2004; Chang et al., 
2011; Flink et al., 2008; 
Gandara et al., 1985; 
0.367, 95% CI 0.110 
– 0.625* 
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Meurman & Rantonen, 
1994; Moritsuka et al., 
2006; Navazesh et al., 1992; 
Parvinen & Larmas, 1982; 
Shern et al., 1993; Smith et 
al., 2013; Streckfus et al., 
2002; Takada et al., 2006; 
Toida et al., 2010)  
Gustatory Stimulus: (Ben-
Aryeh et al., 1984; Ben-
Aryeh et al., 1986; Billings 
et al., 1996; Tanida et al., 
2001). 
Whole 
Salivary 
Flow – 
“Med-
ication-
Free” 
Partici-
pants 
Un-
stimulated 
Whole 
17 899  0.641, 95% CI 0.338 
– 0.944* 
Stimulated 
Whole  
13 850  0.268, 95% CI -
0.239 – 0.775 
Sub-
mandibul
ar/Sub-
lingual 
Salivary 
Flow 
 
All 13 1314  0.582, 95% CI 0.341 
– 0.823* 
Un-
stimulated 
SMSL 
6 637 SMSL saliva was collected 
with a micropipette and light 
suction (Cowman et al., 
1994; Ghezzi et al., 2000; 
Johnson et al., 2000; 
0.569, 95% CI 0.257 
– 0.881* 
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Tylenda et al., 1988; Yeh et 
al., 1998; Yeh et al., 2000), 
or with an originally 
designed collection device 
fitted with a micropipette 
and dropper bulb (Pedersen 
et al., 1985) 
Stimulated 
SMSL 
7 677 Gustatory Stimulus: 
(Cowman et al., 1994; 
Ghezzi et al., 2000; Johnson 
et al., 2000; Pedersen et al., 
1985; Tylenda et al., 1988; 
Yeh et al., 1998; Yeh et al., 
2000) 
0.600, 95% CI 0.222 
– 0.978* 
Sub-
mandibul
ar/Sub-
lingual 
Salivary 
Flow – 
“Med-
ication-
Free” 
Partici-
pants 
Un-
stimulated 
SMSL 
5 238  0.668, 95% CI 0.297 
– 1.039* 
Stimulated 
SMSL 
6 278  0.646, 95% CI 0.158 
– 1.133* 
Parotid 
Salivary 
Flow 
All 27 1856  0.023, 95% CI -
0.099 – 0.146 
Un- 8 433 Parotid saliva was collected 0.045, 95% CI -
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stimulated 
Parotid 
with a modified Carlson 
Crittenden, Curby, or 
Lashley cup 
(Ben-Aryeh et al., 1986; 
Bourdiol et al., 2004; 
Cowman et al., 1994; 
Fischer & Ship, 1999; Heft 
& Baum, 1984; Yeh et al., 
1998) 
0.161 – 0.250 
Stimulated 
Parotid 
19 1423 Gustatory Stimulus: (Baum, 
1981; Baum et al., 1984; 
Ben-Aryeh et al., 1986; 
Bourdiol et al., 2004; 
Chauncey et al., 1987; 
Cowman et al., 1994; 
Fischer & Ship, 1999; 
Gandara et al., 1985; Ghezzi 
et al., 2000; Heft & Baum, 
1984; Johnson et al., 2000; 
Percival et al., 1994; Ship & 
Baum, 1990; Sonnenberg et 
al., 1982; Yeh et al., 1998; 
Yeh et al., 2000) 
0.011, 95% CI -
0.142 – 0.165 
Parotid 
Salivary 
Flow – 
Med-
ication-
Free 
Un-
stimulated 
Parotid 
5 197  0.101, 95% CI -
0.266 – 0.468 
Stimulated 
Parotid 
10 535  0.103, 95% CI -
0.075 – 0.280  
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Partici-
pants 
Minor 
Gland 
Salivary 
Flow 
Un-
stimulated 
Palatal 
4 77 Minor gland saliva was 
collected via the Periotron 
method or with 
chromatography paper 
0.250, 95% CI -
0.566 – 1.065 
Un-
stimulated 
Labial  
4 105 0.069, 95% CI -
0.348 – 0.485 
Un-
stimulated 
Buccal 
4 105 -0.143, 95% CI -
0.912 – 0.626 
 (*p < 0.05) 
3.3.6 Translating Effect Size to the Original Metric 
When converted to a traditional metric, the mean differences in salivary flow rates 
between young and old subjects were: 0.168 mL/min for unstimulated whole salivary 
flow rate; 0.293 mL/min for stimulated whole salivary flow rate; 0.015 mL/min for 
unstimulated SMSL salivary flow rate; and 0.040 mL/min for stimulated SMSL salivary 
flow rate. These rates represent a 40% reduction in flow rate for older participants for 
unstimulated whole saliva; a 15% reduction for stimulated whole saliva; an 11% 
reduction for unstimulated SMSL saliva; and a 9% reduction for stimulated SMSL saliva. 
3.4 Discussion 
The results from the present meta-analysis suggest that salivary flow decreases with age. 
Although this effect was evident for whole saliva, not all subcomponents of saliva 
showed decreased flow. Specifically, SMSL salivary flow rates in both the unstimulated 
and stimulated conditions were lower in older adults, whereas parotid gland and minor 
gland salivary flow rates were not different in young and older adults. These findings are 
consistent with the view that aging is associated with decreased salivary flow in a gland-
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specific manner. Moreover, the age-related decrease in salivary flow was not fully 
explained on the basis of medication or disease. 
3.4.1 Mechanisms 
Both unstimulated and stimulated whole mean salivary flow rates were significantly 
lower in older adults compared to younger adults. The difference in unstimulated whole 
salivary flow rate was approximately 66% greater than the difference in stimulated whole 
salivary flow rate. This finding of greater reduction of unstimulated whole salivary flow 
rate associated with age is consistent with the present finding of decreased SMSL 
salivary flow. The SMSL salivary glands contribute 70% of the overall volume of 
unstimulated whole saliva, but less than 50% of stimulated whole saliva. The present 
finding of a lack of an age effect for parotid salivary flow rate would be consistent with 
this supposition.  
A decline in the functional output of the SMSL glands in elderly subjects could be related 
to degenerative changes in their cellular structure, as has been reported previously, 
(Baum, 1989; Scott, 1977) although these anatomical changes do not explain why age-
related decreases in parotid gland salivary flow rates were not found in the present study.  
The differential effects of age on SMSL and parotid flow rates may be due to inherent 
neuroanatomical and physiological differences between the glands. It has been speculated 
that specific age-related neuroanatomical changes may result in differential gland 
dysfunction (Baum, 1987). The secretory reserve hypothesis, which proposes that 
younger persons may possess an excess of salivary secreting cells beyond what is 
required for normal function, (Scott et al., 1987) may explain the relative age-related 
stability of parotid gland salivary flow in that age-related degeneration of these “reserve” 
cells may result in a decrease in saliva production without functional changes in salivary 
flow rate.  
Although the difference in unstimulated whole salivary flow rate was greater than the 
difference in stimulated whole salivary flow rate, stimulated flow was found to decrease 
with age. Age related changes to oral motor function may result in reduced bite strength 
(Mioche, Bourdiol, Monier, Martin, & Cormier, 2004), potentially resulting in reduced 
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stimulation and reduced salivary flow rate during masticatory stimulated salivary 
collection (Baum, 1979). This mechanism may have influenced any significant decreases 
in salivary flow rates for older adults observed following mastication stimulation. 
3.4.2 Contributions of Effect Modifiers 
Potential sources of heterogeneity among studies, which may have affected effect size 
estimates, included the collection method, gender, medication use, and health status. 
Where feasible, we examined the SMDs between younger and older participants grouped 
by collection method, by gender, and by health status. Despite the fact that substantial 
heterogeneity was observed for the differences in whole, SMSL, and buccal and palatal 
minor gland salivary flow rates between young and older adults, and moderate 
heterogeneity was observed for the differences in parotid and labial minor gland salivary 
flow rates between young and older adults, little variability could be attributed to any of 
these potential sources of variability using this technique, given the overlapping CIs 
among the subgroups (data not shown). Certain salivary collection methods are 
associated with less reliability and greater variability in flow rate (Navazesh & 
Christensen, 1982). There is also evidence to suggest that women have lower mean 
salivary flow rates than men (Inoue et al., 2006; Percival et al., 1994), which may be 
related to smaller gland sizes in women (Inoue et al., 2006). However, the present 
analysis examined the salivary flow rates between age groups, so it can only be stated 
that the age-related decline was proportional between the sexes. Medication use did not 
appear to explain the difference in SMSL and unstimulated whole salivary flow rates 
between the young and older adults. This was an unexpected finding, given that many 
medications, such as antidepressants, diuretics, analgesics, antihistamines, anti-
hypertensives, anti-anxiety medications, and appetite suppressants are known to reduce 
salivary flow. Polypharmacy is also more common with increasing age.  
Other potential sources of variability that could not be explored in the present study due 
to lack of reporting details included timing of salivary collection, and interval between 
gustatory stimulation and collection. Salivary flow rates are known to vary with circadian 
rhythm (Aps & Martens, 2005). Given that the majority of studies included in this meta-
analysis reported that saliva was collected within a specific temporal window (e.g. 
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between 8:00-11:00 am), timing of collection was not considered to be a major source of 
variability. Variation in the time of year when salivary collection occurred may have 
contributed to variability in effect sizes across studies. This information was not 
generally reported and could not be explored. There is evidence to suggest that the timing 
of the interval between stimulus presentation and collection may affect salivary flow rates 
in older adults. Wu and colleagues (1995) reported that older adults demonstrated 
reduced SMSL salivary flow rates when increasing periods of time were observed 
between stimulation and collection (Wu, Baum, & Ship, 1995). If researchers did not 
employ a standard protocol of saliva collection post stimulation, differences specific to 
the elderly group could have contaminated the results. The majority of studies included in 
this meta-analysis, however, reported that saliva was collected immediately post 
stimulation, or during stimulation, for all participants.   
3.4.3 Limitations and Strengths 
A variety of age ranges, and age groupings, were used in the included studies, which 
prevented us from developing an a priori definition of younger and older participants and 
distinct age groups. Although we were often able to form young and older groups based 
on ages 18 to 40 years, and >60 years, respectively, this group assembly was not always 
possible (Ben-Aryeh et al., 1986; Chauncey et al., 1987; Gandara et al., 1985; Johnson et 
al., 2000; Yeh et al., 1998).  
A relative strength of this work is the number of studies included in each pooled analysis. 
Identification and inclusion of many relevant studies allowed us to pool the data for a 
large number of participants allowing us to identify a more precise estimate of the effect 
size.  
A post-hoc sensitivity analysis was conducted after noting the results from a single study 
examining unstimulated and stimulated whole saliva were almost 4 standard deviations 
above the pooled mean (Tanida et al., 2001). Removal of the outlier resulted in an 11% 
reduction of the effect size for unstimulated whole salivary flow and a 3% reduction of 
the effect size for stimulated whole salivary flow, although the overall effect sizes 
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remained significant in both cases. An explanation for the inflated effect size was not 
obvious after reviewing the study’s inclusion criteria and methods. 
We excluded a study with insufficient separation between age groups (e.g. “young” 
subjects were aged 18 to 64 years and “elderly” subjects were aged 65 years and older) to 
reduce the risk of underestimating of effect sizes.  
3.4.4 Future Directions 
The results of the present study suggest that older adults have reduced salivary flow rates 
compared to younger adults. This new evidence provides a strong rationale for future 
longitudinal studies to confirm that the aging process may contribute to the decline in 
whole and glandular salivary flow rates. Further investigation into the mechanisms 
underlying the declines in SMSL salivary flow rates, and the relative stability of parotid 
gland salivary flow, with age would be beneficial in the understanding of the 
neurophysiologic correlates of salivary gland aging and in exploring potential treatment 
options. Saliva plays many important roles in maintaining oral homeostasis. The optimal 
volume of saliva to maintain function may not be equivalent across roles. Future research 
should focus on identifying the minimal volumes necessary to maintain the vital 
functions that saliva performs.  
3.4.5 Clinical Significance 
A difference between the whole and SMSL salivary flow rates of older and younger 
adults was identified and quantified. A moderate decrease of 0.168 mL/min was 
identified for unstimulated whole salivary flow rate, a small decrease of 0.293 mL/min 
was identified for stimulated whole salivary flow rate, a moderate decrease of 0.015 
mL/min was identified for unstimulated SMSL salivary flow rate, and a moderate 
decrease of 0.040 mL/min was identified for stimulated SMSL salivary flow rate. 
Researchers can use these values to determine sample size calculations for future studies. 
The heterogeneity analysis revealed that the studies included in this analysis did not share 
a common effect size and the magnitude of dispersion of the true effect of age on salivary 
flow rate was observed to be large. This perceived variability suggests that not all adults 
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will experience a clinically significant reduction in salivary flow rate as they age. The 
reasons for this heterogeneity may be related to factors such as gender, diet, and health 
status. Variability in the results of the studies examined here may also have been related  
to the different salivary collection methods employed.  
The clinical relevance of the current finding that whole and SMSL salivary flow rates are 
decreased with increasing age remains unknown. While it is known that SMSL salivary 
flow protects the oral tissues, primarily during non-alimentary functions at rest through 
salivary mucins and other constituents (Prakobphol, Levine, Tabak, & Reddy, 1982; 
Wong, 2008), it is not known at what point reductions in the level of production affect 
function. Theoretically, age-related decreases of whole and SMSL salivary flow rates 
could contribute to oral infection, inflammation, and mechanical oral wear (Tabak, 1995). 
In contrast, no age-related reductions in parotid or minor gland salivary flow, which are 
integral for rinsing the oral cavity, neutralizing acids, forming the biofilm found on 
enamel, and digestion, (Dawes & Wood, 1973; Siqueira, Salih, Wan, Helmerhorst, & 
Oppenheim, 2008; Wong, 2008) were found.  This finding suggests that older adults may 
tend to experience preserved digestive salivary functions. 
3.5 Conclusion 
Despite conflicting findings previously reported in the literature, unstimulated and 
stimulated whole and SMSL salivary flow rates are decreased in older adults compared 
with younger adults. In contrast, parotid gland and minor gland salivary flow rates do not 
appear to be significantly reduced in older subjects. Medication effects do not fully 
explain the age-related reduction in SMSL and unstimulated whole salivary flow rates. 
These findings have important clinical implications for maintaining optimal oral health in 
older adults. 
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Chapter 4  
4 The Effects of Oral Stimulation Associated with Manual 
and Electric Tooth Brushing on Whole Salivary Flow 
Rates in Healthy Older Adults 
This study aims to examine the effects of manual and electric tooth brushing on salivary 
flow in older adults free of major systemic disease.  
4.1 Introduction 
Decreased salivary flow, or hyposalivation, results in profound deterioration of oral 
homeostasis. Increased susceptibility to dental caries and infections, decreased regulation 
and control of the oral microflora, and impaired swallowing may occur (Sreebny & 
Vissink, 2010). Salivary gland hypofunction can be caused by developmental or 
congenital disorders (Eveson, 2008), increased medication usage (Sreebny & Schwartz, 
1997), systemic disorders such as Sjögren’s syndrome (Fox, Stern, & Michelson, 2000), 
radiotherapy-induced damage to salivary acinar tissue (Henson, Inglehart, Eisbruch, & 
Ship, 2001), and anxiety (Bergdahl & Bergdahl, 2000). A recent meta-analysis 
demonstrated that aging is associated with decreased whole salivary flow rate in healthy 
older adults (Affoo et al., 2015). It also showed that, while unstimulated and stimulated 
submandibular/sublingual (SMSL) salivary flow rates were significantly decreased in 
healthy older adults compared with healthy young adults, parotid gland flow rate did not 
differ across age groups. Thus, decreased SMSL salivary flow appeared to underlie the 
reduction in whole salivary flow rates (Affoo et al., 2015). Decreased SMSL and parotid 
salivary gland flow rates have been reported in the context of certain diseases, such as 
Alzheimer’s disease (Ship et al., 1990; Ship & Puckett, 1994).  
The paired parotid salivary glands, submandibular salivary glands, and sublingual 
salivary glands are the major routes through which saliva is secreted into the oral cavity. 
The parotid salivary glands are located opposite the maxillary first molars, and the 
submandibular and sublingual glands are located in the floor of the mouth. Humans also 
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have numerous minor salivary glands located in the lower lip, tongue, palate, cheeks, and 
pharynx (Roth & Calmes, 1981).  
There are three types of salivary secretion: spontaneous, resting, and stimulated secretion. 
The minor salivary glands spontaneously secrete saliva in the absence of exogenous 
stimuli, however, these glands are innervated and secretion rates increase in response to 
afferent stimuli (Emmelin, 1967). The oral tissues are among the most richly innervated 
of any in the human body, in terms of the number and variety of peripheral receptors that 
they contain (Haggard & de Boer, 2014). Both slowly and rapidly adapting sensory 
receptors in the tongue, periodontal ligament, gingiva, and palate convey an extensive 
range of sensory information including touch, pressure, vibration, proprioception, pain, 
and temperature (Dong, Shiwaku, Kawakami, & Chudler, 1993; Nordin & Hagbarth, 
1989; Trulsson & Johansson, 2002). Resting and stimulated salivary secretion are nerve-
mediated reflexes (Proctor & Carpenter, 2007). Information from mechanical afferent 
stimulation associated with oral rest conditions, such as contact between different 
surfaces in the mouth, and stimulated conditions, such as mastication, is conveyed by the 
sensory branches of the trigeminal and glossopharyngeal cranial nerves to the trigeminal 
sensory nuclei within the medulla. The salivatory nuclei are also located in the medulla 
and receive central information from areas of the brain such as the hypothalamus, as well 
as the incoming sensory information from the periphery. The superior salivatory nucleus 
contains the preganglionic autonomic motor neurons of the facial nerve, which sends 
secretomotor input to the submandibular, sublingual, and minor salivary glands, whereas 
the inferior salivatory nucleus contains the preganglionic autonomic motor neurons of the 
glossophyarngeal nerve, which sends secretomotor input to the parotid glands (Wilson-
Pauwels, 2010). In response to the sensory stimuli, efferent parasympathetic and 
sympathetic secretomotor nerves conduct excitatory signals to the salivary glands 
resulting in secretion (Proctor & Carpenter, 2007) (Figure 9). Some studies have 
documented that increased oral cavity stimulation is associated with increased salivary 
secretion. Salivary secretion increases with the hardness and the size of an object being 
chewed, as well as the forces generated by the chewing muscles (Anderson & Hector, 
1987; Hector & Linden, 1987; Rosenhek, Macpherson, & Dawes, 1993; Yeh et al., 2000).  
Increased saliva secretion has also been reported following the application of vibration 
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stimuli to the facial skin overlying the bilateral belly of the masseter muscles, possibly 
due to the tonic vibration reflex resulting in contraction of the masseter muscles and/or 
the vibration activating various types of mechanoreceptors through the skin and mucosa 
(Hiraba, Yamaoka, Fukano, Fujiwara, & Ueda, 2008). Thus it appears that mechanical 
stimulation involving stretch, pressure and vibration of the oral cavity have the capacity 
to stimulate saliva production.   
 
Figure 9: Salivation in Response to Mechanical Stimuli. 
Peripheral sensory information is transduced by oral mechanoreceptors located in 
the tongue, periodontal ligament, gingiva, and palate. Sensory information from the 
face, tongue, teeth, and oral cavity is conveyed through the sensory component of 
the trigeminal cranial nerve (V) and sensory information from the posterior third of 
the tongue, tonsil, soft palate, fauces, and uvula is conveyed through the sensory 
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component of the glossopharyngeal cranial nerve (IX). Afferent information is 
conveyed to the trigeminal sensory nuclei within the medulla. The salivatory nuclei 
are also located in the medulla and receive central information from areas of the 
brain such as the hypothalamus as well as the incoming sensory information. The 
superior salivatory nucleus contains the preganglionic autonomic motor neurons of 
the facial nerve, which sends secretomotor input to the submandibular, sublingual 
and minor salivary glands, whereas the inferior salivatory nucleus contains the 
preganglionic autonomic motor neurons of the glossophyarngeal nerve, which sends 
secretomotor input to the parotid glands. Cortex mediated efferent signals are 
conveyed through the sympathetic and parasympathetic pathways to stimulate the 
parotid and submandibular and sublingual glands resulting in salivary secretion. 
The use of tooth brushing as a mechanical form of whole salivary flow stimulation has 
been examined previously in healthy young adults (Hoek, Brand, Veerman, & 
Amerongen, 2002; Ligtenberg et al., 2006) and in older adults with clinically significant 
hyposalivation (Papas et al., 2006). Hoek and colleagues (2002) examined 14 healthy 
adults (Mean age = 32 years, SD = 11 years) to determine whether the volume and/or 
composition of saliva were altered by the mechanical stimulation associated with manual 
tooth brushing. A transient increase in salivary flow rate in the initial 5 minutes 
immediately following the mechanical stimulation was identified. Ligtenberg et al. 
(2006) examined the effects of tooth brushing among 80 healthy student volunteers who 
brushed their teeth with a manual toothbrush and water or dentifrice. Salivary flow rates 
increased significantly following tooth brushing with water and after brushing with 
toothpaste, and remained increased for 60 minutes post stimulation. In older adults with 
clinically significant hyposalivation, Papas et al. (2006) examined electric and manual 
tooth brushing as a technique for salivary stimulation in a longitudinal study design and 
reported that an electric toothbrush tended to stimulate greater salivary flow rates up to 
45 minutes post stimulation. 
Salivary flow rate has been reported to be decreased in healthy older adults compared to 
younger adults (Affoo et al., 2015). Disease and medication use are also associated with 
reduced salivary flow (Fox et al., 2000; Sreebny & Schwartz, 1997). Given the 
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detrimental effects of decreased salivary flow on oral and overall health, it would be 
beneficial to examine a non-invasive, low-cost, and non-pharmacologic method of 
stimulating salivary flow. As discussed above, mechanical stimulation is an effective way 
to stimulate salivary secretion. Tooth brushing has the capacity to produce pressure, 
stretch, and vibratory mechanical stimulation on the tongue, periodontal ligament 
(through pressure on the teeth), gingiva, and palate. Tooth brushing is an inexpensive and 
simple technique that stimulates the oral cavity and cleanses it at the same time. At this 
time however, the literature examining tooth brushing as a form of saliva stimulation is 
limited and the results are conflicting with regard to the duration of the increased salivary 
flow rate post stimulation. A clearer understanding of the effects of tooth brushing on 
salivary flow would inform consideration of the feasibility of this form of stimulation as 
an oral health intervention. In addition, differing study designs have been used 
previously, and no study has examined the salivary responses to tooth brushing in older 
adults without clinically significant hyposalivation.  
Therefore, the present study aimed to: (i) examine whether manual and electric tooth, 
tongue, and palate brushing modulates whole salivary flow rates in older adults free of 
major systemic disease; (ii) ascertain the duration of the tooth/tongue/palate-brushing-
related modulation in salivary flow rates; (iii) compare the salivary flow rate modulation 
associated with manual and electric tooth brushing; and (iv) examine the perceived 
acceptability and comfort of tooth brushing in older adults. We hypothesized that tooth, 
tongue, and palate brushing would result in a salivary flow rate increase. The duration of 
this increase was anticipated to last between 5 to 30 minutes post tooth brushing, based 
on the studies completed by Hoek et al. (2002), Ligtenberg et al. (2006), and Papas et al. 
(2006). We hypothesized that the modulation of salivary flow rates would be greater for 
the electric toothbrush intervention compared to the manual toothbrush intervention due 
to increased vibration and associated greater afferent stimulation. Additionally, we 
hypothesized that the maximum salivary flow rate increase in response to stimulation 
would decrease with increasing age. 
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4.2 Methodology 
4.2.1 Participants 
Twenty-one non-smoking adults who were free of major systemic disease volunteered as 
subjects. Volunteers were recruited through advertisements at a walking group for retired 
seniors. Candidates were excluded if they had less than 20 natural teeth, complained of 
xerostomia or dry mouth, or had been to the dentist in the seven days immediately prior 
to the experimental session. A sample size power calculation indicated that a sample of 
20 subjects was sufficient to detect a difference of one standard deviation (d = 1.0), or a 
large effect, of a two-level, within-subjects independent variable 80.8% of the time, using 
a 0.01 alpha level and assuming a within-subject correlation of 0.30. 
The effects of two tooth brushing interventions on salivary flow rate were examined in 
the present study: manual tooth brushing and electric tooth brushing. The order of the two 
interventions was counterbalanced, with participants randomly assigned to one of two 
groups. Group one used the manual toothbrush in the first experimental session and the 
electric toothbrush in the second experimental session. Group two used the electric 
toothbrush in the first experimental session and the manual toothbrush in the second 
experimental session. Each subject completed the two sessions a minimum of one day 
apart and a maximum of three weeks apart.  
Relevant subject data relating to age, medical history, and dental history was collected 
during a brief interview prior to the experimental session (Appendix I). The participants 
were instructed to eat a typical breakfast and complete their morning oral hygiene routine 
(including tooth brushing) by 8:00 am and to refrain from eating or drinking prior to the 
study session. Each session commenced at 9:00 am and lasted approximately 120 
minutes. Each subject gave written, informed consent before participating in the study, 
which was approved by the Western University Research Ethics Board for Health 
Sciences research involving human subjects (Appendix F). 
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4.2.2 Materials 
Tooth brushing interventions were completed with a Colgate Sensitive Pro-Relief manual 
toothbrush and a Colgate Sonic Power electric toothbrush. 
4.2.3 Protocol  
For the duration of the experimental session, the subjects sat in a chair (approximately 45 
cm in height) that was stationed in front of a table (approximately 41 cm in height). At 
the beginning of the experimental session, a brief visual inspection of the oral cavity was 
completed to ensure there were no gross anatomic abnormalities and to ensure each 
participant had at least 20 natural teeth. Participants then rinsed their mouths with 
distilled water and expectorated into a receptacle. 
Three transducers were positioned on the subject: belt-mounted movement sensors 
positioned around the subject’s neck (Model 1585, CT2 Pediatric Piezo Respiratory 
Effort Sensor, Pro-Tech Services, Inc., License No. 69444) and upper abdomen (Model 
1582, CT2 Adult Piezo Respiratory Effort Sensor, Pro-Tech Services, Inc., License No. 
69444), recorded neck and respiratory movements, respectively. An omnidirectional 
electret microphone (F-SM Snore Electret Microphone, Pro-Tech Services, Inc., License 
No. 69446) affixed to the subject’s neck with medical tape, monitored the acoustic signal 
arising from the upper airway through the tissues of the neck. These physiologic signals 
were recorded continuously throughout the experimental session using an AS40 Comet 
Series PSG/EEG Portable System (Astro-Med Inc., License No. 65827). A video 
recording in the lateral plane at a camera-to-subject distance of approximately 120 cm 
was also made. These video images included the subject’s head, facial profile, neck, 
shoulders, and chest. The video images and physiologic signals enabled the researchers to 
observe whether participants swallowed during the saliva collection periods. The use of 
physiologic signals to identify swallowing events is a validated method that has been 
used previously in the literature (Lowell et al., 2013). The addition of video images to 
identify swallowing events has also been used previously in the literature (Abe et al., 
2014)  
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Each of the two study sessions was comprised of a habituation period, a control 
condition, an experimental condition, a washout period, and 11 salivary collection 
periods (Figure 10). During the 5-minute habituation period, the subjects sat quietly 
making minimal orofacial movements as video recordings and neck movement, 
respiratory, and acoustic data were collected.  
Subjects provided saliva samples using the previously validated draining method 
(Navazesh & Christensen, 1982; Navazesh, 1993), as follows. While seated comfortably 
in a chair with eyes open and head tilted slightly forward, subjects swallowed to clear 
their mouths of residual saliva and then allowed their saliva to drain into a pre-weighed 
autoclaved beaker for 5 minutes while making minimal orofacial movements. After 5 
minutes, subjects were instructed to collect any remaining saliva in the mouth and 
expectorate it into the beaker. Beakers containing saliva were immediately weighed after 
each saliva-draining period and whole salivary flow rates were calculated in grams per 
minute. Saliva was assumed to have a constant density of approximately 
0.978kg/m3(Lamey & Nolan, 1994). The subjects were instructed not to swallow their 
saliva during the draining period. Following the study, the video and physiologic signals 
were reviewed by RHA for evidence of swallow-related respiratory and laryngeal 
movement patterns and swallowing events to verify that swallowing did not occur during 
saliva collection. Five-minute saliva-draining collections were collected at baseline 
following the habituation period, and at 0 to 5 minutes, 10 to 15 minutes, 20 to 25 
minutes, and 30 to 35 minutes following the control condition and experimental 
intervention.  
Participants completed the control condition by placing either the manual or electric 
toothbrush in the oral cavity (without dentifrice, bristles down touching the superior 
surface of the tongue) and holding it unmoving for 2 minutes. The experimental 
stimulation condition involved the participant actively brushing his or her teeth, tongue, 
and palate (without dentifrice) for 2 minutes. Subjects were instructed not to swallow 
their saliva during the control and experimental tooth brushing conditions. Immediately 
following both conditions, subjects expectorated their saliva into a pre-weighed beaker. 
These salivary collections will be referred to as the salivary flow rates collected “during” 
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the control and experimental conditions. Participants sat quietly for a 5-minute washout 
period between the control condition and the experimental intervention.  
Participants were instructed to use a standardized tooth brushing protocol when 
completing each 2-minute oral cavity stimulation intervention with either the manual or 
electric toothbrush. For the manual toothbrush intervention, participants were instructed 
to use a modified Bass technique (Bass, 1954) and systematically brush the outer, inner, 
and chewing surfaces of each quadrant of the mouth for 25-seconds each. On the inner 
and outer surfaces of the molars, subjects were directed to place the toothbrush at the 
gum margin at a 45-degree angle and use circular brushing motions followed by rolling 
the toothbrush down and away from the gums.  Participants were instructed to use a back-
and-forth brushing motion on the inner surfaces of the incisors and on the chewing 
surfaces of the molars. The final 10 seconds of the intervention was spent gently brushing 
the tongue and palate. The electric toothbrush intervention was similar to the manual 
toothbrush intervention except, instead of active brushing, participants were instructed to 
hold the bristles against the teeth and move from tooth to tooth slowly. The instructions 
for each of the standardized tooth brushing protocols were presented in an instructional 
video immediately prior to the experimental intervention. 
A paper-and-pencil 10 cm visual analog scale (VAS) assessment of mouth comfort was 
presented to the participants at six different times during the experimental session 
(Appendix G and Figure 10). The VAS scale was anchored with the terms “normal 
comfort level” at 5 cm, “less comfortable” at 0 cm, and “more comfortable” at 10 cm.  
At the end of the experimental session, each participant completed a questionnaire 
focusing on the ease of use of the tooth brushing protocol and the feasibility of 
implementing the protocol in the participant’s daily oral hygiene routine (Appendix H).  
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Figure 10: Experimental Protocol 
4.2.4 Data Analysis 
Relevant subject data relating to age, medical history, and dental history was analyzed by 
RHA.  
All beakers were weighed immediately prior to the experiment and immediately 
following each saliva-draining period. Whole salivary flow rate at 0 to 5 minutes, 10 to 
15 minutes, 20 to 25 minutes, and 30 to 35 minutes following the control condition and 
experimental intervention were calculated by dividing the weight of the saliva in grams 
by the 5-minute timeframe. Whole salivary flow rate during the control and experimental 
conditions were calculated by finding the weight in grams of the amount expectorated 
immediately following either the control, or experimental, condition and dividing that 
weight by the 2-minute timeframe.  
A research assistant (RA) scored each of the VAS forms by measuring the length in 
centimeters between the far left of the VAS (0 cm) and the point where the participant 
had placed the mark indicating current mouth comfort. The length in centimeters 
represented the VAS score, with higher scores representing greater mouth comfort. VAS 
scores were analyzed by RHA. 
Subject questionnaires were analyzed by RHA. 
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4.2.5 Statistical Analysis 
Whole salivary flow rates were calculated for each collection period in g/min. Planned 
contrasts were completed using paired samples t-tests and a Holm-Bonferroni sequential 
procedure to correct for familywise error (pcorr<0.0045) (Holm, 1979). The comparisons 
of interest included: i) baseline rates compared to the flow rates during the control and 
experimental conditions; ii) baseline rates compared to the flow rates from 0 to 5 
minutes, 10 to 15 minutes, 20 to 25 minutes, and 30 to 35 minutes after the experimental 
condition; and iii) flow rates during the control condition compared to the flow rates 
during the experimental condition, and from 0 to 5 minutes, 10 to 15 minutes, 20 to 25 
minutes, and 30 to 35 minutes after the experimental condition, for both the manual and 
electric toothbrush experimental protocols. The effects of the control and treatment 
conditions on salivary flow rate were estimated using Cohen’s d.  
Potential differences between the effects of the manual and the electric toothbrush were 
examined through descriptive comparisons of the effect sizes (Cohen’s d) calculated for 
the manual and electric toothbrush stimulation. Additionally, the maximum salivary flow 
rate change (i.e., the difference between salivary flow rate during tooth brushing and 
baseline flow rate) associated with the two types of tooth brushing were compared using 
a paired samples t-test (p < 0.05). A potential relationship between the maximum salivary 
flow rate change associated with the manual and electric tooth brushing interventions was 
also examined using a Pearson’s correlation coefficient (p < 0.05).  
The influence of age on the maximum salivary flow rate change was examined using 
Pearson’s correlation coefficient (p < 0.05). Medication use was explored using 
descriptive statistics, as well as a chi-square test (p < 0.05) to determine whether equal 
numbers of participants were taking no, one, two, or three or more medications. 
The effects of the control and experimental conditions on mouth comfort, measured using 
the VAS, were examined using a repeated measures ANOVA. The results of the 
feasibility questionnaire were examined for trends and are reported descriptively.  
Statistical analyses were completed using SPSS (SPSS 2012) and Microsoft Excel. 
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4.3 Results 
4.3.1 Subject Characteristics 
Twenty-one subjects participated in the study (62–83 years of age, M = 71.33 years, SD 
= 6.46 years; 11 female). All participants had at least 20 natural teeth (Range = 22–28, M 
= 25.67, SD = 1.93). No participants were observed to swallow during the salivary 
collection periods. Using Sreebny and Vissink’s “Classification of Xerogenic Drugs” 
(Sreebny & Vissink, 2010), 7 of the 21 subjects reported taking no medications with 
potential xerogenic effects and 14 of the 21 subjects were observed to be taking 
xerogenic medications (Range of xerogenic medications= 0–4, M = 1.25, SD = 1.11) 
(Figure 11). The results of a chi square test (χ2 = 3.19, p = 0.36) indicated that the 
numbers of participants in each category (no, one, two, or three or more xerogenic 
medications) were not significantly different. Xerogenic medications taken by the study 
participants included antihyperlipidemic agents, anti-ulcer agents, antihypertensive 
agents, and anti-inflammatory agents. 
 
Figure 11: The Numbers of Study Participants Taking Different Numbers of 
Xerogenic Medications at the Time of the Study 
The mean ages of participants taking no, one, two, or three or more xerogenic 
medications were similar (Figure 12). 
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Figure 12: The Mean Age (in years) of Study Participants Taking Different 
Numbers of Xerogenic Medications at the Time of the Study 
4.3.2 Effects of Manual and Electric Tooth Brushing on Whole 
Salivary Flow Rate 
The mean whole salivary flow rates for each collection period are presented for the 
experiment using the manual toothbrush (Figure 13) and using the electric toothbrush 
(Figure 14).  
Planned contrasts were completed using paired samples t-tests. The Holm-Bonferroni 
sequential procedure was used to correct for familywise error (pcorr < 0.0045) (Table 6). 
Of the 22 completed planned comparisons, the data associated with four comparisons 
were not normally distributed as assessed by the Shapiro-Wilk’s test (p < 0.05); these 
were the comparison between baseline rates and the flow rates during the manual 
toothbrush control condition; between baseline rates and the flow rates from 0 to 5 
minutes and 10 to 15 minutes after the manual toothbrush experimental condition; and 
between the flow rates during the electric toothbrush control condition and the flow rates 
from 30 to 35 minutes after the electric toothbrush experimental condition. Nevertheless, 
a paired samples t-test was used, as this test is robust to violations of normality 
(Herrendorfer, Rasch, & K.D., 1983; Posten, 1979; Rasch & Guiard, 2004).  
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4.3.2.1 Effects of Manual Tooth Brushing on Whole Salivary Flow 
Rate 
There was a significant, large increase (d = 2.50) in salivary flow rates collected during 
the 2 minutes of manual tooth brushing compared with baseline salivary flow rate (M = 
0.63, SD = 0.34, p < 0.0045) and compared with the salivary flow rate collected during 
the control condition (M = 0.58, SD = 0.33, p < 0.005). Although the salivary flow rate 
was observed to decrease immediately following the manual tooth brushing, the salivary 
flow rate collected from zero to five minutes post manual tooth brushing was found to be 
significantly, moderately increased (d = 0.661) compared with baseline salivary flow rate 
(M = 0.07, SD = 0.07, p < 0.0055).  
Salivary flow rates collected during the periods 10 to 15 minutes, 20 to 25 minutes, and 
30 to 35 minutes after manual tooth brushing were not significantly different from 
baseline flow rates. Similarly, salivary flow rates collected during the periods 0 to 5 
minutes, 10 to 15 minutes, 20 to 25 minutes, and 30 to 35 minutes after manual tooth 
brushing were not significantly different compared with salivary flow rates collected 
during the manual tooth brushing control condition. 
4.3.2.2 Effects of Electric Tooth Brushing on Whole Salivary Flow 
Rate 
There was a significant, moderate increase (d = 0.672) in salivary flow rate during the 2-
minute control condition compared with baseline salivary flow rate during the electric 
toothbrush protocol (M = 0.07, SD = 0.08, p < 0.006). There was a significant, large 
increase (d = 2.54) in salivary flow rates collected during the 2 minutes of electric tooth 
brushing compared with baseline salivary flow rate (M = 0.78,SD = 0.37, p < 0.0045) and 
compared with the salivary flow rate collected during the control condition (M = 0.71,SD 
= 0.35, p < 0.005). Although the salivary flow rate was observed to decrease immediately 
following electric tooth brushing, the salivary flow rate collected from 0 to 5 minutes 
post electric tooth brushing was found to be significantly, moderately increased (d = 
0.681) compared with baseline salivary flow rate (M = 0.08, SD = 0.08, p < 0.0055). 
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Salivary flow rates collected during the periods 10 to 15 minutes, 20 to 25 minutes, and 
30 to 35 minutes after electric tooth brushing were not significantly different from 
baseline flow rates. Similarly, salivary flow rates collected during the periods 0 to 5 
minutes, 10 to 15 minutes, 20 to 25 minutes, and 30 to 35 minutes after electric tooth 
brushing were not significantly different compared with salivary flow rates collected 
during the electric tooth brushing control condition. 
Table 6: Significant Salivary Flow Rate Comparisons and the Holm-Adjusted p 
Values 
Comparison Mean Difference Holm-Adjusted p 
Manual Toothbrush   
Baseline – During Brushing 0.63 0.0045 
During Control – During Brushing 0.58 0.0050 
Baseline – 0 to 5 Minutes Post 
Brushing 
0.07 0.0055 
Electric Toothbrush   
Baseline – During Brushing 0.78 0.0045 
During Control – During Brushing 0.71 0.0050 
Baseline – 0 to 5 Minutes Post 
Brushing 
0.08 0.0055 
Baseline – During Control 0.07 0.0060 
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Figure 13: Mean Whole Salivary Flow Rate Collected at 11 Different Time Points 
Before, During, and Following Control and Manual Tooth Brushing Conditions 
Mean flow rate (g/min) is represented by the bars and the error bars indicate SE.  
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Figure 14: Mean Whole Salivary Flow Rate Collected at 11 Different Time Points 
Before, During, and Following Control and Electric Tooth Brushing Conditions 
Mean flow rate (g/min) is represented by the bars and the error bars indicate SE. 
4.3.3 Manual Compared to Electric Tooth Brushing 
The salivary flow rates collected during the manual and electric tooth brushing protocols 
were compared using descriptive comparisons of their respective effect sizes (manual: d 
= 2.40; electric: d = 2.54). This analysis indicated that the effect sizes were similar. The 
maximum salivary flow rate change (i.e., difference between salivary flow rate during 
tooth brushing and baseline flow rate) associated with the two types of tooth brushing 
were also not significantly different (M = 0.15, SD = 0.42, p = 0.129). There was a small 
correlation between the maximum salivary rate changes associated with the manual and 
electric tooth brushing protocols (r (19) = 0.30, p = 0.184). 
4.3.4 Age and Salivary Flow Rate 
The influence of age on baseline salivary flow rate was examined. Baseline salivary flow 
rate data for the manual toothbrush protocol were not normally distributed, as assessed by 
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Shapiro-Wilk’s test (p = 0.001), however baseline data for the electric toothbrush 
protocol were normally distributed (p > 0.05). Therefore, a Spearman rank-order 
correlation was completed with the manual toothbrush data and a Pearson’s correlation 
coefficient was completed with the electric toothbrush data. Age was not significantly 
correlated with baseline salivary flow rate for the manual rs (19) = 0.05, p = 0.84 or 
electric toothbrush protocols r (19) = 0.1, p = 0.68. 
The influence of age on maximum salivary flow rate change (i.e., the difference between 
salivary flow rate during tooth brushing and baseline flow rate) was examined using a 
Pearson’s correlation coefficient. Age and the maximum salivary flow rate change 
associated with manual tooth brushing was normally distributed, as assessed by Shapiro-
Wilk’s test (p > 0.05). Age was moderately correlated with the maximum salivary flow 
rate change (r (19) = 0.55, p = 0.01) for the manual toothbrush condition (Figure 15).  
The influence of age on maximum salivary flow rate change associated with electric 
tooth brushing was also normally distributed, as assessed by Shapiro-Wilk’s test (p > 
0.05). A small, non-significant correlation was observed (r (19) = 0.18, p = 0.44) for the 
electric toothbrush condition (Figure 16).  
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Figure 15: Scatterplot Illustrating the Correlation Between Age (in years) and the 
Maximum Salivary Change Associated with Manual Tooth Brushing  
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Figure 16: Scatterplot Illustrating the Correlation Between Age (in years) and the 
Maximum Salivary Change Associated with Electric Tooth Brushing  
4.3.5 Mouth Comfort and Feasibility 
Mouth comfort data, as measured by the VAS, were not normally distributed, as assessed 
by Shapiro-Wilk’s test (p < 0.05). Outliers were observed, as assessed by inspection of a 
boxplot. In addition, Mauchly’s Test of Sphericity indicated that the data violated the 
assumption of sphericity (manual: χ2 (2) = 53.81, p < 0.001; electric: χ2 (2) = 129.46, p < 
0.001). Despite the fact that the data violated these assumptions, a one-way repeated 
measures ANOVA was used to examine mouth comfort scores throughout the manual 
and electric toothbrush experiments due its robustness to violations of normality (Glass, 
Peckham, & Sanders, 1972). No significant differences in mouth comfort were detected 
for either the manual or electric toothbrush experiments. 
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The responses to the feasibility questionnaires suggested that 95% of the participants 
reported that the instructions for both the manual and electric tooth brushing methods 
were easy to understand and the methods themselves were easy to complete. Ninety 
percent of the participants reported being amenable to incorporating the standardized 
tooth brushing method, with either the manual or electric toothbrush, into their daily oral 
hygiene routine. Ten percent of the respondents reported being resistant to change their 
oral hygiene routine at this point in their lives. 
 
Figure 17: VAS Scores Recorded at 6 Different Time Points During the Manual 
Toothbrush Experiment 
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Figure 18: VAS Scores Recorded at 6 Different Time Points During the Electric 
Toothbrush Experiment 
4.4 Discussion 
The results of the current study suggest that oral cavity stimulation with a manual or 
electric toothbrush temporarily increases whole salivary flow rates in older adults. 
Specifically, we found that whole salivary flow rates were increased significantly for up 
to 5 minutes following either manual, or electric brushing of the teeth, tongue, and palate 
in healthy adults aged 60 years and older. The increase in salivary flow rate immediately 
following the 2-minute brushing period was large, whereas the increase in salivary flow 
rate 5 minutes following brushing was moderate. The present study also found that 
holding a de-activated electric toothbrush in a stationary position in the oral cavity 
resulted in an immediate, transient increase in whole salivary flow rate.  
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These results are similar to those of Hoek et al. (2002), who reported that brushing the 
teeth without dentifrice induced an increase in the saliva flow rate during the initial 5 
minutes after tooth brushing, which was following by a decrease after 15 minutes. Our 
results are not consistent with those of Ligtenberg et al. (2006), however, who reported 
that, after brushing with water, the salivary secretion rate increased significantly for 60 
minutes. Secretion rates were also significantly increased after brushing with toothpaste. 
This inconsistency may be because the stimulation protocol used by Ligtenberg and 
colleagues (2006) required subjects brush their teeth with water or dentifrice, either of 
which could have caused gustatory or temperature stimulation in addition to the 
mechanical stimulation associated with tooth brushing. This additional stimulation could 
have influenced the duration of increased salivary flow rates post stimulation.  
In the present study, the greatest increase in salivary flow rate was observed immediately 
following manual or electric tooth brushing. We observed a mean salivary increase of 
0.63 g/min  (SD = 0.34 g/min) immediately following manual tooth brushing and a mean 
increase of 0.78 g/min (SD = 0.37 g/min) immediately following electric tooth brushing.  
Previous studies have documented that increased oral cavity stimulation is associated 
with increased salivary secretion. Salivary secretion increases with the hardness and the 
size of an object being chewed, as well as with the forces generated by the chewing 
muscles (Anderson & Hector, 1987; Hector & Linden, 1987; Rosenhek et al., 1993; Yeh 
et al., 2000). Additionally, Papas et al., (2006) reported that Sonicare electric toothbrush 
users tended to have increased salivary flow rates at each 15-minute interval collection 
period up to 45 minutes post stimulation compared with manual toothbrush users. In 
contrast, Hiraba et al. (2008) found that increasing the frequency of vibratory stimuli 
applied to the facial skin overlying the belly of the masseter muscles bilaterally did not 
result in greater salivation possibly because individual mechanoreceptors differ in their 
threshold sensitivity to vibration.  
We hypothesized that the modulation of whole salivary flow rates would be greater for 
electric tooth brushing compared with manual tooth brushing due to increased vibration 
and associated greater afferent stimulation. We found no significant differences, 
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however, between the two tooth brushing protocols with regard to increasing whole 
salivary flow rate. Although it is possible that other brands of electric toothbrushes might 
result in greater salivary stimulation compared with manual tooth brushing, our findings 
appear to suggest that the increased vibration associated with electric toothbrushes 
compared with manual toothbrushes may not result in a greater salivary response. 
In our post hoc analysis, we examined a potential relationship between age and the 
maximum salivary flow rate change (i.e., the maximum difference between salivary flow 
rate during baseline and tooth brushing conditions). We hypothesized that, given that 
older adults have lower unstimulated whole salivary flow rates and lower stimulated and 
unstimulated SMSL salivary flow rates (Affoo et al., 2015) compared with younger 
adults, we would observe that, as age increased, maximum salivary flow rate change 
would decrease. This, however, was not the case. A moderate, positive correlation was 
observed between age and maximum salivary flow rate change. That is, as age increased, 
so too did the maximum salivary flow rate increase observed during tooth brushing. The 
positive relationship between age and maximum salivary flow rate change was found to 
be moderate for manual tooth brushing but small for electric tooth brushing.  In order to 
explain this phenomenon, we hypothesized that the older participants experienced 
reduced baseline salivary flow rates compared with the younger participants. A lower 
baseline salivary flow rate might increase the potential for response to stimulation, 
resulting in a stimulated salivary flow rate similar to the younger participants. However, 
when the relationship between age and baseline salivary flow rates was examined, no 
significant correlations were identified. It appears, therefore, that the oldest adults in our 
sample demonstrated a more robust salivary response to tooth brushing than did the 
younger subjects. While reports confirm that parotid and minor salivary flow rates do not 
decline with increasing age (Affoo et al., 2015) and aspects of somatosensation, such as 
two-point discrimination, also do not decline with advancing age, (Calhoun, Gibson, 
Hartley, Minton, & Hokanson, 1992; Fukunaga, Uematsu, & Sugimoto, 2005) this does 
not explain why we observed a positive relationship between age and maximum salivary 
flow rate change. Older subjects were not observed to have more teeth than younger 
subjects (data not shown), younger subjects were not observed to be taking more 
xerogenic medications than older subjects, and males and females were found to be 
111 
 
equally distributed with regards to age (data not shown). It is currently unclear why we 
observed a positive relationship between age and maximum salivary flow rate change.  
With regards to the finding that the degree of correlation between age and maximum 
salivary flow increase was different for the manual and electric toothbrushes, this is a 
provocative finding given that comparison of the salivary flow rate increases associated 
with the two types of brushing revealed no statistically significant differences. When the 
relationship between maximum salivary flow rate changes associated with manual and 
electric tooth brushing was explored, a small correlation was identified. These findings 
suggest, that while there appears to be similarity between the two types of brushing, there 
are also differences between the two types of brushing resulting in differences in the 
physiological salivary response. 
Mouth comfort remained relatively consistent throughout the experimental protocols 
using the electric and manual toothbrushes. These results are consistent with those of 
Papas et al. (2006) who reported that 96.4% of participants felt that the Sonicare electric 
toothbrush was comfortable to use. Ninety percent of the participants in the present study 
were amenable to incorporating a standardized brushing protocol, with either a manual or 
electric toothbrush, into their daily oral hygiene routine suggesting that participants found 
this method of stimulation to be acceptable for daily use.   
4.4.1 Strengths and Limitations 
Epithelial cells are continually being shed from the oral mucosa into saliva and it has 
been estimated that the surface cells stay attached for only about three hours before being 
desquamated (Dawes, 2003). Participants in our study reported completing their early 
morning oral hygiene routine at least one hour prior to the experiment and all participants 
rinsed their oral cavities with distilled water immediately prior to participating. The 
elements of the present experimental protocol reduce the likelihood of epithelial cells 
making a significant contribution to the salivary collection and adding to the weight of 
the saliva samples. Nevertheless, it is possible that epithelial cells as well as plaque and 
residual food debris in the mouth, displaced by tooth brushing, may have contributed to 
the weight of the saliva samples. 
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One limitation of this study is that we did not complete a comprehensive dental exam on 
participants prior to study enrollment. We do not therefore have detailed information 
regarding the periodontal status of our participants.  
Participants were mainly recruited from an exercise program, introducing a potential bias 
in that the participants may have been more health-conscious than the general population.  
The electric toothbrush used in the experiment had a brush shaped similarly to the manual 
toothbrush and was not circular in shape. A circular brush is a popular shape among name 
brand electric toothbrushes. Therefore, we may not have employed a representative 
electric toothbrush.  
Glandular saliva was not collected in the present study. Thus, it is unclear which glands 
contributed more saliva to the increased flow rates in response to the tooth brushing. 
Based on previous work in this area, however, showing that the percentage contribution 
from the parotid gland increases to more than 50% of total salivary secretions during 
stimulation (Edgar, 1992; Humphrey & Williamson, 2001; Sreebny, 2000), we would 
predict that that the parotid glands contributed the greatest percentage of saliva to the 
increased flow rates observed.  
We observed limited response variability on the VAS scale measuring mouth comfort. 
Additionally, 40% of participants commented that they felt completing the VAS scale 
was the most difficult component of the experiment, possibly due to the complex and 
abstract nature of conceptualizing mouth comfort in individuals who do not experience 
oral discomfort on a regular basis. It is possible that the design of the VAS scale may 
have limited the response variability and in the future we may need to pilot VAS scales 
using different anchor terminology. 
4.4.2 Clinical implications:  
In the present study, we showed that tooth brushing is associated with an increase in 
salivary flow for up to 5 min post stimulation among adults aged 60 years and older who 
have at least 20 teeth and who do not complain of dry mouth or xerostomia. Although we 
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identified only a transient increase in salivary flow rates, this increase would be expected 
to contribute to reducing the bacterial load in the mouth and increasing oral lubrication.  
Saliva is present throughout the oral cavity as a very thin film known as a biofilm. 
According to Collins et al. (1987), given an average volume of saliva in the mouth of 
about 1 ml, and given that the surface area of the adult mouth is just over 200 cm2, saliva 
must be present as a film averaging about 0.1 mm or less in thickness between adjacent 
surfaces (Collins & Dawes, 1987). We observed a mean increase in whole salivary flow 
rates of 0.63 g/min (SD = 0.34 g/min) during manual tooth brushing and a mean increase 
of 0.78 g/min (SD = 0.37 g/min) during electric tooth brushing. These volumes could 
contribute substantially to the oral biofilm in the mouth, promoting optimal oral 
homeostasis, and potentially increasing oral comfort. 
Increasing salivary volume also may affect salivary clearance in that the volume of oral 
saliva contributes to triggering of the pharyngeal stage of swallowing (Dawes, 1983) in 
addition to increasing the rate of swallowing (Lagerlof & Dawes, 1984). Swallowing of 
secreted saliva reduces the concentration of exogenous substances in the oral cavity. A 
rapid salivary clearance of harmful substances is beneficial for oral health (Dawes, 2004). 
An increase in salivary volume, stimulating increased salivary clearance in an individual 
with harmful substances (such as cariogenic substances) in the oral cavity, could have 
beneficial effects on oral and overall health.  
We observed a moderate, positive correlation between age and maximum salivary flow 
rate increase, suggesting that the older adults in our sample tended to have greater 
salivary responses to stimulation. This finding suggests that older adults aged 
approximately 75 years and older could potentially benefit from tooth brushing more than 
their younger counterparts. This finding could have important implications for future 
studies examining saliva stimulation interventions.  
4.4.3 Future Directions 
In order to continue to broaden our understanding of oral physiology for eating and 
swallowing management and rehabilitation, future work in this field should focus on the 
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use of oral stimulation as a means of modulating salivary flow in a large sample of older 
adults. Examining the effects of increased saliva in the oral cavity on outcomes such as 
swallowing efficiency and safety would provide important clinical information. A study 
powered to compare salivary responses in age stratifications from 60 years of age to 90 
years and older would be helpful to replicate the results presented here with regard to the 
moderate, positive correlation observed between age and maximum salivary flow rate 
change. This study would also be beneficial for determining whether the effect continues 
into the older age groups (84 years of age and older) that were not examined in the 
present study.  
Future research should investigate the relative salivary contributions from each major 
salivary gland during tooth brushing. Additionally, examining other brands of electric 
toothbrushes to explore whether different brands result in different salivary stimulation 
profiles would provide practical information in terms of clinical translation.  
Further research exploring the physiology of saliva secretion and the nerve-mediated 
reflex pathway in response to manual and electrical tooth-brushing stimulation would be 
beneficial as our results suggest the potential for some stimulatory differences between 
the two different types of tooth brushing.  
4.5 Conclusion 
The present study suggests that tooth brushing stimulates saliva production for up to 5 
minutes in adults aged 60 years and older who are free of systemic disease. Older 
participants had a more robust salivary response to the tooth brushing compared with 
younger participants, suggesting that older adults may particularly benefit from tooth 
brushing to stimulate salivary secretion. Given that aging is associated with reduced 
salivary flow (Affoo et al., 2015) and reduced salivary flow may lead to impaired oral 
health (Baum, 1989), older adults are at greater risk of  developing poor oral health. The 
ability to increase salivary secretions has important clinical implications with regard to 
improving the oral health of older adults. 
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Chapter 5  
5 Conclusion 
In this dissertation, we used a scoping review technique to examine swallowing 
dysfunction and autonomic system dysfunction, including salivary flow dysfunction, in 
individuals with AD. We found that no studies have directly examined the effect of 
reduced salivary flow on swallowing function in AD despite the fact that salivary flow is 
crucial for optimal oral preparatory and oral phase swallowing (Matsuo, 2013) and may 
be reduced as part of the disease process (Ship et al., 1990; Ship & Puckett, 1994). 
Salivary flow may be reduced in people with AD (Ship et al., 1990; Ship & Puckett, 
1994). Previous research on the effect of aging on saliva production, however, is 
conflicting. As a result, we performed the second study of this dissertation to examine the 
effect of aging on saliva production, and we found that whole and SMSL salivary flow 
rates were reduced in older adults compared with younger adults.  
In the third and final study in this dissertation, in order to examine the potential for 
modulating salivary flow rates in older adults, we examined the effects of manual and 
electric tooth brushing on whole salivary flow rates in adults 60 years of age and older 
who were free of major systemic disease. We found that tooth brushing is associated with 
increased salivary flow rates for up to 5 minutes. The older participants had a more robust 
salivary response to the mechanical stimulation compared with the younger participants. 
Eating, swallowing, and maintaining optimal nutrition is essential to health (Waxman & 
World Health Assembly, 2004) and quality of life (Vailas et al., 1998). There appears to 
be a critical relationship between factors associated with eating and swallowing function, 
oral health, and saliva production. The studies reported in this dissertation were aimed at 
broadening the current understanding of these inter-related factors, both in healthy 
individuals and in individuals with AD. The results provide foundational information 
about eating and swallowing, saliva production, and saliva modulation and may incite 
future research, in many different patient populations, examining each of these individual 
elements and the critical relationship between them. 
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  Appendices  
Appendix A: Clinical Reports Employing Instrumental Assessment of Swallowing in 
Alzheimer's Disease (AD) 
Conclusion Supporting 
Studies 
Study 
Description 
Type of 
Dementia  
Method of 
Assessment 
Results Level 
of 
Evid-
ence 
Prevalence 
of 
dysphagia 
in AD 
Horner et 
al. 1994 
Prospective 
Case Series 
Alzheimer’s 
Disease 
(Moderate 
and Severe) 
Video-
fluoroscopy 
Investigators 
examined the 
frequency of 
swallowing 
abnormalities 
and the 
incidence of 
aspiration in a 
group of 25 
AD subjects 
with moderate 
or severe AD 
Swallowing 
impairment, 
characterized 
by impaired 
oral 
preparatory 
stage and 
delayed 
pharyngeal 
4 
122 
 
swallow, was 
observed in 21 
of 25 (84%) 
individuals 
with moderate 
or severe AD 
Aspiration was 
observed in 6 
of the 25 
individuals 
(28.6%) 
Abnormal 
position of the 
bolus head at 
pharyngeal 
swallow 
initiation was 
also observed  
Feinberg et 
al. 1992 
Retro-
spective 
Cohort 
Alzheimer’s 
Disease 
(Moderate 
and Severe), 
Multi-Infarct 
Dementia, 
and 
Parkinson’s 
Disease 
Dementia 
Video-
fluoroscopy 
Oral and 
pharyngeal 
function was 
examined in 
131 
individuals 
with advanced 
dementia (74 
with AD) 
Swallowing 
2b 
123 
 
impairments 
were observed 
in 93% 
individuals 
(results not 
specific to 
dementia type) 
Oral-stage 
dysfunction 
was observed 
in 93 of 131 
(71%) 
individuals, 
pharyngeal 
dysfunction in 
56 of 131 
(43%) 
individuals, 
and multiple 
stage 
dysfunction 
was observed 
in 55 of 131 
individuals 
Major 
aspiration was 
observed in 31 
(24%) 
individuals and 
minor 
124 
 
aspiration was 
observed in 66 
(50%) 
individuals 
Mizushima 
et al. 2005 
Described/c
haracterize
d dysphagia 
in AD 
through 
comparison 
of two or 
more 
groups of 
individuals 
Alzheimer’s 
Disease and 
Vascular 
Dementia 
(Stage not 
specified) 
Nasal 
Catheter to 
Inject Water 
into the 
Pharynx 
and EMG to 
Record the 
Swallow 
Cough/swallo
wing reflexes 
were 
investigated in 
30 patients 
with dementia 
(20 with AD) 
The 
swallowing 
water reflex 
was induced 
by a bolus 
injection of 
water into the 
pharynx 
through a nasal 
catheter and 
the reflex was 
evaluated by 
the volume 
injected that 
elicited a 
response 
within 4 sec 
following the 
injection 
NA 
125 
 
The cough 
reflex was 
evaluated 
following 
inhalation of 
capsaicin 
There were no 
statistically 
significant 
differences in 
these reflexes 
between 
dementia and 
control groups 
and between 
vascular and 
Alzheimer 
types 
Dysphagia 
occurs 
early in AD 
Humbert et 
al. 2010 
Described/c
haracterize
d dysphagia 
in AD 
through 
comparison 
of two or 
more 
groups of 
individuals 
Alzheimer’s 
Disease 
(Early and 
Mild) 
Video-
fluoroscopy
& fMRI 
Investigators 
examined 
whether 
functional 
changes in the 
cortical control 
of swallowing 
are evident in 
early AD 
On VFSS 
NA 
126 
 
(prone 
position), AD 
subjects 
demonstrated 
longer 
laryngeal 
vestibule 
closure, 
reduced hyo-
larnygeal 
excursion, and 
decreased 
laryngeal 
elevation 
Significantly 
lower BOLD 
response was 
identified in 
many cortical 
areas that are 
traditionally 
involved in 
normal 
swallowing 
Priefer & 
Robbins 
1997 
Described/c
haracterize
d dysphagia 
in AD 
through 
comparison 
Alzheimer’s 
Disease 
(Mild) 
Video-
fluoroscopy 
Investigators 
explored 
swallowing 
durations and 
self-feeding 
dependency in 
NA 
127 
 
of two or 
more 
groups of 
individuals 
normal elderly 
and early stage 
AD 
Individuals 
with early AD 
demonstrated 
impaired oral 
preparatory 
stage, delay of 
the initiation of 
the pharyngeal 
swallow, and 
prolonged 
overall 
swallow 
duration 
No subjects 
demonstrated 
aspiration 
during VFSS 
Humbert et 
al. 2011 
See Above See Above See Above See Above See 
Above 
Dysphagia 
in early AD 
may be 
associated 
with 
functional 
Humbert et 
al. 2010 
See Above See Above See Above See Above See 
Above 
Humbert et 
al. 2011 
Described/c
haracterize
d dysphagia 
in AD 
Alzheimer’s 
Disease 
(Mild) 
fMRI Investigators 
examined the 
frontal cortical 
activation in 
NA 
128 
 
change of 
the cortical 
swallowing 
network 
through 
comparison 
of two or 
more 
groups of 
individuals 
response to a 
“Do Not 
Swallow” task 
In response to 
a “Do Not 
Swallow” 
instruction, the 
AD group had 
a significantly 
greater BOLD 
response in the 
insula/operculu
m as compared 
to healthy age-
matched 
controls 
Dysphagia 
occurs in 
both the 
oral and 
pharyngeal 
phases of 
swallowing 
Humbert et 
al. 2010 
See Above See Above See Above See Above 4 
Garon et al. 
2009 
Retro-
spective 
Cohort 
Alzheimer’s 
Disease 
(Stage Not 
Specified) 
and General 
Dementia 
Video-
fluoroscopy 
Of 106 
individuals 
with dementia 
and complaints 
of dysphagia, 
68% had 
tracheal 
aspiration 
during 
imaging69% 
of those who 
2b 
129 
 
had tracheal 
aspiration 
demonstrated 
silent tracheal 
aspiration 
 
Suh et al. 
2009 
Described/c
haracterize
d dysphagia 
in AD 
through 
comparison 
of two or 
more 
groups of 
individuals 
Alzheimer’s 
Disease 
(Moderate) 
and 
Vascular 
Dementia 
Video-
fluoroscopy 
Investigators 
examined 
swallowing in 
two dementia 
groups using 
VFSS and 
observed that 
individuals 
with AD 
demonstrated 
the following: 
Prolonged oral 
transit, delayed 
initiation of the 
pharyngeal 
swallow, 
laryngeal 
penetration, 
and pharyngeal 
residue post 
swallow 
Investigators 
NA 
130 
 
observed that 
individuals 
with vascular 
dementia 
demonstrated 
the following: 
Delayed 
initiation of the 
pharyngeal 
swallow, 
reduced hyo-
laryngeal 
excursion, and 
pharyngeal 
residue post 
swallow 
Wada et al. 
2001 
Described/c
haracterize
d dysphagia 
in AD 
through 
comparison 
of two or 
more 
groups of 
individuals 
Alzheimer’s 
Disease 
(Mild, 
Moderate, 
and Severe) 
Nasal 
Catheter to 
Inject Water 
into the 
Pharynx 
and EMG to 
Record the 
Swallow 
The mean 
latency of the 
“swallowing 
reflex” was 
examined in 
individuals 
with AD 
In the severe 
AD group, 
latency of the 
reflex was 
significantly 
longer 
NA 
131 
 
compared to 
the mild-
moderate AD 
group 
No significant 
difference was 
observed 
between the 
mild and the 
moderate AD 
group 
Priefer & 
Robbins 
1997 
See Above See Above See Above See Above See 
Above 
Horner et 
al. 1994 
See Above See Above See Above See Above See 
Above 
Disease 
severity 
may be 
associated 
with 
dysphagia 
severity 
Wada et al. 
2001 
See Above See Above See Above See Above See 
Above 
Horner et 
al. 1994 
See Above See Above See Above See Above See 
Above 
 
Appendix B: Clinical Reports Employing Clinical Assessment of Swallowing in 
Alzheimer's Disease (AD) 
Conclusion Supporting Study Type of Method of Results Level 
132 
 
Studies Description Dementia  Assessment of 
Evid-
ence 
Prevalence 
of 
dysphagia 
in AD 
Volicer et 
al. 1989 
Described/ 
characteriz
ed an 
aspect of 
eating or 
swallowing 
dysfunction 
through the 
examinatio
n of a 
single 
group of 
patients 
with AD 
Alzheimer’s 
Disease 
(Stage Not 
Specified) 
Quest-
ionnaire 
completed 
by care staff 
Investigators 
examined 
eating 
difficulties in a 
group of AD 
patients in a 
long-term care 
facility 
23 (32.4%) of 
the residents 
were observed 
to choke on 
food or drink, 
some of these 
were also 
known to 
refuse food 
NA 
Chouinard 
et al. 1998 
Retro-
spective 
Cohort 
Alzheimer’s, 
Disease 
(Severe), 
Multi-Infarct 
Dementia, 
Other/Non-
Specified 
Chart 
review 
Investigators 
completed 
retrospective 
chart review of 
individuals 
with advanced 
dementia who 
died of 
pneumonia 
2b 
133 
 
21 of 47 
patients had 
Alzheimer’s 
disease (45%). 
21 of 47 
patients had 
significant 
swallowing 
abnormalities 
(45%). 
Swallowing 
abnormalities 
were described 
as: difficulty 
taking liquids, 
presence of 
coughing/chok
ing, poor 
tongue control, 
forgetting to 
swallow, and 
absence of 
chewing. 
The presence 
of swallowing 
disorders 
tended to 
correlate with 
134 
 
death from 
pneumonia 
Dysphagia 
may occur 
in all stages 
of AD 
Correia et 
al. 2010 
Described/c
haracterize
d 
dysphagia 
in AD 
through 
comparison 
of two or 
more 
groups of 
individuals 
Alzheimer’s 
Disease 
(Moderate 
and Severe) 
Quest-
ionnaire 
completed 
by caregiver 
and meal 
assessment 
using the 
Swallowing 
Rating 
Scale  
Swallowing 
and feeding 
problems were 
characterized 
in a group with 
AD subjects 
with moderate 
or severe AD 
The moderate 
AD group 
demonstrated 
passivity, 
distraction, and 
refusal to eat. 
The severe AD 
group 
demonstrated 
distraction, 
passivity, and 
inappropriate 
feeding 
velocity 
5 of the 18 
subjects with 
moderate AD 
(27.8%) and 
NA 
135 
 
23 of the 32 
individuals 
with severe 
AD (71.9%) 
had difficulty 
with the 
ingestion of 
specific 
consistencies 
12 individuals 
with severe 
AD (37.5%) 
with delayed 
swallowing 
Severe 
swallowing 
problems were 
observed in 7 
of the 
individuals 
from the 
severe AD 
group 
(21.87%) 
Edahiro et 
al. 2012 
Prospective 
Cohort 
Alzheimer’s 
Disease 
(Mild, 
Moderate, 
and Severe) 
Meal 
Assessment
s completed 
by 
researchers 
Factors 
affecting self-
feeding in 
elderly 
subjects with 
2b 
136 
 
AD were 
examined 
Signs of 
dysphagia and 
behavioural 
eating deficits 
were observed 
in individuals 
with mild, 
moderate and 
severe AD  
Logistic 
regression 
identified the 
following 
factors as 
predictors of 
decreased 
eating 
independence: 
difficulty 
beginning a 
meal, presence 
of dysphagia 
signs, and the 
severity of 
dementia 
Behavioura
l eating 
Priefer & 
Robbins, 
Described/c
haracterize
Alzheimer’s 
Disease 
Meal 
Assessment
Investigators 
examined 
NA  
137 
 
difficulties 
may occur 
in all stages 
of AD 
1997 d 
dysphagia 
in AD 
through 
comparison 
of two or 
more 
groups of 
individuals 
(Mild) s completed 
by 
researchers 
swallowing 
durations and 
self-feeding 
dependency in 
healthy elderly 
and early stage 
AD 
16 partner-
initiated cued 
behaviours 
and/or 
assistance 
were directed 
at 4 subjects 
with AD 
8 subject-
initiated cued 
behaviours 
were 
completed by 7 
subjects with 
AD 
Both partner-
initiated cues 
and subject-
initiated cues 
occurred 
significantly 
more 
138 
 
frequently 
compared to 
controls 
Durnbaugh 
et al. 1996 
Described/c
haracterize
d an aspect 
of eating or 
swallowing 
dysfunction 
through the 
examinatio
n of a 
single 
group of 
patients 
with AD 
Alzheimer’s 
Disease 
(Mid-Stage) 
Feeding 
Behaviour 
Inventory 
completed 
by nursing 
staff 
Feeding 
behavior was 
examined in 20 
subjects with 
AD 
11 of the 20 
(55%) subjects 
were on 
mechanically 
altered diets 
The most 
common 
mealtime 
behavioral 
problems 
were: 
distraction at 
meals, eating 
non-finger 
food with 
hands, playing 
with food, 
eating pieces 
that are too 
big, preference 
for sweet 
NA 
139 
 
foods, 
incorrect use 
of utensils, 
staring without 
eating, 
impatient 
behaviours 
demonstrated 
during or prior 
to mealtime, 
eating other 
residents’ 
food, refusing 
meals 
Morris et al. 
1989 
Described/c
haracterize
d an aspect 
of eating or 
swallowing 
dysfunction 
through the 
examinatio
n of a 
single 
group of 
patients 
with AD 
Alzheimer’s 
Disease 
(mild, 
moderate, 
and severe), 
Multi-Infarct 
Dementia, 
and Mixed 
Dementia 
Caregiver 
semi-
structured 
interview  
Investigators 
evaluated the 
eating habits of 
33 patients 
with dementia 
(27 having 
AD) 
63% of the 
sample 
demonstrated 
reduced food 
intake, 26% 
demonstrated 
increased food 
intake, 37% 
showed 
NA 
140 
 
changed food 
preferences, 
60% 
demonstrated 
abnormal 
utensil use, 
and 26% 
demonstrated 
aberrant oral 
eating 
behaviour such 
as eating 
inappropriate 
non-food 
items. 
Edahiro et 
al. 2012 
See Above See Above See Above See Above See 
Above 
Burge 1994 
 
Described/c
haracterize
d an aspect 
of eating or 
swallowing 
dysfunction 
through the 
examinatio
n of a 
single 
group of 
patients 
with AD 
Alzheimer’s 
Disease 
(Severe) and 
Vascular 
Dementia 
Meal time 
observation
s 
Eating 
behavior was 
examined in a 
group of 
individuals 
with dementia 
Slightly less 
than half of 
150 patients 
received some 
form of a 
texture 
NA 
141 
 
modified diet 
22% of all 
patients were 
totally 
dependent for 
feeding and, of 
these patients, 
all received a 
modified diet 
regardless of 
the presence of 
a swallowing 
problem 
Suski & 
Nielsen 
1989 
Described/c
haracterize
d an aspect 
of eating or 
swallowing 
dysfunction 
through the 
examinatio
n of a 
single 
group of 
patients 
with AD 
Alzheimer’s 
Disease 
(Severe) 
Comprehen
sive 
nutritional 
assessment 
Nutritional 
intake and 
feeding 
difficulties 
were recorded 
in 19 women 
with advanced 
AD 
19 of the 19 
subjects 
(100%) 
required diet 
modifications 
NA 
Dysphagia 
and eating 
Ikeda et al. 
2002 
Described/c
haracterize
Fronto 
temporal 
Quest-
ionnaire 
Frequency and 
characteristics 
NA 
142 
 
difficulties 
in AD may 
be less 
severe than 
in other 
types of 
dementia 
d 
dysphagia 
in AD 
through 
comparison 
of two or 
more 
groups of 
individuals 
Lobe 
Dementia 
and 
Alzheimer’s 
Disease 
(Mild, 
Moderate, 
and Severe) 
completed 
by caregiver 
of eating 
problems were 
recorded 
through 
caregiver 
questionnaires 
Caregivers of 
AD patients 
reported lower 
frequencies of 
swallowing 
problems, 
appetite 
changes, food 
preferences, 
and eating 
habits as 
compared to 
the caregivers 
of patients 
with 
frontotemporal 
lobe dementia. 
AD caregivers 
reported that 
58.1% of the 
AD patients 
demonstrated 
at least one 
symptom of 
143 
 
eating and 
swallowing 
difficulties 
AD caregivers 
report that 
swallowing 
problems 
appear early in 
the disease 
process 
Shinagawa 
et al. 2009 
Described/c
haracterize
d 
dysphagia 
in AD 
through 
comparison 
of two or 
more 
groups of 
individuals 
Lewy Body 
Dementia 
and 
Alzheimer’s 
Disease 
(Mild and 
Moderate) 
Quest-
ionnaire 
completed 
by caregiver 
Frequency and 
characteristics 
of eating 
problems were 
recorded 
through 
caregiver 
questionnaires  
Caregivers of 
patients with 
Lewy body 
dementia 
reported 
significantly 
greater/more 
severe eating 
and 
swallowing 
difficulties 
NA 
144 
 
compared with 
caregivers of 
AD patients 
The AD 
caregivers 
reported a 
number of 
eating and 
swallowing 
abnormalities 
 
Appendix C: Clinical Reports Examining the Treatment of Dysphagia in 
Alzheimer's Disease (AD) 
Conclusion Supporting 
Studies 
Study 
Description 
Dementia 
Studied 
Method  Results Level 
of 
Evid-
ence 
Thickening 
liquids to a 
honey-
thickened 
consistency 
may 
eliminate 
thin liquid 
aspiration 
in 
individuals 
Logemann 
et al. 2008 
Prospective 
Randomize
d Clinical 
Trial 
Dementia 
with 
Alzheimer’s 
disease, 
Dementia 
due to single 
or 
multistroke, 
Dementia 
(general), 
Parkinson’s 
711 thin 
liquid 
aspirators 
(confirmed 
during 
VFSS) were 
included in 
the study 
and 
received 3 
intervention
Immediate 
elimination of 
aspiration on 
thin liquids 
occurred most 
often with 
honey-
thickened 
liquids for 
patients in 
each 
2b 
145 
 
with AD, 
however 
this 
intervention 
may not 
affect long-
term 
morbidity 
and 
mortality 
disease, and 
Parkinson’s 
disease with 
dementia 
s (chin-
down 
posture, 
nectar-
thickened 
liquids, or 
honey-
thickened 
liquids) in a 
random 
order, 
during 
VFSS  
diagnostic 
category 
This 
intervention 
was least 
preferred by 
the patients 
 
Robbins et 
al. 2008 
Prospective 
Randomize
d Clinical 
Trial 
Dementia 
with 
Alzheimer’s 
disease, 
Dementia 
due to single 
or 
multistroke, 
Dementia 
(general), 
Parkinson’s 
disease, and 
Parkinson’s 
disease with 
dementia 
504 thin 
liquid 
aspirators 
(confirmed 
during 
VFSS) were 
randomly 
assigned 1 
of 3 
intervention
s (chin-
down 
posture, 
nectar-
thickened 
liquids, or 
honey-
No statistically 
significant 
differences in 
outcome were 
identified 
following the 
use of the three 
interventions  
2b 
146 
 
thickened 
liquids) and 
followed 
until death 
or four 
months  
A 
physiothera
pist 
administere
d cervical 
spine 
mobilizatio
n protocol 
may 
improve 
“dysphagia 
limit” in 
individuals 
with severe 
AD and 
altered 
neck 
posture 
Bautmans 
et al. 2008 
Prospective 
Randomize
d 
Controlled 
Trial with 
Cross-Over 
Design 
Alzheimer’s 
Disease 
(Severe) 
15 nursing 
home 
residents 
were 
randomized 
to 
participate 
in either an 
intervention 
condition 
(cervical 
spine 
mobilizatio
n) followed 
by a wash-
out period 
followed by 
a control 
condition, 
or a control 
period 
followed by 
a washout 
period 
Following the 
treatment 
paradigm the 
subjects 
demonstrated 
improved 
“dysphagia 
limit” (the 
maximum 
sized bolus of 
water that can 
be swallowed 
in a single 
movement) 
2b 
147 
 
followed by 
a treatment 
condition 
 
Appendix D: Clinical Reports Examining Autonomic Nervous System (ANS) 
Dysfunction in Alzheimer's Disease (AD) 
Conclusion Supporting 
Studies 
Study Description Results Level 
of 
Evid-
ence 
Individuals 
with AD 
demonstrate 
blood pressure 
differences at 
baseline and 
following 
stimulation, as 
compared with 
controls 
Lampe et 
al., 1989 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Investigators examined 
changes in blood pressure, 
plasma norepinephrine 
(NE), serum prolactin, 
luteinizing hormone, and 
follicle-stimulating 
hormone associated with 
infusions of 2 thyrotropin-
releasing doses in 10 men 
with early onset AD and in 
9 age-matched controls 
Diastolic pressor responses 
to thyrotropin-releasing 
hormone (TRH) were 
substantially blunted in AD 
subjects relative to controls, 
even at the higher dose of 
TRH 
NA 
148 
 
There was a trend towards 
attenuation of the systolic 
and plasma NE response as 
well 
Otsuka et 
al. 1990 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Blood pressure and heart 
rate measurements were 
recorded in 31 elderly 
hospitalized patients, who 
were classified into 4 
groups: group D comprised 
8 bedridden patients with 
AD; group R comprised 7 
bedridden patients that did 
not have dementia; group N 
comprised 9 normotensive, 
ambulatory patients; and 
group H comprised 7 
hypertensive, ambulatory 
patients  
For group D, mean systolic 
blood pressure over a 24-
hour period was statistically 
higher compared with 
group R 
Also, in group D, the 
circadian rhythm of blood 
pressure was abnormal, 
showing no nocturnal 
NA 
149 
 
decrease as compared to the 
control groups 
Elmstahl et 
al. 1992 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Investigators studied 24 
women with late-onset AD 
and 54 age-matched healthy 
controls using tilting and 
breathing tasks 
AD patients had lower 
baseline mean systolic and 
diastolic blood pressure 
compared with control 
patients 
After tilting, the AD 
patients had a greater 
increase in heart rate, and 
the mean systolic blood 
pressure fell significantly 
compared with the controls 
Acceleration indices were 
significantly higher in the 
AD patients and brake 
indices were significantly 
lower 
NA 
Burke et al. 
1994 
Retrospective chart 
review and 
neuroanatomical 
analysis of 3 
postmortem AD 
Chart review of 3 patients 
with autopsy-confirmed AD 
indicated that yearly 
systolic, diastolic, and mean 
arterial blood pressures 
NA 
150 
 
subjects and 
characterization of an 
aspect of ANS 
dysfunction in AD 
through comparison of 
two or more groups of 
individuals, one or more 
of these groups being 
comprised of AD 
patients 
decreased in all patients 
following the year of 
diagnosis 
Up to 30% of C-1 neurons 
were atrophied in sections 
from the same AD patients 
The number of C-1 neurons 
correlated strongly with 
mean arterial pressure and 
systolic blood pressure  
Hypothalamic 
phenylethanolamine N-
methyl-transferase activity 
was significantly decreased 
in 5 AD patients compared 
with controls 
Neuropathology analysis 
documented neurofibrillary 
tangles in the 
paraventricular nucleus of 
an individual with 
Alzheimer’s disease but not 
in a control subject  
Idiaquez et 
al. 1997 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Investigators studied 7 AD 
subjects and 23 controls 
before and after a meal to 
identify the presence/degree 
of postprandial hypotension 
NA 
151 
 
in AD 
70% of 10 AD patients 
experienced postprandial 
hypotension compared to 
26% of 23 controls.  
Guo et al. 
1998 
Prospective cohort study  Investigators examined a 
relationship between low 
blood pressure and 
increased mortality in 202 
patients with dementia (112 
with AD) 
There was a positive linear 
relationship between blood 
pressure and Mini Mental 
State Exam score (every 10 
mm Hg increase in systolic 
pressure was related to a 0.6 
unit increase in score) for 
the total sample of 
individuals with dementia 
(results are not specific to 
dementia type, individuals 
with AD comprised 55.4% 
of the sample) 
Patients with moderate and 
severe dementia had 
significantly lower systolic 
and diastolic blood pressure 
2b 
152 
 
than did those with 
questionable and mild 
dementia 
When the sample was 
examined as a whole, 
patients with low blood 
pressures had shorter 
survival time than did those 
with higher blood pressures 
Kalman et 
al. 2002 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Cutaneous active 
vasodilation was assessed 
in 22 patients with AD and 
20 age-matched controls 
using an isometric handgrip 
exercise 
A significantly smaller 
reduction of R wave 
intervals (i.e., a measure of 
heart rate) was observed in 
the AD group 
Static exercise was 
associated with increased 
variation in both systolic 
blood pressure and diastolic 
blood pressure in both 
groups, but the systolic 
blood pressure change was 
significantly smaller in AD 
NA 
153 
 
patients 
Significantly higher 
cutaneous vascular 
resistance and decreased 
skin blood flow were 
observed following the 
stimulus in the AD group  
The resting R wave interval 
was significantly correlated 
with the Mini Mental State 
Exam score and a highly 
significant negative 
correlation was calculated 
for the resting skin blood 
flow and age for all AD 
subjects 
Bordier et 
al. 2007 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
10 (30%) of AD subjects 
had positive carotid sinus 
massage, with prolonged 
ventricular standstill in two 
subjects (6.7%) 
The response to carotid 
sinus massage did not 
predict increased risk in 
bradycardia-mediated 
syncope 
Syncope was identified in 3 
AD subjects during follow-
NA 
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up (10%) 
Individuals 
with AD 
demonstrate 
significantly 
greater falls in 
blood pressure 
(particularly 
systolic) when 
transitioning 
from supine to 
standing 
(orthostatic 
hypotension) 
compared with 
healthy age-
matched 
controls 
Elmstahl et 
al. 1992 
See Above See Above See 
Above 
Vitiello et 
al. 1993 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Investigators measured the 
autonomic nervous system 
in AD using lying and 
standing blood pressure, 
pulse and plasma 
epinephrine and 
norepinephrine in 60 AD 
subjects and 20 normal 
elderly controls 
Following a supine to 
standing task, mean systolic 
BP decreased in the 
subjects with AD but 
increased in the controls  
In AD patients with 
depression, during 
orthostasis, systolic BP was 
significantly decreased 
compared to AD patients 
with no signs of depression 
The non-depressed AD 
patients had significantly 
lower systolic BP during 
orthostasis as compared to 
the controls 
NA 
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Subjects with AD 
demonstrated no differences 
in basal or standing plasma 
levels of norepinephrine 
and epinephrine 
Wang et al. 
1994 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Authors investigated 
cardiovascular autonomic 
function in 23 AD subjects 
and 23 age-matched 
controls 
Subjects with AD had 
significantly lower systolic 
and mean blood pressure 
levels in the supine position 
and 3 min after standing 
compared with controls 
There was a tendency 
toward lower systolic blood 
pressure in the patients with 
more severe disease 
NA 
Jhee et al. 
1995 
Retrospective 
description of ANS 
dysfunction in AD 
through examination of 
a single group of AD 
subjects 
Authors conducted a 
retrospective analysis of 
blood pressures and heart 
rates of 31 patients with AD 
Significant mean decreases 
in systolic and diastolic 
blood pressures were noted 
NA 
156 
 
in AD patients 
While the investigators 
report that these decreases 
were noted to be 
significantly different from 
baseline pressures, there 
was no comparison with 
healthy controls  
The mean decreases are 
consistent with other 
clinical reports that 
demonstrated significantly 
greater pressure drops in 
AD patients as compared to 
controls, when transitioning 
from sitting to standing 
Passant et 
al. 1997 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Investigators examined the 
prevalence of orthostatic 
hypotension, low blood 
pressure, dizziness, falls 
and fractures in patients 
with dementia (46 with AD) 
The mean supine/resting 
systolic blood pressure was 
generally lower than in 
normal healthy aged 
population (i.e., compared 
to norms as there was no 
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control group in this study) 
18 of the 46 AD patients 
demonstrated orthostatic 
hypotension (a blood 
pressure decrease of 20 mm 
Hg or more)  
Only 39% of the AD 
patients with orthostatic 
hypotension experienced 
clinical symptoms of 
dizziness; 50-56% of those 
AD patients with orthostatic 
hypotension had 
experienced falls and more 
than one fracture 
53% of the patients with 
AD and orthostatic 
hypotension experienced 
blood pressure falls after 3 
min of standing or later, 
however, 27% didn’t 
experience the maximum 
blood pressure drop until 
after 10 min of standing 
All AD patients 
demonstrated highly 
significant heart rate 
increases from supine to 
158 
 
standing position 
Kalman et 
al. 2002 
See Above See Above See 
Above 
Andin et al. 
2007 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Investigators 
retrospectively studied 22 
AD cases with white matter 
disease and 22 AD cases 
without white matter 
disease, both based on 
neuropathology analysis	
Reports of hypertension, 
orthostatic hypotension, and 
dizziness/unsteadiness were 
significantly more frequent 
in the AD group with white 
matter disease compared 
with the AD group without 
white matter disease	
NA 
Allan et al. 
2007 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Investigators compared 
cardiovascular autonomic 
function in subjects with 
AD (39), vascular 
dementia, Lewy body 
dementia, Parkinson’s 
disease dementia, and 
controls 
AD patients demonstrated a 
significantly greater mean 
NA 
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fall in systolic blood 
pressure on standing when 
compared to an age 
matched group 
These AD patients also 
demonstrated a significantly 
greater prevalence of 
sustained orthostatic 
hypotension as well as a 
greater median time for 
return of systolic blood 
pressure to baseline 
AD patients were also more 
likely to have an autonomic 
neuropathy and severe, 
definite and atypical 
autonomic neuropathy, 
using the Ewing 
classification, as compared 
to controls 
Individuals with AD 
demonstrated the least 
amount of autonomic 
dysfunction as compared to 
individuals with other types 
of dementia 
Andersson 
et al. 2008 
Described/characterized 
ANS dysfunction in AD 
Investigators aimed to 
determine whether 
NA 
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through comparison of 
two or more groups of 
individuals 
orthostatic hypotension is 
more common in patients 
with dementia (235 having 
AD) as compared to 62 
elderly controls  
Orthostatic hypotension 
occurred in 42% of the AD 
patients compared with 
only 13% of the controls 
Allan et al. 
2009 
Prospective Cohort  Investigators aimed to 
identify potentially 
modifiable predictors of 
falls in older people with 
mild-moderate dementia 
(38 with AD) compared to 
39 controls 
Univariate predictors of 
falls in dementia, stratified 
by diagnosis, were noted to 
include duration of 
dementia, history of falls or 
recurrent falls in the 
preceding 12 months, use of 
cardioactive medication, 
autonomic symptom scale 
greater than 7 and time 
taken for blood pressure to 
return to baseline on 
standing 
2b 
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Multivariate predictors of 
falls in dementia, stratified 
by diagnosis, were noted to 
be symptomatic orthostatic 
hypotension, and use of 
cardioactive medications 
Physical activity was noted 
to be protective in both 
models 
Mehrabian 
et al. 2010 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Investigators examined the 
relationship between 
orthostatic hypotension and 
cognitive function in a 
group of 495 consecutive 
elderly made up of those 
with normal cognitive 
function, mild cognitive 
impairment, AD, or 
vascular dementia 
Orthostatic hypotension 
was identified in 15% of the 
sample of 233 AD patients 
There was a significant 
relationship between 
orthostatic hypotension and 
cognitive status.  Greater 
mean fall in systolic blood 
pressure after standing was 
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observed in patients with 
vascular dementia or AD as 
compared to those with 
normal cognitive function 
Zakrzewska
-Pniewska 
et al. 2012 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Investigators evaluated 
clinical dysautonomia in 54 
AD patients and 37 healthy 
age-matched controls using 
clinical autonomic 
assessment, functional 
assessment, the sympathetic 
skin response and the R-R 
interval variation test 
Clinical symptoms of 
dysautonomia were found 
in 66% of a group of 54 AD 
patients but were relatively 
mild  
In AD patients, orthostatic 
hypotension was observed 
in 34.5%, constipation in 
17.2%, and urinary 
incontinence in 13.8 
Sympathetic skin response 
was abnormal in 27% of 
AD patients and heart rate 
variability was abnormal in 
88% of cases as compared 
NA 
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with controls 
Significantly 
less heart rate 
variability has 
been reported in 
individuals with 
AD 
Franceschi 
et al. 1986 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Study examined cardiac 
ANS function during sleep 
in 16 AD patients compared 
with 7 healthy controls 
The mean body movement 
ratio (body movement 
related heart rate variation) 
during non-REM and REM 
sleep was significantly 
lower for AD patients 
compared with the controls 
NA 
Aharon-
Peretz et al. 
199270 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Investigators examined 
heart rate variability in AD 
A group of 20 AD patients 
demonstrated significant 
differences in power 
spectrum density of 
echocardiogram as 
compared to 7 volunteer 
controls 
AD patients demonstrated a 
relatively 
hypersympathetic, 
hypoparasympathetic state 
with regard to heart rate, 
both when standing and 
supine 
NA 
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The peak-to-peak amplitude 
of the tachogram in a 
normal subject was about 3 
times greater than the peak-
to-peak amplitude of the 
tachogram of the patient 
with AD 
Algotsson 
et al. 1995 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Investigators measured 
heart rate variability and 
sympathetic skin response 
to electrical stimulation in 
order to assess 
parasympathetic and 
sympathetic ANS function 
in 29 AD patients and 15 
controls 
Very few patients or 
caregivers reported 
symptoms of ANS 
dysfunction 
AD patients had 
significantly lower heart 
rate reactions to passive 
tilting and the Valsalva 
maneuver and a 
significantly greater 
reduction of finger pulse 
amplitude during the 
NA 
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Valsalva maneuver 
AD patients also 
demonstrated a decreased 
response the sympathetic 
skin response test 
The AD patients showed 
signs suggesting autonomic 
dysfunction affecting both 
parasympathethic and 
vasomotor sympathetic 
functions  
At one-year follow up, 
there was a slight 
deterioration for relative 
beat-to-beat variations 
during deep breathing but 
there was a slight 
improvement in heart 
reactions to the tilt test 
Szili-Torok 
et al. 2001 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals  
A group 24 AD patients 
demonstrated significantly 
shorter R-R interval length 
on echocardiogram 
recordings as compared to a 
group of 22 controls 
Baroreflex sensitivity was 
also markedly reduced in 
AD patients as compared to 
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controls 
Patients with AD showed 
significantly higher basal 
heart rate and decreased R-
R interval oscillation and 
increased systolic arterial 
blood pressure oscillation 
as compared to controls 
Idiaquez et 
al. 2002 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Investigators examined the 
association between 
specific neuropsychiatric 
deficits and autonomic 
dysfunction in patients with 
AD 
Measures of heart rate 
variation to deep breathing 
were consistently reduced 
in a group of 20 AD 
patients compared to a 
group of 20 age-matched 
controls 
In those AD patients who 
demonstrated abnormal 
heart rate variation, there 
were significant 
abnormalities in the Blessed 
score and in the apathy, 
delusions, and aberrant 
NA 
167 
 
motor behavior items of the 
neuropsychiatric inventory 
Zulli et al. 
2005 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
A group of 33 AD patients 
demonstrated significantly 
greater QT dispersion (i.e. 
an index of ventricular 
repolarization 
inhomogeneity) as 
compared to a group of 29 
controls  
These subjects also 
demonstrated significantly 
decreased heart rate 
variability compared to the 
control group 
Investigators reported a 
positive linear correlation 
between the Mini Mental 
State Exam and 
Alzheimer’s Disease 
Assessment Scale – 
cognitive subscale scores, 
and the measures of QT 
dispersion, QT corrected 
dispersion, low-frequency 
power, and high frequency 
power 
NA 
Toledo and Described/characterized Investigators measured NA 
168 
 
Junqueira 
Jr, 2008 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
cardiac autonomic 
modulation and 
sympathovagal balance in 
the supine and active 
standing positions based on 
short-term time- and 
frequency-domain heart 
interval variability analysis 
in 22 AD patients as 
compared to 24 controls 
The mean high frequency 
power showed a significant, 
borderline reduction in the 
supine posture and was 
significantly reduced after 
standing in AD 
Sympathovagal balance (as 
measured by short-term 
time and frequency domain 
heart interval variability) 
was significantly altered 
towards relative depression 
of parasympathetic and 
enhancement of 
sympathetic modulation in 
the supine but not the 
standing posture 
AD patients demonstrated 
subtle, absolute and relative 
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parasympathetic depression 
and relative sympathetic 
exacerbation 
Toledo and 
Junqueira 
Jr, 
2010 
Described/characterized 
an aspect of ANS 
dysfunction through the 
examination of a single 
group of patients with 
AD 
Investigators examined the 
relationship between 
measures of cardiac 
sympathogvagal 
modulation of heart interval 
variability and the cognitive 
part of the Cambridge 
Examination for Mental 
Disorders of the Elderly 
(CAMCOG) and the Mini 
Mental State Exam 
(MMSE) in 22 AD subjects 
There was a significant 
positive correlation, in both 
supine and standing, 
between the cognitive 
performance and cardiac 
autonomic modulation of 5 
min heart interval 
variability evaluated by 
time-and frequency- 
domain indexes 
(parasympathetic 
modulation) in 22 AD 
patients  
Negative trend correlation 
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was observed between 
absolute sympathetic 
modulations in supine 
posture  
Individuals with higher 
cognitive deficiency 
showed significantly lower 
cardiac parasympathetic 
modulation and trend for 
sympathetic over activity 
Zakrzewska
-Pniewska 
et al. 2012 
See Above See Above See 
Above 
Individuals 
with AD also 
demonstrate 
altered blood 
pressure and 
heart rate 
responses to 
pain stimuli 
Rainero et 
al. 2000 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Investigators analyzed the 
effects of electrical noxious 
stimulation on the ANS of 
20 AD subjects compared 
with 20 healthy subjects 
Following presentation of 
threshold pain stimulation, 
there was a dramatic 
increase in heart rate in 
controls but only a slight 
increase in AD patients and 
the peak heart rate was 
significantly less 
pronounced for the AD 
patients  
NA 
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Heart rates increased in 
expectation of the pain 
stimuli and this was 
significantly less 
pronounced in the AD 
patients 
The changes in blood 
pressure paralleled the 
changes in heart rate but 
were not statistically 
significant  
AD patients reported 
experiencing the same pain 
intensity as the controls 
when the stimulation was at 
the pain threshold and just 
above the pain threshold. 
However, AD patients 
reported experiencing 
significantly less pain 
intensity in response to 
stimulation at twice pain 
threshold, 
Linear regression showed 
that pain rating of the twice 
pain-threshold stimulus was 
closely related to the 
severity of AD, as assessed 
172 
 
by the Mini Mental State 
Exam. 
Benedetti et 
al. 2004 
Described/characterized 
an aspect of ANS 
dysfunction through the 
examination of a single 
group of patients with 
AD 
Neither stimulus detection 
nor pain threshold was 
correlated with cognitive 
status or brain electrical 
activity decline 
There was a correlation 
between heart rate 
responses and deterioration 
of both cognitive functions 
and brain electrical activity 
This correlation was also 
found for the anticipatory 
heart rate increases 
preceding pain stimulation. 
NA 
Autonomic 
nervous system 
dysfunction 
appears to be 
subtle in 
patients with 
AD when 
compared with 
other types of 
dementia 
Allan et al. 
2007 
See Above See Above See 
Above 
Allan et al. 
2006 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Investigators examined the 
presence and severity of 
autonomic symptoms in 
patients with different 
subtypes of dementia (40 
with AD) compared to 
healthy controls 
Individuals with AD had 
significantly lower activity 
NA 
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scores and significantly 
worse ADL scores 
compared to controls  
Individuals with AD scored 
similar to controls with 
respect to a self-reported 
autonomic symptoms scale 
All other subtypes of 
dementia scored higher on 
the self-reported autonomic 
symptoms scale 
Plasma 
norepinephrine 
levels may be 
altered in AD 
Borson et 
al. 1989 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Indicators of SNS function 
were examined in 10 
college educated males with 
AD and 7 education-
matched, healthy controls 
Normal older subjects 
responded to mental effort 
with a rise in plasma 
norepinephrine, plasma 
epinephrine, mean arterial 
pressure, and heart rate 
AD patients responded to 
cognitive challenge with a 
significant but un-sustained 
rise in plasma epinephrine  
There were clear 
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differences between groups 
on 3 measures of 
sympathetic nervous system 
activity during cognitive 
effort, with AD subjects 
showing a blunted response 
as compared to controls  
Raskind et 
al. 1984 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Investigators measured 
CNS and peripheral 
noradrenergic function by 
measuring norepinephrine 
and 3-methoxy-4-
hydroxyphenylglcol levels 
in CSF and plasma  
Norepinephrine and 3-
methoxy-4-
hydroxyphenylglcol levels 
were significantly higher in 
both CSF and plasma in 
patients with advanced AD 
as compared to individuals 
with moderate AD or 
controls 
Heart rate was higher in the 
patients with advanced AD 
compared with the other 
two groups and there was a 
tendency for mean arterial 
blood pressure to be higher 
NA 
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in patients with advanced 
AD 
Lampe et al. 
1989 
See Above See Above  See 
Above 
Peskind et 
al. 1995 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Cerebrospinal fluid and 
plasma norepinephrine 
concentrations were 
examined in response to an 
alpha-2 adrenergic 
antagonist in individuals 
with AD, healthy older 
controls, and healthy young 
controls 
Plasma norepinephrine 
concentrations in the 
placebo treatment condition 
was significantly higher in 
normal older and AD 
subjects compared with 
young subjects 
Mean arterial pressure in 
the placebo treatment 
condition was higher both 
normal older and AD 
subjects compared with 
young subjects 
NA 
Ahlskog et 
al. 1996 
Described/characterized 
ANS dysfunction in AD 
Investigators evaluated 
plasma catechols in 15 
NA 
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through comparison of 
two or more groups of 
individuals 
patients with Parkinson’s 
disease, 12 AD subjects, 
and 15 controls 
A non-significant trend 
towards greater median 
plasma norephinephrine 
concentrations in the AD 
group compared with 
controls was reported 
Peskind et 
al. 1998 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Resting CNS adrenergic 
activity was evaluated in 
AD and normal aging by 
measuring cerebrospinal 
and plasma epinephrine 
concentration, as well as 
heart rate and blood 
pressure in individuals with 
AD, healthy older controls, 
and healthy young controls 
The effects of AD and 
aging on the responsiveness 
of the CNS adrenergic 
systems were measured by 
evaluating the changes in 
cerebrospinal epinephrine 
following administration of 
an alpha-2 adrenergic 
receptor antagonist and an 
alpha-2 agonist 
NA 
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Plasma epinephrine was 
significantly higher in AD 
than normal older or normal 
younger subjects 
Blood pressure was affected 
by aging but not AD 
Higher heart rates were 
observed in the AD group 
as compared to the normal 
older and normal younger 
subjects 
Systolic and diastolic blood 
pressure measurements 
were significantly higher in 
the alpha-2 adrenoreceptor 
agonist condition in both 
older and AD subjects 
Pascualy et 
al. 2000 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Plasma adrenocorticotropic 
hormone, cortisol, 
norepinephrine, and 
epinephrine responses to a 
one-minute cold pressor test 
were measured in 9 AD 
subjects and 9 age-matched 
controls 
Cortisol response was 
increased in the AD group 
NA 
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but the plasma 
adrenocorticotropic 
hormone response did not 
differ  
Basal norepinephrine 
concentrations were higher 
in the AD group, but 
norepinephrine responses to 
the cold pressor test did not 
differ between groups 
The blood pressure 
response to the cold pressor 
test was higher in the AD 
subjects, however there 
were no significant 
differences in heart rate 
Vasomotor 
function may be 
reduced in 
individuals with 
AD 
Hornqvist et 
al. 1987 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Peripheral reactivity to an 
alpha1-agonist, a beta-
agonist, and cholinergic 
agonist was examined in 12 
AD subjects as compared to 
16 controls 
A reduced response towards 
the adrenergic agonists and 
for the beta-agonist was 
seen in the AD patients 
The response to the 
cholinergic agonist did not 
NA 
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differ between individuals 
with AD and healthy 
controls 
Increasing age did not 
significantly influence the 
cutaneous responses in the 
controls 
Algotsson 
et al. 1995 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Investigators studied skin 
vessel reactivity in response 
to three vasodilating 
substances in 15 AD 
subjects as compared to 16 
age-matched controls 
Skin vascular responses of 
the AD subjects to 
acetylcholine and 
isoprenaline (but not 
nitroprusside) were greatly 
attenuated compared with 
controls 
NA 
Kalman et 
al. 2002 
See Above See Above See 
Above 
Individuals 
with AD may 
demonstrate an 
impaired sweat 
response 
Elmstahl 
and Winge 
1993 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Investigators evaluated 
sweat electrolyte 
concentrations following 
pilocarpine iontophoresis 
stimulation in 15 females 
with AD compared to 29 
NA 
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healthy female controls 
Mean sweat sodium 
concentration was 
significantly higher among 
the AD subjects 
There was a higher 
proportion of non-
responders among the AD 
women than among the 
controls 
Pupillary 
responses in 
AD are altered 
in AD  
Idiaquez et 
al., 1994 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Investigators studied 
cholinergic dysfunction in 
the iris in 26 subjects with 
AD and 23 healthy controls 
AD patients demonstrated 
significantly increased 
sensitivity to a 
parasympathetic agent 
(greater change in pupillary 
constriction) compared to 
controls 
NA 
Grunberger 
et al. 1999 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Investigators examined 
pupillary dilatation after 
application of an 
acetylcholine transmission 
antagonist in 29 AD 
patients and 29 controls 
NA 
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Initial pupillary diameters 
of the AD patients were 
significantly smaller than 
those of the controls 
Both AD patients and 
controls responded to the 
acetycholine agonist with 
pupillary dilation 
Patients with AD showed a 
larger relative change of 
pupillary diameter than the 
controls 
Fotiou et al. 
2009 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Central cholinergic 
dysfunction was examined 
with pupillometry in 23 
patients with AD and in 22 
patients with PD (11 with 
cognitive impairment and 
11 without) compared with 
23 normal controls 
AD patients had 
significantly lower levels of 
maximum constriction 
velocity, maximum 
constriction acceleration, 
amplitude, and percentage 
amplitude compared with 
controls 
NA 
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AD patients had 
significantly higher levels 
of percentage recovery – 
redilatation, latency, time 
for maximum velocity, and 
time for maximum 
constriction compared with 
controls 
AD patients 
may experience 
constipation and 
urinary 
incontinence 
Davidson et 
al. 1991 
Described/characterized 
an aspect of ANS 
dysfunction through the 
examination of a single 
group of patients with 
AD 
Subjects with AD and 
incontinence scored 
significantly lower on a 
cube copying task than 
those demonstrating 
continence 
Qualitative analysis 
revealed that the drawings 
by incontinent patients 
showed features 
comparable with those 
observed in the drawings by 
patients with right-sided 
parietal lesions, in 
particular, poor 
representation of 
perspective and spatial 
orientation 
NA 
Del-Ser et 
al. 1996 
Described/characterized 
ANS dysfunction in AD 
Investigators followed 73 
patients with dementia (29 
NA 
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through comparison of 
two or more groups of 
individuals 
autopsy confirmed cases of 
AD) for 5.6 + 2.5 years and 
recorded the date of onset 
of urinary incontinence 
Loss of continence was 
associated with severe 
cognitive decline in pure 
AD but tended to precede 
severe cognitive decline in 
Lewy Body dementia 
Ransmayr 
et al. 2008 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Investigators evaluated 
frequency, urgency, 
incontinence, and nocturia, 
without major bladder 
outflow obstruction in 31 
patients with dementia (16 
with AD)  
Urge episodes and urge 
incontinence were observed 
in 12% of the AD patients 
and detrusor over activity 
occurred in 40% of the AD 
patients  
NA 
Zakrzewska
-Pniewska 
et al. 2012 
See Above See Above See 
Above 
Heightened 
arousal during 
Eisdorfer 
and Cohen 
Described/characterized 
an aspect of ANS 
A pilot investigation with 
13 AD patients compared 
NA 
184 
 
learning may 
occur in AD 
in 1978 dysfunction through the 
examination of a single 
group of patients with 
AD 
data against pre-existing 
literature on normative 
values for a number of 
autonomic function 
measures 
AD patients demonstrated 
heightened ANS activity 
during learning situations 
that would induce minimal 
arousal in normal elderly 
males 
Salivary flow is 
reduced in AD 
Ship et al. 
1990 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Saliva production from the 
major salivary glands was 
evaluated in 28 
unmedicated patients with 
early AD and 35 age-
matched controls  
Submandibular salivary 
flow rates (resting and 
stimulated) were 
significantly lower among 
the AD patients compared 
with controls 
NA 
The 
neuropathology 
of AD may 
affect central 
ANS control 
Chu et al. 
1997 
Neuroanatomical 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
Investigators examined the 
brains of 20 AD compared 
with 7 age-compatible 
healthy controls 
In all cortical regions, the 
NA 
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mediated by the 
ventromedial 
frontal cortex 
individuals laminar pattern of 
neurofibrillary tangle 
involvement showed a 
predilection for layers III 
and V 
Layer V was most severely 
affected with neurofibrillary 
tangles, followed by layer 
III and then layer VI  
Layers II and VI contained 
few neurofibrillary tangles 
There were significant 
differences between 
mesocortex and granular 
cortex in all 3 layers 
The posteromedial 
autonomic-related cortical 
regions were most severely 
affected 
The patterns of regional 
distribution were consistent 
in all AD subjects with 
duration of dementia 
ranging from 3-15 years 
In neuropathologically less 
severe cases, pathological 
changes involved 
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predominantly autonomic-
related cortex regions and 
spared granular areas 
entirely.  
The 
neuropathology 
of AD may 
affect central 
ANS central 
control 
mediated by the 
pontine regions 
of the brainstem 
Rub et al. 
2000 
Neuroanatomical 
Described/characterized 
an aspect of ANS 
dysfunction through the 
examination of a single 
group of patients with 
AD 
Investigators examined 
three nuclei of the pontine 
parabrachial region in 27 
autopsy confirmed cases of 
AD 
Cytoskeletal anomalies 
emerged early in the nuclei 
of the pontine parabrachial 
region and in the 
intermediate zone of the 
medullary reticular 
formation 
The development of the 
neurofibrillary pathology 
was found in the medial 
parabrachial nucleus, 
subpeduncular pigmented 
nucleus, and intermediate 
zone of the medullary 
reticular formation 
commences already in 
cortical stage I and in the 
lateral parabrachial nucleus 
in cortical stage II 
NA 
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At all four sites, the 
progression of the lesions 
correlated linearly with the 
neurofibrillary tangles 
cortical staging sequence I-
VI 
Investigators concluded that 
neurofibrillary tangles 
stages I-VI most probably 
reflect not only the progress 
of the AD related 
cytoskeletal pathology in 
cortical areas but also its 
evolution in specific 
subcortical sites. It is 
conceivable that a 
progressive deterioration of 
cardiovascular and 
respiratory functions occurs 
with advancing cortical 
neurofibrillary tangles 
stages 
The 
neuropathology 
of AD may 
affect the insula 
Bonthius et 
al. 2005 
Neuroanatomical  
Described/characterized 
an aspect of ANS 
dysfunction through 
comparison of two or 
more groups of 
Insular pathology was 
examined in 17 autopsy 
confirmed cases of AD 
compared with 5 controls 
Investigators observed 
evidence of AD pathology 
NA 
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individuals in the insular cortex in all 
17 cases of AD  
The control cases had no 
neuritic plaques and only 
very rare and isolated 
neurofibrillary tangles 
Density of insular 
neurofibrillary tangles, but 
not neuritic plaques 
correlated with years of 
clinical dementia 
AD related pathology in the 
insula increased as 
pathology in the entorhinal 
cortex increased 
The human insula contains 
3 distinct architectonic 
areas and severity of AD 
pathology varies among the 
insula’s cytoarchitectonic 
regions  
The 
neuropathology 
of AD may 
affect the C-1 
neurons of the 
rostral 
ventrolateral 
Burke et al. 
in 1994 
See Above See Above See 
Above 
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reticular 
nucleus 
No significant 
differences 
between 
individuals with 
AD and 
controls 
Khurana 
and Garcia 
1981 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Investigators measured 
ANS function in 2 patients 
with subacute spongigorm 
encephalopathy compared 
with 2 patients with AD and 
2 patients with 
Huntington’s disease 
Individuals with subacute 
spongiform encephalopathy 
exhibited autonomic 
dysfunctions but the AD 
patients did not 
Measures included 
evaluation of lacrimation, 
pupillary responses to 
topically applied autonomic 
drugs, pulse rate in 
response to cold face test 
and atropine administration, 
and blood pressure in 
response to the cold pressor 
test 
NA 
Shankle et 
al. 1993 
Neuroanatomical  
Described/characterized 
ANS dysfunction in AD 
through comparison of 
Investigators measured 
enteric neurons in the 
myenteric plexus of the 
esophagus, stomach, small 
NA 
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two or more groups of 
individuals 
intestine, colon, and rectum 
in 18 AD subjects, 8 with 
other types of dementia, 
and 4 non-demented elderly 
control subjects 
There was age-related loss 
of enteric neurons and of 
plexus mass in the 
Auerbach plexus 
The size of the Auerbach 
plexus did not differ from 
control values for elderly 
patients with AD, 
suggesting that the neurons 
of the enteric nervous 
system are not affected by 
the degenerative processes 
of AD 
Wakabayas
hi et al. 
1999 
Neuroanatomical  
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Investigators examined 
neurofibrillary tangle 
formation in the peripheral 
nervous system and central 
nervous systems in 20 AD 
subjects, 8 with progressive 
supranuclear palsy, and 100 
elderly, non-demented 
individuals 
Neurofibrillary tangles were 
NA 
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not identified in the 
sympathetic or spinal 
ganglia in patients with AD 
Taki et al. 
2001 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Investigators examined 
whether meta-
iodobenzylguanidine 
mysocardial scintigraphic 
study could be used to 
explore the contribution of 
myocardial accumulation of 
meta-iodobenzylguanidine 
to the differential diagnosis 
between AD and Lewy 
body dementia 
AD patients demonstrated 
successful cardiac uptake of 
meta-iodobenzylguanidine 
in both early and delayed 
images, as compared to 
patients with Lewy body 
dementia who demonstrated 
reduced cardiac 
accumulation 
NA 
Allen et al. 
2004 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Investigators evaluated 
ANS function in 14 AD 
subjects, 80 controls, and 
20 subjects with vascular 
dementia, using power 
spectral analysis of heart 
NA 
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rate variability 
There were no differences 
in heart rate variability in 
patients with AD as 
compared with controls 
Orimo et al. 
2005 
Neuroanatomical 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Investigators evaluated 
whether cardiac 
sympathetic denervation 
might account for the 
decreased uptake of meta-
iodobenzylguanidine on 
meta-iodobenzylguanidine 
myocardial scintigraphy in 
Parkinson’s disease and 
Lewy body disease 
Examined frequency and 
pattern of cardiac 
sympathetic nerve 
involvement in 10 subjects 
with pure AD 
AD patients did not show 
depletion of the cardiac 
sympathetic nerves 
NA 
Choi et al. 
in 2009 
Described/ 
characterized ANS 
dysfunction in AD 
through comparison of 
Investigators reported no 
differences between AD 
patients (N=23) and 
controls (N=24) on a 
variety of measures of 
NA 
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two or more groups of 
individuals 
cardiovascular autonomic 
function including heart 
rate responses to standing 
and deep breathing, and 
Valsava ratio 
Watanabe et 
al. 2001 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
Heart/mediastinum ratio of 
meta-iodobenzylguanidine 
uptake in 10 patients with 
AD was indistinguishable 
from that in 10 control 
subjects 
NA 
Raskind et 
al. 1999 
Described/characterized 
ANS dysfunction in AD 
through comparison of 
two or more groups of 
individuals 
The effects of normal aging 
and AD on cerebrospinal 
fluid and plasma catechols 
were assessed using high-
performance liquid 
chromatography  
No plasma norepinephrine 
differences were found 
between groups 
Cerebrospinal 3,4-
dihydroxyphenylalanine 
following an alpha-2 
adrenoreceptor agonist, was 
higher in older and AD than 
in young subjects 
Cerebrospinal 3,4-
dihydroxyphenylglycol did 
NA 
194 
 
not differ among groups 
Plasma 3,4-
dihydroxyphenylalanine 
following an alpha-2 
adrenoreceptor agonist, was 
higher in AD than in young 
subjects 
 
Appendix E: Meta-Analysis Search Terms 
((((((((((((Saliva)) OR (Salivation)) OR (Salivary proteins and peptides)) OR (salivary 
duct)) OR (salivary gland)) OR (Parotid gland)) OR (submandibular gland)) OR 
(sublingual gland))) AND (healthy OR normal OR "disease free")) AND (aged OR 
aging)) AND (flow OR production OR secretion OR secret* OR produc* OR secretory 
rate) 
Appendix F: Summary of Studies Included in Meta-Analysis Arranged 
Chronologically 
Study Salivary 
Source & 
Condition 
Participants* 
*(Groups 
included in 
analysis are in 
bold) 
Method of 
Salivary 
Collection 
Medication 
Use 
Results* 
= No 
difference 
- Increased 
saliva with 
increasing 
age 
+ 
Decreasing 
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saliva with 
increasing 
age 
Gutman & 
Ben-Aryeh, 
1974 
Unstim 
Whole 
N=22, 12 
Females 10 
Males  
Children:  n=7 
Younger adults 
(15-21 years): 
n=6 
Older adults 
(60-76 years): 
n=9  
Examined the 
salivary flow 
rates of males 
and females 
separately 
Unstim whole: 
spitting 
method 
Medication use 
not reported 
Participants 
described as 
“healthy” or 
“generally 
healthy” 
+  
Baum, 1981  Stim Parotid N=208, 85 
Females 123 
Males 
Younger 
Group (20-39 
years): n=29 
Middle-Aged 
Group (40-59 
Modified 
Carlsson-
Crittenden cup 
with 2% citric 
acid as 
stimulus 
 
95 men were 
non-medicated 
and 48 women 
were non-
medicated. 
Reported using 
data from 
cohorts of 
community-
= 
196 
 
years): n=35 
Older Group, 
Non-medicated 
(60-88 years): 
n=31 
Older Group, 
Medicated (60-
88 years): 
n=19 
Examined the 
salivary flow 
rates of males 
and females 
separately 
dwelling 
volunteers  
Parvinen & 
Larmas, 1982  
Stim Whole N=642, 316 
Females 326 
Males  
30-34 years: 
n=145 
35-39 years: 
n=116 
40-44 years: 
n=93 
45-49 years: 
n=77 
50-54 years: 
Paraffin 
mastication 
All subjects 
were 
reportedly 
unmedicated. 
Reported 
excluding 
participants 
with health 
problems that 
could affect 
salivary flow 
= 
197 
 
n=60 
55-59 years: 
n=40 
60-64 years: 
n=46 
65-69 years: 
n=41 
≥ 70 years: 
n=24 
Examined the 
salivary flow 
rates of males 
and females 
separately 
Sonnenberg et 
al., 1982 
Unstim 
Whole & 
Stim Parotid 
N=132 (total) 
n=40* 14 
Females 26 
Males 
*Used the 
control group 
for data 
extraction  
Younger 
Group (mean 
age 28 + 3 
years): n=20 
Unstim whole: 
draining 
method 
Stim parotid: 
double 
chamber 
suction capsule 
(similar to 
Lashley 
capsule) with 
sublingual 
perfusion of 2 
% citric acid  
Medication use 
was not 
reported  
= 
198 
 
Older Group 
(mean age 55 
+ 7 years): 
n=20 
Ogura et al., 
1983 
Unstim 
Whole 
N=14 All 
males 
Younger 
Group (mean 
age 22.7 
years): n=7 
Older Group 
(mean age 70.6 
years): n=7 
Examined the 
salivary flow 
rates of males 
and females 
separately 
Peck’s method No medication 
use 2 weeks 
prior to study. 
Reported 
excluding 
participants 
with health 
problems that 
could affect 
salivary flow 
= 
Baum et al., 
1984 
Stim Parotid N=202, 79 
Females 23 
Males 
Younger 
Group (20-39 
years): n=38M, 
28F 
Middle-aged 
Modified 
Carlson-
Crittenden cup 
with 2% citric 
acid as 
stimulus 
No participants 
were taking 
prescription 
medications. 
Participants 
described as 
“healthy” or 
“generally 
healthy” 
= 
199 
 
Group (40-59 
years): n=44M, 
24F 
Older Group 
(60-88 years): 
n=41M, 27F 
Examined the 
salivary flow 
rates of males 
and females 
separately 
Ben-Aryeh et 
al., 1984  
Unstim & 
Stim Whole 
N=61, 30 
Females 31 
Males 
Younger 
Group (mean 
age 26 ± 2 
years): n=31 
Older Group 
(mean age 69 ± 
5 F, 68 + 3 M): 
n=30 
Examined the 
salivary flow 
rates of males 
and females 
separately 
Unstim whole: 
spitting 
method 
Stim whole: 2 
% citric acid  
Participants 
were reported 
to be 
unmedicated. 
Participants 
described as 
“healthy” or 
“generally 
healthy” 
+ unstim 
whole 
= stim 
whole 
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Heft & Baum, 
1984 
Unstim & 
Stim Parotid 
N=58, 39 
Females 46 
Males   Age 
Range: 23-81 
years 
Younger 
Group (20-39 
years): n=13M, 
17F 
Middle-aged 
Group (40-59 
years): n=14M 
Older Group 
(≥ 60 years): 
n=19M, 22F 
Examined the 
salivary flow 
rates of males 
and females 
separately 
Unstim 
parotid: 
modified 
Carlson-
Crittenden cup 
over Stenson’s 
duct   
Stim parotid: 
2% citric acid 
to dorsal 
surface of 
tongue 
No participants 
were taking 
any 
medications on 
a regular basis. 
Participants 
described as 
“healthy” or 
“generally 
healthy” 
= 
Gandara et al., 
1985 
Unstim 
Whole & 
Stim Whole 
& Parotid  
N=50 (total), 
n=25* 
*Used the 
control group 
for data 
extraction  
Unstim whole: 
spitting 
method 
Stim whole: 
paraffin 
mastication 
No participants 
were taking 
any 
medications on 
a regular basis. 
Reported 
excluding 
= 
201 
 
Younger 
Group (mean 
age 44 years): 
n=12 
Older Group 
(mean age 68 
years): n=13 
Stim parotid: 
via sour lemon 
drops 
stimulation 
participants 
with health 
problems that 
could affect 
salivary flow 
Pedersen et 
al., 1985  
Unstim & 
Stim SMSL 
N=54   Age 
Range: 18-91 
years 
Younger 
Group (mean 
age 25.7 
years): n=28 
Older Group 
(mean age 81.4 
years): n=26 
Examined the 
salivary flow 
rates of males 
and females 
separately 
Unstim SMSL: 
novel 
collection 
device 
(Drummond 
micropipette 
holder, 2 ml 
amber latex 
rubber bulb for 
suction, 50 
microliter 
Van-Lab 
micropipette 
collection 
chamber) over 
Wharton's duct 
Stim SMSL: 3 
minutes of a 
lemon drop 
stimulus and 
then collection 
No participants 
were taking 
medications 
known to 
affect 
salivation. 
Participants 
described as 
“healthy” or 
“generally 
healthy” 
+ 
202 
 
Yaegaki et al., 
1985 
Unstim 
Whole 
N=32, 15 
Females 17 
Males   Age 
Range: 20-83 
years 
Younger 
Group (20-35 
years): n=17 
Older Group 
(50+ years): 
n=15 
Spitting 
method 
Medication use 
was not 
reported  
Participants 
described as 
“healthy” or 
“generally 
healthy” 
+ 
Ben-Aryeh et 
al., 1986  
Unstim & 
Stim 
Whole & 
Parotid 
N=63, 31 
Females 32 
Males  
Younger 
Group (mean 
age 37 ± 10.5 
years): n=39 
Older Group 
(mean age 66 ± 
3.3 years): 
n=24 
Unstim whole: 
spitting 
method  
Unstim 
parotid: Curby 
cup 
Stim whole 
and parotid: 
2% citric acid  
Participants 
were reported 
to be 
unmedicated. 
Participants 
described as 
“healthy” or 
“generally 
healthy” 
= 
Chauncey et 
al., 1987 
 
Unstim & 
Stim Parotid 
N=203, All 
male   Age 
Range: 39-64 
years 
Unstim 
parotid: 
vacuum-
maintained 
metal 
Medication use 
not reported. 
Participants 
described as 
= 
203 
 
<45 years: 
n=48         
45-49 years: 
n=40       
50-54 years: 
n=31 
55-59 years: 
n=53 
60+ years: 
n=41 
collection 
device 
positioned 
over Stensen's 
duct 
Stim parotid: 
sour lemon-
flavored 
lozenge  
“healthy” or 
“generally 
healthy” 
Tylenda et al., 
1988 
Unstim & 
Stim SMSL 
N=90   Age 
Range: 29-93 
years 
Younger 
Group: n=22 
Middle aged 
Group: n=32 
Older Group: 
n=35 
Examined the 
salivary flow 
rates of males 
and females 
separately 
Unstim SMSL: 
Wharton’s 
duct was 
isolated with 
cotton gauze 
and saliva 
collected from 
the duct orifice 
by use of a 
micropipette 
under light 
suction 
Participants 
were not 
taking any 
prescription 
medications. 
Reported using 
data from 
cohorts of 
community-
dwelling 
volunteers  
+ 
204 
 
 
Ship & Baum, 
1990 
Stim Parotid N=50, 23 
Females 27 
Males 
Longitudinal 
Study (over 7-
12 years, mean 
9.7 years, 1.2 
(SD)) 
Age Range: 
29-72 years 
2% citric acid 
from a single 
gland 
Some 
medication use 
but 24 were 
not taking 
medication. 
Participants 
described as 
“healthy” or 
“generally 
healthy” 
= 
Navazesh et 
al., 1992 
Unstim & 
Stim Whole  
N=42, 18 
Females 24 
Males 
Younger 
Group (mean 
age 25.4 
years): n=21 
Older Group 
(mean age 71.7 
years): n=21 
 
Unstim whole: 
draining 
method 
Stim whole: 
gum base 
mastication 
No participants 
were taking 
medication 
with xerogenic 
effects.  
Participants 
described as 
“healthy” or 
“generally 
healthy” 
+ unstim 
whole 
- stim 
whole 
Shern et al., 
1993 
Unstim & 
Stim Minor 
N=51 26 
Females 25 
Males   Age 
Minor: strips 
cut from 
chromatograph
No participants 
were taking 
medications 
= labial 
and buccal  
+ palatal  
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Range: 21-93 
years 
Younger 
Group (< 41 
years): n=17 
Older Group 
(>60 years): 
n=18 
Examined the 
salivary flow 
rates of males 
and females 
separately 
y paper at 
labial, buccal, 
and palatal 
sites 
Stim whole: 
Parafilm 
mastication 
that would 
influence with 
oral secretion. 
Participants 
described as 
“healthy” or 
“generally 
healthy” 
- stim 
whole 
= unstim 
whole 
Cowman et 
al., 1994  
 
Unstim & 
Stim 
Parotid & 
SMSL 
N=85 (total), 
n= 60* 32 
Females 28 
Males    
Age Range: 
20-81 years 
*Used the 
control group 
for data 
extraction 
Younger 
Group (20-39 
years): n=23 
Parotid: 
modified 
Carlsson-
Crittenden cup 
SMSL: cotton 
rolls isolate 
Wharton's duct 
& saliva 
collected by 
micropipette 
with light 
suction 
Stim parotid & 
SMSL: sterile 
Participants 
were not using 
any medication 
with possible 
salivary gland 
effects (control 
group only) 
+ unstim 
and stim 
SMSL and 
unstim 
parotid 
= stim 
parotid 
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Middle-aged 
Group (40-59 
years): n=15 
Older Group 
(>60 years): 
n=22 
2% citric acid 
solution to 
dorsal face of 
tongue at 30-
sec intervals 
Meurman & 
Rantonen, 
1994  
 
Unstim & 
Stim Whole 
N=187   Age 
Range: 20-60+ 
years 
Younger 
Group (20-40 
years): n=36 
Middle aged 
Group (41-60 
years): n=88 
Older Group 
(>60 years): 
n=63 
Examined the 
salivary flow 
rates of males 
and females 
separately 
Unstim whole: 
draining 
Stim whole: 
paraffin wax 
mastication 
Typical 
population 
with regular 
medication 
use. 
Reported 
recruiting 
participants 
from dental 
clinic registries 
where older 
individuals 
appeared to be 
free of major 
systemic 
disease, but 
may have had 
some common 
age-related 
conditions.  
+ unstim 
whole 
= stim 
whole 
Percival et al., 
1994 
Unstim 
Whole & 
N=116, 61 
Females 55 
Unstim whole: 
spitting 
Participants 
were 
+ unstim 
whole 
207 
 
Stim Parotid Males 
mean age 
26.7+ 1.06 
years: n=29 
mean age 50.4 
+ 1.08 years: 
n=30 
mean age 71.7 
+ 1.07 years: 
n=28 
mean age 
84.03 + 0.61 
years: n=29 
method 
Stim parotid: 
Lashley cup 
with 2% citric 
acid 
stimulation 
reportedly 
unmedicated. 
Participants 
described as 
“healthy” or 
“generally 
healthy” 
= stim 
parotid 
Billings et al., 
1996  
 
Unstim & 
Stim 
Whole 
N=710, 484 
Females 226 
Males   Age 
Range: 19-88 
years 
<30 years: 
n=55M, 99F  
30-49 years: 
n=59M, 166F      
50-69 years: 
n=61M, 110F 
70+ years: 
n=51M, 109F 
Unstim whole: 
Suction 
method of 
Bertram 
Stim whole: 
2% citric acid  
Older subjects 
were observed 
to take 
medications 
 
= 
208 
 
Examined the 
salivary flow 
rates of males 
and females 
separately 
Eliasson et al., 
1996 
Unstim 
Minor 
(Palatal, 
Buccal, and 
Labial) 
N=127, 61 
Females 66 
Males   Age 
Range: 22-89 
years 
Younger 
Group (<40 
years): n=14M, 
12F 
Middle-aged 
Group (40-65 
years): n=32M, 
25F 
Older Group 
(>65 years): 
n=11M, 13F 
Examined the 
salivary flow 
rates of males 
and females 
separately 
Periotron 6000 
model 2 with 
standard filter 
paper 
Some 
medication 
use. 
Reported using 
data from 
cohorts of 
community-
dwelling 
volunteers  
= 
Fischer & Unstim & N=28, 14 Unstim No participants = 
209 
 
Ship, 1997; 
Fischer & 
Ship, 1999; 
Ship & 
Fischer, 1997 
Stim Parotid Females 14 
Males 
Younger 
Group (20-35 
years): n=14 
Older Group 
(64-74 years): 
n=14 
parotid: 
modified 
Carlson-
Crittenden cup 
over Stenson's 
duct-parotid 
Stim parotid: 
2% citric acid 
to dorsal 
lateral surface 
of tongue  
were being 
treated for any 
systemic 
disease or 
taking any 
prescription or 
non-
prescription 
medication. 
Participants 
described as 
“healthy” or 
“generally 
healthy” 
Yeh et al., 
1998 
Unstim 
Whole & 
Unstim & 
Stim Parotid 
& SMSL 
N=1006 (total) 
n=247* 562 
Females 444 
Males 
*Used the 
nonmedicated  
group for 
Unstim Whole 
and Unstim & 
Stim SMSL 
*35-44 years: 
n=116 
45-54 years: 
n=198 
Unstim whole: 
spitting 
method  
Stim parotid & 
SMSL: citrate 
Unstim 
parotid: 
modified 
Carlson-
Crittenden cup 
Unstim SMSL: 
micropipette 
connected to 
mini-vacuum 
Participants 
were taking 
some 
medications in 
the whole 
population. 
Participants 
reported taking 
no prescribed 
or over the 
counter 
medications in 
the 
unmedicated 
subgroup. 
+ unstim 
whole 
= unstim 
parotid 
+ stim 
parotid 
+ unstim & 
stim SMSL 
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55-64 years: 
n=222 
70-74 years: 
n=97 
*>75 years: 
n=75 
nonmedicated 
35-44 years: 
n=55 
45-54 years: 
n=58 
55-64 years: 
n=50 
65-69 years: 
n=41 
70-74 years: 
n=30 
>75 years: 
n=13 
Examined the 
salivary flow 
rates of males 
and females 
separately 
pump held 
over Wharton's 
duct  
Reported using 
data from 
cohorts of 
community-
dwelling 
volunteers 
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Ghezzi et al., 
2000;Ghezzi 
& Ship, 2003 
 
 
 
Stim Parotid 
& SMSL 
 
N=36, 18 
Females 18 
Males 
Younger 
Group (mean 
age 24.3 
years): n=18 
Older Group 
(mean age 69.9 
years): n=18 
Stim parotid: 
Modified 
Carlson-
Crittenden cup 
over orifice of 
one gland with 
2% citric acid 
applied to the 
dorsal surface 
of the tongue 
Stim SMSL: 
collected by 
light suction 
with 2% citric 
acid applied to 
the dorsal 
surface of the 
tongue 
No 
prescription 
medications 
(other than 
HRT and birth 
control, and no 
non 
prescription 
antihistamines 
within 7 days). 
Participants 
described as 
“healthy” or 
“generally 
healthy” 
 
 
 
= 
Johnson et al., 
2000 
Stim Parotid 
& SMSL 
N=80, 38 
Females 42 
Males   Age 
Range: 35-76 
years 
35-44 years: 
n=19 
45-54 years: 
Stim parotid: 
mastication 
and gustatory 
stimulation - 
0.1M citric 
acid was 
applied to the 
lateral surfaces 
of the tongue 
No participants 
were taking 
medications. 
Reported using 
data from 
cohorts of 
community-
dwelling 
volunteers 
+ stim 
SMSL 
= stim 
parotid 
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n=20 
55-64 years: 
n=19 
65-75 years: 
n=22 
Stim SMSL: 
0.1M citric 
acid was 
applied to the 
lateral surfaces 
of the tongue 
Salvolini et 
al., 2000 
Unstim 
Whole 
N=169, 95 
Females 59 
Males   Age 
Range: 10-77 
years 
10-24 years: 
n=38 
25-39 years: 
n=52 
40-54 years: 
n=40 
55-69 years: 
n=27 
>70 years: 
n=12 
Spitting 
method 
No participants 
were taking 
any medication  
that would 
interfere with 
salivary 
secretion. 
Participants 
described as 
“healthy” or 
“generally 
healthy”  
=  
Yeh et al., 
2000 
Unstim 
Whole, Stim 
Parotid, & 
Unstim & 
Stim SMSL 
N=399, 215 
Females 184 
Males 
Age Range: 
Unstim whole: 
spitting 
method 
Unstim 
Normal 
population 
with 
medication 
use. 
+ unstim 
whole 
= stim 
parotid 
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34-64 years 
Mean Age: 
62.8 + 0.6 
years 
Examined the 
salivary flow 
rates of males 
and females 
separately 
parotid: 
modified 
Carlson-
Crittenden cup 
Unstim SMSL: 
micropipette 
over orifices of 
Wharton’s 
duct and 
connected to 
mini-vacuum 
pump 
Stim parotid & 
SMSL: 2% 
citric acid 
swabbed over 
the lateral 
surfaces of the 
tongue 
Reported using 
data from 
cohorts of 
community-
dwelling 
volunteers 
+ unstim & 
stim SMSL 
Tanida et al., 
2001 
Unstim & 
Stim Whole 
N=105 
Healthy 
controls   Age 
Range: 26-89 
years 
3rd decade: n=3 
4th decade: n=5 
5th decade: n=5  
Unstim whole: 
Cotton rolls for 
saliva 
absorption 
Stim whole: 
ascorbic acid 
 
Medication use 
was not 
reported  
+ 
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6th decade: 
n=11 
7th decade: 
n=10 
8th decade: n=5 
9th decade: n=6 
Streckfus et 
al., 2002 
Stim Whole N=50 Females 
only 
Age Range: 
20-90 years 
 
Mastication of 
a gum base  
Participants 
were not 
taking any 
prescription 
medications. 
Participants 
described as 
“healthy” or 
“generally 
healthy” 
+ 
Bakke et al., 
2004 
 
Unstim 
Whole 
N=26 Females 
Younger 
Group (mean 
age 24 ± 3 
years): n=13 
Older Group 
(mean age 62 ± 
4 years): n=13 
Examined the 
Draining 
Method 
5 of the 
subjects took 
prescribed 
medications  
(birth control, 
hormones, 
NSAIDs). 
Participants 
described as 
= 
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salivary flow 
rates of males 
and females 
separately 
“healthy” or 
“generally 
healthy” 
Bourdiol et 
al., 2004 
 
Unstim & 
Stim 
Whole & 
Parotid 
N=45, 22 
Females 23 
Males 
Younger 
Group (mean 
age 27.4 ± 2.3 
years): n=25 
Older Group 
(mean age 71.2 
± 2.1 years): 
n=20 
Unstim whole 
& parotid: 
Cotton rolls for 
saliva 
absorption 
Stim parotid: 
Cotton rolls 
and parafilm 
chewing  
Stim whole: 
meat 
mastication 
Medication use 
not reported. 
Participants 
described as 
“healthy” or 
“generally 
healthy”. 
= 
Fenoll-
Palomares et 
al., 2004 
Unstim 
Whole 
N=159, 107 
Females 52 
Males 
Age Range: 
18-75 years 
Mean Age: 
44.16 + 14.23 
years 
Spitting 
method  
Medication use 
not reported. 
Reported 
excluding 
participants 
with health 
problems that 
could affect 
salivary flow 
+ 
Nagler & 
Hershkovich, 
Unstim 
Whole 
N=43, 22 
Females 21 
Unstim whole: 
spitting 
Standard age-
related 
+ 
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2005a, 2005b Males 
Younger 
Group (mean 
age 21.2 ± 1.8 
years): n=15 
Older Group 
(mean age 75.8 
± 8.2 years): 
n=28 
method medication 
use, but no 
participant was 
using 
antidepressants 
or 
anticholinergic
s. 
Reported 
excluding 
participants 
with health 
problems that 
could affect 
salivary flow 
Moritsuka et 
al., 2006 
Stim Whole N=117, 84 
Females 33 
Males  
Younger 
Group (20-29 
years): n=40 
Middle aged 
Group (30-59 
years): n=37 
Older Group 
(60-88 years): 
n=40 
Paraffin wax 
mastication 
Some 
medication use 
for 18 subjects 
in the elderly 
group. 
Reported using 
data from 
cohorts of 
community-
dwelling 
volunteers and 
recruiting 
participants 
from dental 
+ 
217 
 
clinic registries 
where older 
individuals 
appeared to be 
free of major 
systemic 
disease, but 
may have had 
some common 
age-related 
conditions.  
Takada et al., 
2006 
Stim Whole N=185 (total) 
n= 65* All 
female 
*Used the 
control group 
for data 
extraction  
Mean Age: 
50.3 + 12 years 
Saxon Test Medication use 
was not 
reported  
= 
Henkin et al., 
2007 
Stim Parotid N=61, 21 
Females 40 
Males   Age 
Range: 18-75 
years 
<20 years: n=5 
21-30 years: 
Modified 
Lashley cup 
with lemon 
juice 
stimulation on 
the tongue 
Participants 
were not 
taking any 
medication. 
Participants 
described as 
“healthy” or 
“generally 
= 
218 
 
n=15 
31-40 years: 
n=23 
41-50 years: 
n=46 
51-60 years: 
n=46 
61-70 years: 
n=37 
>70 years: 
n=30 
healthy” 
Hershkovich 
et al., 2007 
Unstim 
Whole  
N=44   Age 
Range: 20-80 
years 
Younger 
Group (20-25 
years): n=22 
Older Group 
(70-80 years): 
n=22 
Spitting 
method 
No participants 
were taking 
saliva affecting 
drugs (e.g. 
anti-
cholinergics or 
antidepressants
) 
Participants 
described as 
“healthy” or 
“generally 
healthy” 
+  
Flink et al., 
2008 
Unstim & 
Stim Whole 
N=1427, 758 
Females 669 
Unstim whole: 
draining 
No exclusions 
based on 
+ unstim 
whole 
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Males   
22-29 years: 
n=90M, 110F      
30-39 years: 
n=120M, 157F      
40-49 years: 
n=139M, 161F 
50-59 years: 
n=155M, 158F 
60-69 years: 
n=165M, 172F 
Examined the 
salivary flow 
rates of males 
and females 
separately 
method 
Stim whole: 
paraffin 
mastication  
medication 
use. 
Reported using 
data from 
cohorts of 
community-
dwelling 
volunteers and 
recruiting 
participants 
from dental 
clinic registries 
where older 
individuals 
appeared to be 
free of major 
systemic 
disease, but 
may have had 
some common 
age-related 
conditions.  
= stim 
whole 
Malhotra et 
al., 2009 
Unstim 
Whole 
N=48   Age 
Range: 18-77 
years 
Younger 
Group (18-40 
years): n=16M 
Cotton rolls for 
saliva 
absorption 
Medication use 
not reported. 
Participants 
described as 
“healthy” or 
“generally 
healthy” 
= 
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Older Group 
(>65 years): 
n=16M, 16F 
Examined the 
salivary flow 
rates of males 
and females 
separately 
Sawair et al., 
2009 
Unstim 
Whole 
N=244, 134 
Females 110 
Males   Age 
Range: 15-76 
years 
15-19 years: 
n=32 
20-29 years: 
n=106 
30-39 years: 
n=32 
40-49 years: 
n=28 
50-59 years: 
n=29 
≥ 60 years: 
n=17 
Spitting 
method 
No participants 
were taking 
any medication 
that would 
interfere with 
salivary flow.  
Participants 
described as 
“healthy” or 
“generally 
healthy”. 
+ 
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Toida et al., 
2010 
Stim Whole N=1188, 815 
Females 373 
Males 
Age Range: 
20-90 years  
Mean Age: 
51.4 + 20.0 
years 
Examined the 
salivary flow 
rates of males 
and females 
separately 
Modified 
Saxon Test 
Medication use 
was not 
reported. 
Reported using 
data from 
cohorts of 
community-
dwelling 
volunteers 
+ 
Chang et al., 
2011 
 
Unstim & 
Stim Whole 
 
N=60, 30 
Females 30 
Males 
Younger 
Group (mean 
age 26.4 ± 2.4 
years): n=30 
Older Group 
(mean age 71.1 
± 4.6 years): 
n=30 
Examined the 
salivary flow 
Unstim whole: 
spitting 
method  
Stim whole: 
gum base 
mastication 
 
No participants 
were taking 
psychiatric/neu
rologic 
medication or 
antihistamines. 
Reported 
excluding 
participants 
with health 
problems that 
could affect 
salivary flow 
 
+ unstim 
whole M/F 
+ stim 
whole M 
= stim 
whole F 
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rates of males 
and females 
separately 
Marotta et al., 
2012 
Unstim 
Whole 
N=90   Age 
Range: 20-65+ 
years 
Younger 
Group (20-40 
years): n=30 
Middle aged 
Group (41-65 
years): n=30 
Older Group 
(>65 years): 
n=30 
Spitting 
method 
No participants 
were taking 
inhaled, 
topical, or 
systemic 
corticosteroids 
or other 
immune 
modulating 
meds. 
Reported that 
participants 
with common 
illnesses such 
as 
hypertension 
and 
compensated 
diabetes were 
NOT excluded 
+ 
Wang et al., 
2012 
Unstim 
Whole  
N=191, 95 
Females 96 
Males 
18-30 years 
(mean age 26 ± 
Draining 
method  
No participants 
were using 
medications 
that affects 
salivary 
production. 
+ 
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3 years): n=48 
31-40 years: 
n=48 
41-50 years: 
n=48 
51-75 years 
(mean age 56 ± 
4 years): n=47   
Reported 
excluding 
participants 
with health 
problems that 
could affect 
salivary flow 
Yoshikawa et 
al., 2012 
Unstim & 
Stim Whole 
N=70*, 19 
Females 21 
Males   Age 
Range 42-79 
years 
* Used healthy 
control group 
n=30 
Younger 
(mean age 28.9 
years): n=15 
Older (mean 
age 68.2 
years): n=15 
Saxon test  Medication use 
was not 
reported 
= 
Smith et al., 
2013 
Stim Whole N=540, 270 
Females 270 
Males 
Gauze 
mastication 
No participants 
were taking 
medications 
known to 
+ 
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Younger 
Group (mean 
age 24.0 + 3.1 
years): n=180 
Middle Aged 
Group (40-50 
years): n=180 
Older Group 
(mean age 75.2 
+ 5.5 years):n= 
180 
Examined the 
salivary flow 
rates of males 
and females 
separately 
affect 
salivation. 
Reported 
excluding 
participants 
with health 
problems that 
could affect 
salivary flow 
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